ERP	B-protein
,	O
a	O
new	O
member	O
of	O
the	O
ets	B-protein
transcription	I-protein
factor/oncoprotein	I-protein
family	I-protein
:	O
cloning	O
,	O
characterization	O
,	O
and	O
differential	O
expression	O
during	O
B-lymphocyte	O
development	O
.	O

The	O
ets	B-DNA
gene	I-DNA
family	I-DNA
encodes	O
a	O
group	O
of	O
proteins	O
which	O
function	O
as	O
transcription	B-protein
factors	I-protein
under	O
physiological	O
conditions	O
and	O
,	O
if	O
aberrantly	O
expressed	O
,	O
can	O
cause	O
cellular	O
transformation	O
.	O

We	O
have	O
recently	O
identified	O
two	O
regulatory	O
elements	O
in	O
the	O
murine	B-DNA
immunoglobulin	I-DNA
heavy-chain	I-DNA
(	I-DNA
IgH	I-DNA
)	I-DNA
enhancer	I-DNA
,	O
pi	B-DNA
and	O
microB	B-DNA
,	O
which	O
exhibit	O
striking	O
similarity	O
to	O
binding	B-DNA
sites	I-DNA
for	O
ets-related	B-DNA
proteins	I-DNA
.	O

To	O
identify	O
ets-related	B-protein
transcriptional	I-protein
regulators	I-protein
expressed	O
in	O
pre-B	B-cell_type
lymphocytes	I-cell_type
that	O
may	O
interact	O
with	O
either	O
the	O
pi	B-DNA
or	O
the	O
microB	B-DNA
site	I-DNA
,	O
we	O
have	O
used	O
a	O
PCR	O
approach	O
with	O
degenerate	O
oligonucleotides	O
encoding	O
conserved	O
sequences	O
in	O
all	O
members	O
of	O
the	O
ets	B-DNA
family	I-DNA
.	O

We	O
have	O
cloned	O
the	O
gene	O
for	O
a	O
new	O
ets-related	B-protein
transcription	I-protein
factor	I-protein
,	O
ERP	B-protein
(	O
ets-related	B-protein
protein	I-protein
)	O
,	O
from	O
the	O
murine	B-cell_line
pre-B	I-cell_line
cell	I-cell_line
line	I-cell_line
BASC	B-cell_line
6C2	I-cell_line
and	O
from	O
mouse	O
lung	O
tissue	O
.	O

The	O
ERP	B-protein
protein	O
contains	O
a	O
region	O
of	O
high	O
homology	O
with	O
the	O
ETS	O
DNA-binding	O
domain	O
common	O
to	O
all	O
members	O
of	O
the	O
ets	B-protein
transcription	I-protein
factor/oncoprotein	I-protein
family	I-protein
.	O

Three	O
additional	O
smaller	O
regions	O
show	O
homology	O
to	O
the	O
ELK-1	O
and	O
SAP-1	B-protein
genes	O
,	O
a	O
subgroup	O
of	O
the	O
ets	B-DNA
gene	I-DNA
family	I-DNA
that	O
interacts	O
with	O
the	O
serum	B-protein
response	I-protein
factor	I-protein
.	O

Full-length	O
ERP	B-protein
expresses	O
only	O
negligible	O
DNA-binding	O
activity	O
by	O
itself	O
.	O

Removal	O
of	O
the	O
carboxy	B-protein
terminus	I-protein
enables	O
ERP	B-protein
to	O
interact	O
with	O
a	O
variety	O
of	O
ets-binding	B-DNA
sites	I-DNA
including	O
the	O
E74	B-DNA
site	I-DNA
,	O
the	O
IgH	B-DNA
enhancer	I-DNA
pi	I-DNA
site	I-DNA
,	O
and	O
the	O
lck	B-DNA
promoter	I-DNA
ets	I-DNA
site	I-DNA
,	O
suggesting	O
a	O
carboxy-terminal	B-protein
negative	I-protein
regulatory	I-protein
domain	I-protein
.	O

At	O
least	O
three	O
ERP-related	B-protein
transcripts	I-protein
are	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
.	O

However	O
,	O
within	O
the	O
B-cell	B-cell_type
lineage	I-cell_type
,	O
ERP	B-protein
is	O
highly	O
expressed	O
primarily	O
at	O
early	O
stages	O
of	O
B-lymphocyte	B-cell_type
development	O
,	O
and	O
expression	O
declines	O
drastically	O
upon	O
B-cell	O
maturation	O
,	O
correlating	O
with	O
the	O
enhancer	O
activity	O
of	O
the	O
IgH	B-DNA
pi	I-DNA
site	I-DNA
.	O

These	O
data	O
suggest	O
that	O
ERP	B-protein
might	O
play	O
a	O
role	O
in	O
B-cell	B-cell_type
development	O
and	O
in	O
IgH	B-DNA
gene	I-DNA
regulation	O
.	O

MorEcurar	NULL
anp	NULL
CELLULAR	NULL
BioLocgy	NULL
,	NULL
May	NULL
1994	NULL
,	NULL
p.	NULL
3292-3309	NULL
0270-7306/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

14	NULL
,	NULL
No	NULL
.	NULL

5	NULL
ERP	NULL
,	NULL
a	NULL
New	NULL
Member	NULL
of	NULL
the	NULL
ets	NULL
Transcription	NULL
Factor/Oncoprotein	NULL
Family	NULL
:	NULL
Cloning	NULL
,	NULL
Characterization	NULL
,	NULL
and	NULL
Differential	NULL
Expression	NULL
during	NULL
B-Lymphocyte	NULL
Development	NULL
MONICA	NULL
LOPEZ	NULL
,	NULL
PETER	NULL
OETTGEN	NULL
,	NULL
YASMIN	NULL
AKBARALI	NULL
,	NULL
ULRICH	NULL
DENDORFER	NULL
,	NULL
AND	NULL
TOWIA	NULL
A.	NULL
LIBERMANN*	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02215	NULL
Received	NULL
23	NULL
July	NULL
1993/Returned	NULL
for	NULL
modification	NULL
18	NULL
January	NULL
1994/Accepted	NULL
17	NULL
February	NULL
1994	NULL
The	NULL
ets	NULL
gene	NULL
family	NULL
encodes	NULL
a	NULL
group	NULL
of	NULL
proteins	NULL
which	NULL
function	NULL
as	NULL
transcription	NULL
factors	NULL
under	NULL
physiological	NULL
conditions	NULL
and	NULL
,	NULL
if	NULL
aberrantly	NULL
expressed	NULL
,	NULL
can	NULL
cause	NULL
cellular	NULL
transformation	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
identified	NULL
two	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
heavy-chain	NULL
(	NULL
IgH	NULL
)	NULL
enhancer	NULL
,	NULL
#	NULL
and	NULL
pB	NULL
,	NULL
which	NULL
exhibit	NULL
striking	NULL
similarity	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
efs-related	NULL
proteins	NULL
.	NULL

To	NULL
identify	NULL
efs-related	NULL
transcriptional	NULL
regulators	NULL
expressed	NULL
in	NULL
pre-B	NULL
lymphocytes	NULL
that	NULL
may	NULL
interact	NULL
with	NULL
either	NULL
the	NULL
#	NULL
or	NULL
the	NULL
pB	NULL
site	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
PCR	NULL
approach	NULL
with	NULL
degenerate	NULL
oligonucleotides	NULL
encoding	NULL
conserved	NULL
sequences	NULL
in	NULL
all	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
.	NULL

We	NULL
have	NULL
cloned	NULL
the	NULL
gene	NULL
for	NULL
a	NULL
new	NULL
ets-related	NULL
transcription	NULL
factor	NULL
,	NULL
ERP	NULL
(	NULL
ets-related	NULL
protein	NULL
)	NULL
,	NULL
from	NULL
the	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
BASC	NULL
6C2	NULL
and	NULL
from	NULL
mouse	NULL
lung	NULL
tissue	NULL
.	NULL

The	NULL
ERP	NULL
protein	NULL
contains	NULL
a	NULL
region	NULL
of	NULL
high	NULL
homology	NULL
with	NULL
the	NULL
ETS	NULL
DNA-binding	NULL
domain	NULL
common	NULL
to	NULL
all	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
transcription	NULL
factor/oncoprotein	NULL
family	NULL
.	NULL

Three	NULL
additional	NULL
smaller	NULL
regions	NULL
show	NULL
homology	NULL
to	NULL
the	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
genes	NULL
,	NULL
a	NULL
subgroup	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
.	NULL

Full-length	NULL
ERP	NULL
expresses	NULL
only	NULL
negligible	NULL
DNA-binding	NULL
activity	NULL
by	NULL
itself	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
carboxy	NULL
terminus	NULL
enables	NULL
ERP	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
efs-binding	NULL
sites	NULL
including	NULL
the	NULL
E74	NULL
site	NULL
,	NULL
the	NULL
IgH	NULL
enhancer	NULL
m	NULL
site	NULL
,	NULL
and	NULL
the	NULL
ick	NULL
promoter	NULL
ets	NULL
site	NULL
,	NULL
suggesting	NULL
a	NULL
carboxy-terminal	NULL
negative	NULL
regulatory	NULL
domain	NULL
.	NULL

At	NULL
least	NULL
three	NULL
ERP-related	NULL
transcripts	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
.	NULL

However	NULL
,	NULL
within	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
ERP	NULL
is	NULL
highly	NULL
expressed	NULL
primarily	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
B-lymphocyte	NULL
development	NULL
,	NULL
and	NULL
expression	NULL
declines	NULL
drastically	NULL
upon	NULL
B-cell	NULL
maturation	NULL
,	NULL
correlating	NULL
with	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
IgH	NULL
#	NULL
site	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
ERP	NULL
might	NULL
play	NULL
a	NULL
role	NULL
in	NULL
B-cell	NULL
development	NULL
and	NULL
in	NULL
IgH	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
are	NULL
characterized	NULL
by	NULL
differential	NULL
expression	NULL
of	NULL
a	NULL
whole	NULL
set	NULL
of	NULL
genes	NULL
,	NULL
most	NULL
prominently	NULL
the	NULL
members	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
family	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
differential	NULL
immunoglobulin	NULL
gene	NULL
rearrangement	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
7	NULL
)	NULL
.	NULL

Differential	NULL
expression	NULL
and/or	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
leading	NULL
to	NULL
stage-specific	NULL
expression	NULL
of	NULL
a	NULL
certain	NULL
set	NULL
of	NULL
genes	NULL
appear	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
cell	NULL
differentiation	NULL
in	NULL
general	NULL
and	NULL
B-cell	NULL
development	NULL
in	NULL
particular	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
46	NULL
)	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
of	NULL
special	NULL
interest	NULL
for	NULL
B-cell	NULL
differentiation	NULL
,	NULL
because	NULL
different	NULL
classes	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
are	NULL
switched	NULL
on	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
(	NULL
7	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
whereas	NULL
immunoglobulin	NULL
heavy-chain	NULL
(	NULL
IgH	NULL
)	NULL
gene	NULL
expression	NULL
occurs	NULL
at	NULL
the	NULL
earliest	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
prior	NULL
to	NULL
IgH	NULL
gene	NULL
rearrangement	NULL
and	NULL
continues	NULL
throughout	NULL
B-cell	NULL
development	NULL
,	NULL
immunoglobulin	NULL
light-chain	NULL
genes	NULL
are	NULL
transcribed	NULL
only	NULL
upon	NULL
maturation	NULL
of	NULL
B	NULL
cells	NULL
after	NULL
IgH	NULL
gene	NULL
rearrangement	NULL
(	NULL
7	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
regulatory	NULL
elements	NULL
involved	NULL
in	NULL
IgH	NULL
gene	NULL
expression	NULL
has	NULL
resulted	NULL
in	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
at	NULL
least	NULL
three	NULL
regulatory	NULL
regions	NULL
including	NULL
the	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
IgH	NULL
gene	NULL
,	NULL
an	NULL
intronic	NULL
enhancer	NULL
,	NULL
and	NULL
an	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
the	NULL
IgH	NULL
gene	NULL
(	NULL
15	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Several	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
appear	NULL
to	NULL
be	NULL
distributed	NULL
within	NULL
these	NULL
regulatory	NULL
regions	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
46	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
elements	NULL
appear	NULL
to	NULL
be	NULL
ubiquitously	NULL
active	NULL
;	NULL
however	NULL
,	NULL
some	NULL
B-cell-specific	NULL
regulatory	NULL
elements	NULL
have	NULL
been	NULL
described	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
330	NULL
Brookline	NULL
Ave.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
735-3393	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
735-3547	NULL
.	NULL

3292	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
46	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
each	NULL
of	NULL
these	NULL
regulatory	NULL
regions	NULL
contains	NULL
several	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
redundant	NULL
B-cell-specific	NULL
enhancer	NULL
elements	NULL
,	NULL
none	NULL
of	NULL
them	NULL
being	NULL
completely	NULL
essential	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IgH	NULL
gene	NULL
(	NULL
42	NULL
,	NULL
49	NULL
,	NULL
58	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
identified	NULL
two	NULL
new	NULL
enhancer	NULL
elements	NULL
,	NULL
#	NULL
and	NULL
pB	NULL
,	NULL
in	NULL
the	NULL
intronic	NULL
IgH	NULL
enhancer	NULL
with	NULL
characteristic	NULL
functional	NULL
differences	NULL
(	NULL
47	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Whereas	NULL
the	NULL
mB	NULL
element	NULL
is	NULL
active	NULL
throughout	NULL
B-cell	NULL
development	NULL
(	NULL
49	NULL
)	NULL
,	NULL
the	NULL
#	NULL
enhancer	NULL
element	NULL
functions	NULL
primarily	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
whereas	NULL
the	NULL
wB	NULL
element	NULL
does	NULL
not	NULL
act	NULL
as	NULL
an	NULL
enhancer	NULL
by	NULL
itself	NULL
,	NULL
m	NULL
alone	NULL
works	NULL
as	NULL
a	NULL
very	NULL
potent	NULL
enhancer	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
47	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
of	NULL
both	NULL
enhancer	NULL
elements	NULL
show	NULL
striking	NULL
homology	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
ets	NULL
transcription	NULL
factor/oncoprotein	NULL
family	NULL
,	NULL
with	NULL
a	NULL
GGAA	NULL
sequence	NULL
in	NULL
the	NULL
core	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
(	NULL
55	NULL
,	NULL
61	NULL
,	NULL
85	NULL
,	NULL
94	NULL
)	NULL
.	NULL

All	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
share	NULL
a	NULL
highly	NULL
homologous	NULL
80-	NULL
to	NULL
90-amino-acid	NULL
DNA-binding	NULL
domain	NULL
,	NULL
the	NULL
ETS	NULL
domain	NULL
,	NULL
although	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
proteins	NULL
are	NULL
strikingly	NULL
divergent	NULL
among	NULL
different	NULL
members	NULL
of	NULL
the	NULL
family	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
55	NULL
,	NULL
61	NULL
,	NULL
and	NULL
85	NULL
)	NULL
.	NULL

The	NULL
ETS	NULL
domain	NULL
is	NULL
sufficient	NULL
to	NULL
interact	NULL
specifically	NULL
with	NULL
DNA	NULL
sequences	NULL
containing	NULL
a	NULL
GGA	NULL
(	NULL
A/T	NULL
)	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
(	NULL
20	NULL
,	NULL
53	NULL
,	NULL
61	NULL
,	NULL
94	NULL
,	NULL
97	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
have	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
play	NULL
essential	NULL
roles	NULL
as	NULL
transcriptional	NULL
regulators	NULL
of	NULL
a	NULL
whole	NULL
set	NULL
of	NULL
genes	NULL
including	NULL
many	NULL
T-cell-specific	NULL
genes	NULL
such	NULL
as	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
(	NULL
88	NULL
)	NULL
,	NULL
CD3	NULL
(	NULL
40	NULL
,	NULL
88	NULL
)	NULL
,	NULL
T-cell	NULL
receptors	NULL
Â«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
8	NULL
(	NULL
26	NULL
,	NULL
40	NULL
,	NULL
88	NULL
,	NULL
94	NULL
)	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
(	NULL
HIV-2	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
41	NULL
,	NULL
57	NULL
,	NULL
94	NULL
)	NULL
,	NULL
stromelysin	NULL
(	NULL
96	NULL
)	NULL
,	NULL
c-fos	NULL
(	NULL
14	NULL
,	NULL
25	NULL
)	NULL
,	NULL
and	NULL
urokinase	NULL
(	NULL
60	NULL
)	NULL
genes	NULL
.	NULL

Furthermore	NULL
,	NULL
several	NULL
ets-related	NULL
genes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
19	NULL
,	NULL
31	NULL
,	NULL
72	NULL
)	NULL
.	NULL

As	NULL
a	NULL
first	NULL
step	NULL
in	NULL
identifying	NULL
putative	NULL
novel	NULL
members	NULL
of	NULL
the	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
ets	NULL
gene	NULL
family	NULL
which	NULL
are	NULL
expressed	NULL
in	NULL
pre-B	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
applied	NULL
a	NULL
PCR	NULL
approach	NULL
using	NULL
degenerate	NULL
oligonucleotides	NULL
encoding	NULL
conserved	NULL
domains	NULL
of	NULL
all	NULL
known	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
and	NULL
mRNA	NULL
derived	NULL
from	NULL
a	NULL
pre-B-cell	NULL
line	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
encoding	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
,	NULL
named	NULL
ERP	NULL
(	NULL
ets-related	NULL
protein	NULL
)	NULL
.	NULL

The	NULL
ERP	NULL
gene	NULL
is	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
and	NULL
ELK-1	NULL
(	NULL
68	NULL
)	NULL
,	NULL
two	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
(	NULL
14	NULL
,	NULL
25	NULL
)	NULL
.	NULL

ERP	NULL
mRNA	NULL
is	NULL
expressed	NULL
to	NULL
different	NULL
extents	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
but	NULL
,	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
is	NULL
much	NULL
more	NULL
abundant	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
than	NULL
at	NULL
later	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
carboxy	NULL
terminus-deleted	NULL
ERP	NULL
interacts	NULL
with	NULL
several	NULL
ets-related	NULL
binding	NULL
sites	NULL
including	NULL
the	NULL
E74	NULL
and	NULL
the	NULL
IgH	NULL
T	NULL
sites	NULL
,	NULL
suggesting	NULL
a	NULL
potential	NULL
role	NULL
in	NULL
IgH	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

$	NULL
194	NULL
(	NULL
murine	NULL
myeloma	NULL
)	NULL
,	NULL
NIH	NULL
3T3	NULL
(	NULL
murine	NULL
fibroblast	NULL
)	NULL
,	NULL
and	NULL
P19	NULL
(	NULL
murine	NULL
teratocarcinoma	NULL
)	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

PD31	NULL
(	NULL
murine	NULL
pre-B	NULL
)	NULL
,	NULL
230-238	NULL
(	NULL
murine	NULL
pre-B	NULL
)	NULL
,	NULL
NFS	NULL
5.3	NULL
(	NULL
murine	NULL
late	NULL
pre-B	NULL
)	NULL
,	NULL
BASC6C2	NULL
(	NULL
murine	NULL
pre-B	NULL
)	NULL
,	NULL
WEHI231	NULL
(	NULL
murine	NULL
mature-B	NULL
)	NULL
,	NULL
A-20	NULL
(	NULL
murine	NULL
mature-B	NULL
)	NULL
,	NULL
J558	NULL
(	NULL
murine	NULL
myeloma	NULL
)	NULL
,	NULL
MPC11	NULL
(	NULL
murine	NULL
myeloma	NULL
)	NULL
,	NULL
P3X63	NULL
AG8	NULL
(	NULL
murine	NULL
myeloma	NULL
)	NULL
,	NULL
EL.4	NULL
(	NULL
murine-T	NULL
)	NULL
,	NULL
and	NULL
PuS-1.8	NULL
(	NULL
murine	NULL
monocyte	NULL
)	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
50	NULL
mM	NULL
2-mercaptoethanol	NULL
.	NULL

HAFTL	NULL
(	NULL
murine	NULL
early-pre-B	NULL
)	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
15	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
50	NULL
wM	NULL
2-mercaptoethanol	NULL
.	NULL

Isolation	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNAs	NULL
were	NULL
isolated	NULL
from	NULL
~10Â°	NULL
cells	NULL
as	NULL
described	NULL
by	NULL
Libermann	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
.	NULL

cDNA	NULL
synthesis	NULL
.	NULL

First-strand	NULL
cDNA	NULL
synthesis	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
SuperScript	NULL
Choice	NULL
system	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
according	NULL
to	NULL
protocols	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Briefly	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
derived	NULL
from	NULL
BASC6C2	NULL
cells	NULL
was	NULL
reverse	NULL
transcribed	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37Â°C	NULL
by	NULL
using	NULL
7.4-pg	NULL
random	NULL
hexamers	NULL
as	NULL
primers	NULL
and	NULL
200	NULL
U	NULL
of	NULL
SuperScript	NULL
reverse	NULL
transcriptase	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
precipitated	NULL
with	NULL
ethanol	NULL
and	NULL
dissolved	NULL
in	NULL
10	NULL
pl	NULL
of	NULL
water	NULL
.	NULL

PCR	NULL
cloning	NULL
.	NULL

BASC6C2	NULL
cDNA	NULL
(	NULL
0.5	NULL
pl	NULL
)	NULL
was	NULL
amplified	NULL
with	NULL
100	NULL
pmol	NULL
each	NULL
of	NULL
the	NULL
following	NULL
degenerate	NULL
oligonucleotide	NULL
primers	NULL
:	NULL
5-GCTAGCGGCCGCTGGCA	NULL
(	NULL
A/G	NULL
)	NULL
TT	NULL
(	NULL
T/C	NULL
)	NULL
(	NULL
T/C	NULL
)	NULL
T	NULL
(	NULL
A/G/C/T	NULL
)	NULL
(	NULL
TC	NULL
)	NULL
T	NULL
(	NULL
A/G/C/T	NULL
)	NULL
(	NULL
C/G	NULL
)	NULL
A-3	NULL
'	NULL
(	NULL
5	NULL
'	NULL
primer	NULL
A	NULL
)	NULL
,	NULL
5-GC	NULL
TAGCGGCCGCTA	NULL
(	NULL
T/IC	NULL
)	NULL
CA	NULL
(	NULL
A/G	NULL
)	NULL
TT	NULL
(	NULL
T/C	NULL
)	NULL
(	NULL
T/C	NULL
)	NULL
T	NULL
(	NULL
AW/G/C/T	NULL
)	NULL
(	NULL
TC	NULL
)	NULL
T	NULL
(	NULL
A/G/C/IT	NULL
)	NULL
(	NULL
C/G	NULL
)	NULL
A-3	NULL
'	NULL
(	NULL
5	NULL
'	NULL
primer	NULL
B	NULL
)	NULL
,	NULL
5-GGAGTCGAC	NULL
TT	NULL
(	NULL
A/G/CIT	NULL
)	NULL
T	NULL
(	NULL
CG	NULL
)	NULL
(	NULL
A/G	NULL
)	NULL
TA	NULL
(	NULL
W/G/CT	NULL
)	NULL
GTCAT	NULL
(	NULL
A/G/C/T	NULL
)	NULL
TT-3	NULL
'	NULL
(	NULL
3	NULL
'	NULL
primer	NULL
C	NULL
)	NULL
,	NULL
55-GGAGTCGACTT	NULL
(	NULL
A/G/CTT	NULL
(	NULL
C/G	NULL
)	NULL
(	NULL
A/G	NULL
)	NULL
TA	NULL
(	NULL
A/G	NULL
)	NULL
TTCAT	NULL
(	NULL
A/G/C/T	NULL
)	NULL
TT-3	NULL
'	NULL
(	NULL
3	NULL
'	NULL
primer	NULL
D	NULL
)	NULL
,	NULL
5-GC	NULL
TAGCGGCCGC	NULL
AA	NULL
(	NULL
T/IC	NULL
)	NULL
ATGAA	NULL
(	NULL
T/C	NULL
)	NULL
TA	NULL
(	NULL
T/C	NULL
)	NULL
GA	NULL
(	NULL
T/C	NULL
)	NULL
AA-3	NULL
'	NULL
(	NULL
5	NULL
'	NULL
primer	NULL
E	NULL
)	NULL
,	NULL
and	NULL
55-GCTAGCGGCCGCGT	NULL
(	NULL
A/G/C/	NULL
T	NULL
)	NULL
(	NULL
G/C	NULL
)	NULL
(	NULL
T/A	NULL
)	NULL
CCA	NULL
(	NULL
A/G	NULL
)	NULL
AA	NULL
(	NULL
A/G	NULL
)	NULL
TG	NULL
(	NULL
A/G/T	NULL
)	NULL
AT-3	NULL
'	NULL
(	NULL
3	NULL
'	NULL
primer	NULL
F	NULL
)	NULL
.	NULL

Standard	NULL
PCR	NULL
amplifications	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
containing	NULL
200	NULL
ng	NULL
of	NULL
cDNA	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
deoxynucleoside	NULL
triphosphates	NULL
(	NULL
dNTPs	NULL
)	NULL
,	NULL
5	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
and	NULL
0.2	NULL
pl	NULL
of	NULL
AmpliTaq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
)	NULL
and	NULL
combinations	NULL
of	NULL
either	NULL
5	NULL
'	NULL
primer	NULL
A	NULL
or	NULL
B	NULL
with	NULL
3	NULL
'	NULL
primer	NULL
C	NULL
or	NULL
D	NULL
or	NULL
5	NULL
'	NULL
primer	NULL
E	NULL
with	NULL
3	NULL
'	NULL
primer	NULL
F.	NULL
Reaction	NULL
mixtures	NULL
were	NULL
overlaid	NULL
with	NULL
mineral	NULL
oil	NULL
and	NULL
amplified	NULL
by	NULL
using	NULL
Perkin-Elmer	NULL
Cetus	NULL
thermal	NULL
cycler	NULL
480	NULL
as	NULL
follows	NULL
:	NULL
2	NULL
cycles	NULL
of	NULL
60	NULL
s	NULL
at	NULL
95Â°C	NULL
,	NULL
60	NULL
s	NULL
at	NULL
32Â°C	NULL
,	NULL
and	NULL
150	NULL
s	NULL
at	NULL
68Â°C	NULL
;	NULL
then	NULL
45	NULL
cycles	NULL
of	NULL
60	NULL
s	NULL
at	NULL
94Â°C	NULL
,	NULL
60	NULL
s	NULL
at	NULL
55Â°C	NULL
,	NULL
and	NULL
45	NULL
s	NULL
at	NULL
72Â°C	NULL
followed	NULL
by	NULL
7	NULL
min	NULL
at	NULL
72Â°C	NULL
.	NULL

Ten	NULL
microliters	NULL
of	NULL
the	NULL
reaction	NULL
products	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
2	NULL
%	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
eis	NULL
FAMILY	NULL
3293	NULL
agarose	NULL
gel	NULL
.	NULL

The	NULL
relevant	NULL
amplified	NULL
DNA	NULL
fragments	NULL
were	NULL
eluted	NULL
with	NULL
glass	NULL
beads	NULL
(	NULL
Geneclean	NULL
;	NULL
Bio	NULL
101	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Eluted	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
NotI	NULL
and	NULL
Sall	NULL
(	NULL
for	NULL
primers	NULL
A	NULL
to	NULL
D	NULL
)	NULL
or	NULL
NotI	NULL
alone	NULL
(	NULL
for	NULL
primers	NULL
E	NULL
and	NULL
F	NULL
)	NULL
,	NULL
repurified	NULL
via	NULL
glass	NULL
beads	NULL
,	NULL
and	NULL
subcloned	NULL
into	NULL
either	NULL
NofI-Sa/l-or	NULL
Notl-digested	NULL
pSL1180	NULL
(	NULL
Pharmacia	NULL
)	NULL
or	NULL
Bluescript	NULL
SK+*	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Colonies	NULL
of	NULL
recombinant	NULL
clones	NULL
were	NULL
randomly	NULL
picked	NULL
,	NULL
and	NULL
minipreparations	NULL
of	NULL
DNA	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
the	NULL
Magic	NULL
Miniprep	NULL
(	NULL
Promega	NULL
)	NULL
procedure	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
clones	NULL
were	NULL
digested	NULL
with	NULL
Sell	NULL
and	NULL
Xhol	NULL
or	NULL
NotI	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Double-stranded	NULL
sequencing	NULL
of	NULL
positive	NULL
clones	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
Sequenase	NULL
II	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemical	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

5	NULL
'	NULL
RACE	NULL
(	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
)	NULL
primer	NULL
exten-sion	NULL
.	NULL

First-strand	NULL
cDNA	NULL
synthesis	NULL
and	NULL
5	NULL
'	NULL
tailing	NULL
with	NULL
dCTP	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
5Â°	NULL
RACE	NULL
system	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
according	NULL
to	NULL
protocols	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Briefly	NULL
,	NULL
1	NULL
jpg	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
derived	NULL
from	NULL
BASC6C2	NULL
cells	NULL
was	NULL
reverse	NULL
transcribed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
42Â°C	NULL
by	NULL
using	NULL
200	NULL
U	NULL
of	NULL
SuperScript	NULL
reverse	NULL
transcriptase	NULL
and	NULL
200	NULL
ng	NULL
of	NULL
ERP-specific	NULL
oligonucleotide	NULL
primer	NULL
5-GCTAGCGGCCGCT	NULL
GAGGAGCTITGAACTCGCC-3	NULL
'	NULL
(	NULL
primer	NULL
G	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
RNase	NULL
H	NULL
treated	NULL
and	NULL
purified	NULL
over	NULL
GlassMax	NULL
spin	NULL
cartridges	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
tailed	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
with	NULL
10	NULL
U	NULL
of	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
(	NULL
TdT	NULL
)	NULL
and	NULL
200	NULL
nM	NULL
dCTP	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

Deoxycytidine-tailed	NULL
cDNA	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
an	NULL
anchor	NULL
primer	NULL
(	NULL
5-CUACUACUACUAGGCCACGCGTCG	NULL
ACTAGTACGGGIHIGGGIHIGGGIIG-3	NULL
'	NULL
)	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
and	NULL
a	NULL
nested	NULL
ERP-specific	NULL
primer	NULL
(	NULL
5'-GCCACG	NULL
GTCGACCTCGCCATCGTTCGATGTCC-3	NULL
'	NULL
[	NULL
primer	NULL
HJ	NULL
)	NULL
upstream	NULL
of	NULL
primer	NULL
G.	NULL
5	NULL
'	NULL
RACE	NULL
PCR	NULL
amplifications	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
containing	NULL
10	NULL
%	NULL
of	NULL
the	NULL
tailed	NULL
cDNA	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
dNTPs	NULL
,	NULL
0.5	NULL
ul	NULL
of	NULL
AmpliTaq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
)	NULL
,	NULL
20	NULL
pmol	NULL
of	NULL
the	NULL
anchor	NULL
primer	NULL
,	NULL
and	NULL
25	NULL
pmol	NULL
of	NULL
primer	NULL
H.	NULL
Reaction	NULL
mixtures	NULL
were	NULL
overlaid	NULL
with	NULL
mineral	NULL
oil	NULL
and	NULL
amplified	NULL
by	NULL
using	NULL
Perkin-Elmer	NULL
Cetus	NULL
thermal	NULL
cycler	NULL
480	NULL
as	NULL
follows	NULL
:	NULL
2	NULL
cycles	NULL
of	NULL
60	NULL
s	NULL
at	NULL
95Â°C	NULL
,	NULL
60	NULL
s	NULL
at	NULL
37Â°C	NULL
,	NULL
and	NULL
10	NULL
min	NULL
at	NULL
68Â°C	NULL
;	NULL
then	NULL
40	NULL
cycles	NULL
of	NULL
60	NULL
s	NULL
at	NULL
94Â°C	NULL
,	NULL
60	NULL
s	NULL
at	NULL
55Â°C	NULL
,	NULL
and	NULL
3	NULL
min	NULL
at	NULL
72Â°C	NULL
followed	NULL
by	NULL
7	NULL
min	NULL
at	NULL
72Â°C	NULL
.	NULL

Ten	NULL
microliters	NULL
of	NULL
the	NULL
reaction	NULL
products	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Forty	NULL
microliters	NULL
of	NULL
amplified	NULL
DNA	NULL
was	NULL
eluted	NULL
with	NULL
glass	NULL
beads	NULL
(	NULL
Geneclean	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Eluted	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
Sall	NULL
,	NULL
repurified	NULL
via	NULL
glass	NULL
beads	NULL
and	NULL
subcloned	NULL
into	NULL
Sa/l-digested	NULL
Bluescript	NULL
SK+*	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Minipreparations	NULL
of	NULL
recombinant	NULL
clones	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
the	NULL
Magic	NULL
Miniprep	NULL
procedure	NULL
.	NULL

The	NULL
clones	NULL
were	NULL
digested	NULL
with	NULL
Sa/l	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Double-stranded	NULL
sequencing	NULL
of	NULL
positive	NULL
clones	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Sequenase	NULL
II	NULL
kit	NULL
.	NULL

cDNA	NULL
library	NULL
screening	NULL
.	NULL

A	NULL
murine	NULL
lung	NULL
cDNA	NULL
library	NULL
in	NULL
Agt10	NULL
was	NULL
obtained	NULL
from	NULL
Clontech	NULL
.	NULL

The	NULL
900-bp	NULL
ERP	NULL
fragment	NULL
derived	NULL
by	NULL
PCR	NULL
from	NULL
BASC6C2	NULL
mRNA	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
Â«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
JdCTP	NULL
by	NULL
random	NULL
priming	NULL
using	NULL
a	NULL
random	NULL
priming	NULL
kit	NULL
(	NULL
Boehringer	NULL
)	NULL
.	NULL

Replica	NULL
filters	NULL
of	NULL
~7.5	NULL
x	NULL
10Â°	NULL
recombinant	NULL
phage	NULL
were	NULL
hybridized	NULL
with	NULL
~9	NULL
x	NULL
10Â°	NULL
cpm	NULL
of	NULL
the	NULL
ERP	NULL
probe	NULL
per	NULL
ml	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
for	NULL
1	NULL
h	NULL
at	NULL
68Â°C	NULL
with	NULL
the	NULL
Quickhyb	NULL
solution	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
sheared	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Stratagene	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
twice	NULL
for	NULL
15	NULL
min	NULL
each	NULL
time	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
(	NULL
1	NULL
%	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
-0.2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
and	NULL
twice	NULL
for	NULL
30	NULL
min	NULL
each	NULL
time	NULL
at	NULL
68Â°C	NULL
in	NULL
0.2	NULL
%	NULL
SSC-0.2	NULL
%	NULL
SDS	NULL
.	NULL

Six	NULL
positive	NULL
clones	NULL
were	NULL
rescreened	NULL
and	NULL
used	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Inserts	NULL
were	NULL
cut	NULL
out	NULL
from	NULL
the	NULL
3294	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

Agt10	NULL
phage	NULL
miniprep	NULL
DNA	NULL
by	NULL
EcoRI	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
Bluescript	NULL
SK	NULL
*	NULL
.	NULL

DNA	NULL
sequencing	NULL
.	NULL

All	NULL
cDNA	NULL
clones	NULL
were	NULL
sequenced	NULL
either	NULL
with	NULL
Sequenase	NULL
II	NULL
or	NULL
by	NULL
Lori	NULL
Wirth	NULL
(	NULL
Molecular	NULL
Biology	NULL
Core	NULL
Facility	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
using	NULL
an	NULL
Applied	NULL
Biosystems	NULL
automatic	NULL
DNA	NULL
sequencer	NULL
model	NULL
373A	NULL
,	NULL
the	NULL
Taq	NULL
DyeDeoxy	NULL
Terminator	NULL
Cycle	NULL
Sequencing	NULL
kit	NULL
(	NULL
Applied	NULL
Biosys-tems	NULL
)	NULL
,	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
specific	NULL
oligonucleotide	NULL
primers	NULL
.	NULL

DNA	NULL
and	NULL
protein	NULL
sequence	NULL
analysis	NULL
.	NULL

DNA	NULL
and	NULL
protein	NULL
sequences	NULL
were	NULL
analyzed	NULL
and	NULL
aligned	NULL
by	NULL
using	NULL
programs	NULL
DNA	NULL
Strider	NULL
1.2	NULL
,	NULL
Gene	NULL
Jockey	NULL
,	NULL
Blast	NULL
,	NULL
Seqapp	NULL
,	NULL
and	NULL
Clustal	NULL
V.	NULL
In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
.	NULL

Full-length	NULL
ERP	NULL
cDNA	NULL
encoding	NULL
the	NULL
whole	NULL
open	NULL
reading	NULL
frame	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
Bluescript	NULL
SK*	NULL
plasmid	NULL
(	NULL
Stratagene	NULL
)	NULL
with	NULL
the	NULL
T7	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
initiator	NULL
methionine	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
linearized	NULL
either	NULL
with	NULL
Smal	NULL
to	NULL
generate	NULL
full-length	NULL
ERP	NULL
or	NULL
with	NULL
Sacl	NULL
(	NULL
ERPAC396	NULL
)	NULL
,	NULL
BstXI	NULL
(	NULL
ERPA	NULL
C298	NULL
)	NULL
,	NULL
Beill	NULL
(	NULL
ERPAC222	NULL
)	NULL
,	NULL
EcoNI	NULL
(	NULL
ERPAC106	NULL
)	NULL
,	NULL
or	NULL
Eco47IlI	NULL
(	NULL
ERPAC6K1	NULL
)	NULL
to	NULL
generate	NULL
various	NULL
deletion	NULL
mutants	NULL
of	NULL
ERP	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
linearized	NULL
plasmids	NULL
by	NULL
using	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
kit	NULL
and	NULL
T7	NULL
RNA	NULL
polymerase	NULL
(	NULL
Promega	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
,	NULL
ethanol	NULL
precipitated	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
40	NULL
pl	NULL
of	NULL
water	NULL
.	NULL

Part	NULL
of	NULL
the	NULL
reaction	NULL
was	NULL
tested	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
for	NULL
size	NULL
and	NULL
quality	NULL
.	NULL

Wild-type	NULL
and	NULL
mutant	NULL
ERP	NULL
proteins	NULL
were	NULL
synthesized	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
RNA	NULL
in	NULL
micrococcal	NULL
nuclease-treated	NULL
wheat	NULL
germ	NULL
extracts	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
[	NULL
Â°Â°SJmethionine	NULL
(	NULL
NEN	NULL
)	NULL
or	NULL
unlabeled	NULL
methionine	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
the	NULL
labeled	NULL
in	NULL
vitro	NULL
translation	NULL
products	NULL
was	NULL
analyzed	NULL
on	NULL
an	NULL
SDS-20	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Renaturation	NULL
of	NULL
ERP	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
products	NULL
were	NULL
denatured	NULL
in	NULL
SDS-sample	NULL
buffer	NULL
(	NULL
36	NULL
)	NULL
containing	NULL
3.3	NULL
%	NULL
2-mer-captoethanol	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

After	NULL
separation	NULL
of	NULL
proteins	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
,	NULL
gel	NULL
slices	NULL
from	NULL
different	NULL
molecular	NULL
weight	NULL
regions	NULL
were	NULL
cut	NULL
out	NULL
and	NULL
ground	NULL
.	NULL

Proteins	NULL
were	NULL
eluted	NULL
,	NULL
precipitated	NULL
with	NULL
acetone	NULL
,	NULL
denatured	NULL
in	NULL
2.5	NULL
pl	NULL
of	NULL
saturated	NULL
urea	NULL
,	NULL
and	NULL
renatured	NULL
for	NULL
>	NULL
18	NULL
h	NULL
at	NULL
4Â°C	NULL
in	NULL
125	NULL
pl	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
twofold-concentrated	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
binding	NULL
buffer	NULL
(	NULL
4	NULL
)	NULL
,	NULL
10	NULL
%	NULL
buffer	NULL
D	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Nonidet	NULL
P-40	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
molecular	NULL
weights	NULL
of	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
in	NULL
a	NULL
particular	NULL
gel	NULL
slice	NULL
,	NULL
15	NULL
pl	NULL
of	NULL
renatured	NULL
protein	NULL
was	NULL
reprecipitated	NULL
with	NULL
4	NULL
volumes	NULL
of	NULL
acetone	NULL
,	NULL
washed	NULL
with	NULL
methanol	NULL
,	NULL
resuspended	NULL
in	NULL
10	NULL
wl	NULL
of	NULL
SDS-sample	NULL
buffer	NULL
,	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
EMSAs	NULL
,	NULL
10-pl	NULL
renatured	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
10-pl	NULL
reaction	NULL
mix	NULL
containing	NULL
20	NULL
pg	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
,	NULL
0.5	NULL
pug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
the	NULL
*Â°P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
analyzed	NULL
on	NULL
4	NULL
%	NULL
acrylamide	NULL
gels	NULL
as	NULL
described	NULL
below	NULL
.	NULL

EMSA	NULL
.	NULL

DNA-binding	NULL
reactions	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
45	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Samples	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
2	NULL
to	NULL
4	NULL
pl	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
product	NULL
were	NULL
incubated	NULL
with	NULL
0.1	NULL
to	NULL
0.2	NULL
ng	NULL
of	NULL
*Â°P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
5,000	NULL
to	NULL
10,000	NULL
cpm	NULL
)	NULL
,	NULL
10	NULL
%	NULL
buffer	NULL
D	NULL
(	NULL
17	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
dithio-threitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
20	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
(	NULL
Boehringer	NULL
)	NULL
,	NULL
and	NULL
0.5	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
run	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
containing	NULL
as	NULL
Mor	NULL
.	NULL

Cec	NULL
.	NULL

Bio	NULL
.	NULL

buffer	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
1x	NULL
TBE	NULL
is	NULL
89	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
89	NULL
mM	NULL
sodium	NULL
borate	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
EDTA	NULL
[	NULL
pH	NULL
8.3	NULL
]	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
and	NULL
for	NULL
competition	NULL
studies	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Northern	NULL
and	NULL
Southern	NULL
blots	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blots	NULL
were	NULL
made	NULL
as	NULL
described	NULL
by	NULL
Libermann	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
selected	NULL
mRNA	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
containing	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
selected	NULL
mRNA	NULL
derived	NULL
from	NULL
different	NULL
murine	NULL
tissues	NULL
was	NULL
obtained	NULL
from	NULL
Clontech	NULL
.	NULL

A	NULL
Southern	NULL
blot	NULL
containing	NULL
genomic	NULL
DNA	NULL
derived	NULL
from	NULL
different	NULL
species	NULL
was	NULL
obtained	NULL
from	NULL
Bios	NULL
Corp.	NULL
(	NULL
New	NULL
Haven	NULL
,	NULL
Conn.	NULL
)	NULL
.	NULL

Northern	NULL
and	NULL
Southern	NULL
blot	NULL
analysis	NULL
.	NULL

Northern	NULL
and	NULL
Southern	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
2	NULL
x	NULL
10Â°	NULL
cpm	NULL
of	NULL
random-prime-labeled	NULL
0.9-kb	NULL
ERP	NULL
cDNA	NULL
fragment	NULL
per	NULL
ml	NULL
at	NULL
42Â°C	NULL
for	NULL
1	NULL
h	NULL
in	NULL
QuickHyb	NULL
solution	NULL
(	NULL
Stratagene	NULL
)	NULL
containing	NULL
200	NULL
mg	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
per	NULL
ml	NULL
.	NULL

After	NULL
being	NULL
washed	NULL
at	NULL
68Â°C	NULL
with	NULL
0.2	NULL
%	NULL
SSC-0.2	NULL
%	NULL
SDS	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
autoradiographed	NULL
for	NULL
2	NULL
days	NULL
at	NULL
-	NULL
70Â°C	NULL
with	NULL
intensifier	NULL
screens	NULL
.	NULL

Chromosomal	NULL
|	NULL
localization	NULL
.	NULL

Southern	NULL
blots	NULL
containing	NULL
genomic	NULL
DNAs	NULL
derived	NULL
from	NULL
different	NULL
hamster-human	NULL
hybrid	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
Bios	NULL
and	NULL
hybridized	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
.	NULL

The	NULL
GenBank	NULL
nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
for	NULL
the	NULL
sequence	NULL
reported	NULL
here	NULL
is	NULL
L19953	NULL
.	NULL

RESULTS	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
murine	NULL
ets-related	NULL
eDNA	NULL
,	NULL
ERP	NULL
.	NULL

Isolation	NULL
of	NULL
several	NULL
genes	NULL
related	NULL
to	NULL
the	NULL
gene	NULL
has	NULL
recently	NULL
led	NULL
to	NULL
the	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
DNA-binding	NULL
motif	NULL
,	NULL
the	NULL
ETS	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
all	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
55	NULL
,	NULL
61	NULL
,	NULL
and	NULL
85	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
of	NULL
the	NULL
80-	NULL
to	NULL
85-amino-acid	NULL
ETS	NULL
domains	NULL
of	NULL
the	NULL
different	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
revealed	NULL
several	NULL
regions	NULL
of	NULL
high	NULL
homology	NULL
between	NULL
all	NULL
ets-related	NULL
proteins	NULL
.	NULL

Of	NULL
these	NULL
,	NULL
two	NULL
particular	NULL
highly	NULL
conserved	NULL
regions	NULL
,	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
suitable	NULL
for	NULL
designing	NULL
degenerate	NULL
oligonucleotides	NULL
which	NULL
would	NULL
encode	NULL
all	NULL
genes	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
that	NULL
had	NULL
been	NULL
cloned	NULL
at	NULL
that	NULL
time	NULL
and	NULL
which	NULL
could	NULL
be	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
of	NULL
ets-related	NULL
genes	NULL
from	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
sequence	NULL
(	NULL
W/Y	NULL
)	NULL
QFLL	NULL
(	NULL
E/D/Q	NULL
)	NULL
defined	NULL
the	NULL
5	NULL
'	NULL
border	NULL
of	NULL
the	NULL
region	NULL
of	NULL
cDNA	NULL
to	NULL
be	NULL
amplified	NULL
,	NULL
and	NULL
the	NULL
sequence	NULL
(	NULL
K/N	NULL
)	NULL
MN	NULL
(	NULL
Y/T	NULL
)	NULL
(	NULL
D/E/Q	NULL
)	NULL
K	NULL
defined	NULL
the	NULL
3	NULL
'	NULL
border	NULL
.	NULL

The	NULL
amplified	NULL
product	NULL
between	NULL
these	NULL
two	NULL
sequences	NULL
was	NULL
expected	NULL
to	NULL
be	NULL
170	NULL
to	NULL
180	NULL
bp	NULL
long	NULL
including	NULL
21	NULL
bp	NULL
derived	NULL
from	NULL
the	NULL
flanking	NULL
No	NULL
#	NULL
I	NULL
and	NULL
Sail	NULL
restriction	NULL
sites	NULL
.	NULL

To	NULL
identify	NULL
members	NULL
of	NULL
diverse	NULL
subfamilies	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
which	NULL
differ	NULL
in	NULL
one	NULL
or	NULL
two	NULL
amino	NULL
acids	NULL
,	NULL
we	NULL
generated	NULL
two	NULL
different	NULL
sets	NULL
of	NULL
each	NULL
degenerate	NULL
oligonucleotide	NULL
primer	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
primers	NULL
were	NULL
based	NULL
upon	NULL
the	NULL
DNA	NULL
sequences	NULL
encoding	NULL
the	NULL
two	NULL
consensus	NULL
amino	NULL
acid	NULL
sequences	NULL
and	NULL
differed	NULL
in	NULL
the	NULL
codons	NULL
for	NULL
one	NULL
amino	NULL
acid	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

The	NULL
oligonucleotide	NULL
primers	NULL
were	NULL
thus	NULL
mixtures	NULL
of	NULL
512	NULL
different	NULL
oligonucleotides	NULL
for	NULL
primer	NULL
A	NULL
,	NULL
1,024	NULL
oligonucleotides	NULL
for	NULL
primer	NULL
B	NULL
,	NULL
128	NULL
oligonucleotides	NULL
for	NULL
primer	NULL
C	NULL
,	NULL
and	NULL
256	NULL
oligonucleotides	NULL
for	NULL
primer	NULL
D.	NULL
The	NULL
predicted	NULL
thermal	NULL
denaturation	NULL
range	NULL
of	NULL
primers	NULL
A	NULL
and	NULL
B	NULL
was	NULL
42	NULL
to	NULL
54Â°C	NULL
,	NULL
and	NULL
that	NULL
of	NULL
primers	NULL
C	NULL
and	NULL
D	NULL
was	NULL
38	NULL
to	NULL
46Â°C	NULL
.	NULL

To	NULL
ensure	NULL
hybridization	NULL
and	NULL
extension	NULL
in	NULL
early	NULL
amplification	NULL
cycles	NULL
,	NULL
when	NULL
only	NULL
the	NULL
amino	NULL
acid-encoding	NULL
nucleotides	NULL
hybridize	NULL
,	NULL
and	NULL
to	NULL
increase	NULL
specificity	NULL
later	NULL
on	NULL
,	NULL
we	NULL
annealed	NULL
the	NULL
primers	NULL
at	NULL
32Â°C	NULL
for	NULL
two	NULL
cycles	NULL
and	NULL
then	NULL
increased	NULL
the	NULL
annealing	NULL
temperature	NULL
to	NULL
55Â°C	NULL
for	NULL
the	NULL
remaining	NULL
cycles	NULL
.	NULL

PCRs	NULL
were	NULL
performed	NULL
with	NULL
random	NULL
hexamer-primed	NULL
cDNA	NULL
derived	NULL
from	NULL
the	NULL
murine	NULL
pre-B-cell	NULL
line	NULL
BASC6C2	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
strategy	NULL
enabled	NULL
us	NULL
to	NULL
obtain	NULL
one	NULL
predominant	NULL
ethidium	NULL
bromide-stained	NULL
amplifica-	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
eis	NULL
FAMILY	NULL
3295	NULL
TABLE	NULL
1	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
and	NULL
for	NULL
competition	NULL
studies	NULL
Oligonucleotide	NULL
E74	NULL
WT	NULL
Sequence	NULL
5'-TCGAGTAACCGGAAGTAACTCAG-3	NULL
'	NULL
E74	NULL
mutant	NULL
IgH	NULL
enhancer	NULL
#	NULL
WT	NULL
IgH	NULL
enhancer	NULL
#	NULL
mutant	NULL
Ick	NULL
promoter	NULL
WT	NULL
Ick	NULL
promoter	NULL
mutant	NULL
HSV	NULL
ICP4	NULL
WT	NULL
Polyomavirus	NULL
PEA3	NULL
WT	NULL
MSV	NULL
LTR	NULL
WT	NULL
HIV-2	NULL
LTR	NULL
WT	NULL
HTLV-I	NULL
LTR	NULL
WT	NULL
3'-CATTGGCCTTCATTGAGTCAGCT-5	NULL
'	NULL
5'-TCGAGTAACCTTTAGTAACTCAG-3	NULL
'	NULL
3'-CATTGGAAATCATTGAGTCAGCT-5	NULL
'	NULL
5'-TCGACTGGCAGGAAGCAGGTCATGC-3	NULL
'	NULL
3'-GACCGTCCTTCGTCCAGTACGAGCT-5	NULL
'	NULL
5'-TCGACTGGCATTAAGCAGGTCATGC-3	NULL
'	NULL
3'-GACCGTAATTCGTCCAGTACGAGCT-5	NULL
'	NULL
5'-TCGAGGTGGCAGGAAGCTTGG-3	NULL
'	NULL
3'-CCACCGTCCTTCGAACCAGCT-5	NULL
'	NULL
5'-TCGAGGTGGCAATTAGCTTGG-3	NULL
'	NULL
3'-CCACCGTTAATCGAACCAGCT-5	NULL
'	NULL
5'-TCGAGCGGAACGGAAGCGGAAACCG-3	NULL
'	NULL
3'-CGCCTTGCCTTeGccTTreecasct-5	NULL
'	NULL
5'-TCGAGCAGGAAGTGACG-3	NULL
'	NULL
3-CGTCCTTCACTGCAGCT-5	NULL
'	NULL
3'-CTCGCCTTeGcececacct-5	NULL
'	NULL
5'-TCGAGTTAAAGACAGGAACAGCTATG-3	NULL
'	NULL
3-CAATTTCTGTCCTTGTCGATACAGCT-5	NULL
'	NULL
5'-TCGAGGGGAGGAAATGGGTG-3	NULL
'	NULL
Stromelysin	NULL
promoter	NULL
WT	NULL
5'-TCGAGCAGGAAGCATTTCCTGG-3	NULL
'	NULL
3'-CGTCCTTCGTAAAGGACCAGCT-5	NULL
'	NULL
5'-TCGAGTCCAGGAGGAAATGAAGTCAG-3	NULL
'	NULL
Urokinase	NULL
promoter	NULL
WT	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
Te2	NULL
WT	NULL
IL-2	NULL
NF-AT	NULL
WT	NULL
IL-2	NULL
IL-2B	NULL
WT	NULL
3'-CAGGTCCTCCTTTACTTCAGTCAGCT-5	NULL
'	NULL
5'-TCCCGCAGAAGCCACATCCTCTG-3	NULL
'	NULL
3'-AGGGCGTCTTCGGTGTAGGAGAC-5	NULL
'	NULL
5'-TCGAGAAAGGAGGAAAAACTG-3	NULL
'	NULL
3'-CTTTCCTCCTTTTTGACAGCT-5	NULL
'	NULL
5	NULL
-TCGAGAAGAGGAAAAATGAAG-3	NULL
'	NULL
3'-CTTCTCCTTTTTACTTCAGCT-5	NULL
'	NULL
5'-TCGAGCTTACACAGGATGTCCATATTAGGACATCTG-3	NULL
'	NULL
fos	NULL
SRE	NULL
WT	NULL
3'-CGAATGTGTCCTACAGGTATAATCCTGTAGACAGCT-5	NULL
'	NULL
5'-TCGAGGGAGGAAGCACCG-3	NULL
'	NULL
vpreB	NULL
promoter	NULL
WT	NULL
3'-CCCTCCTTCGTGSCAGCT-5	NULL
'	NULL
5'-TCGAGCTTTGAGGAACTGAAAACAG-3	NULL
'	NULL
Ig	NULL
(	NULL
Â«	NULL
)	NULL
3	NULL
'	NULL
enhancer	NULL
WT	NULL
3'-CGAAACTCCTTGACTTTTGTCAGCT-5	NULL
'	NULL
5'-TCGAGAGTGAGGAACCAATCAG-3	NULL
'	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
WT	NULL
3'-CTCACTCCTTGGTTAGTCAGCT-5	NULL
'	NULL
``	NULL
WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

tion	NULL
product	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
of	NULL
~170	NULL
to	NULL
180	NULL
bp	NULL
by	NULL
using	NULL
primer	NULL
A	NULL
together	NULL
with	NULL
primer	NULL
C	NULL
and	NULL
lower	NULL
yields	NULL
with	NULL
primers	NULL
A	NULL
and	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
primer	NULL
B	NULL
with	NULL
primer	NULL
D	NULL
or	NULL
primer	NULL
C	NULL
resulted	NULL
in	NULL
much	NULL
lower	NULL
yields	NULL
of	NULL
the	NULL
predicted	NULL
DNA	NULL
band	NULL
.	NULL

Additional	NULL
larger	NULL
products	NULL
whose	NULL
origins	NULL
were	NULL
not	NULL
further	NULL
explored	NULL
were	NULL
observed	NULL
with	NULL
some	NULL
combinations	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
amplified	NULL
by	NULL
primers	NULL
A	NULL
and	NULL
C	NULL
was	NULL
digested	NULL
with	NULL
NotI	NULL
and	NULL
Sall	NULL
and	NULL
subcloned	NULL
into	NULL
NofI-Sall-cleaved	NULL
pSL1180	NULL
or	NULL
Bluescript	NULL
SK*	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

In	NULL
our	NULL
preliminary	NULL
analysis	NULL
,	NULL
15	NULL
independent	NULL
clones	NULL
containing	NULL
the	NULL
amplified	NULL
product	NULL
were	NULL
analyzed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Of	NULL
these	NULL
15	NULL
clones	NULL
,	NULL
14	NULL
contained	NULL
efs-related	NULL
sequences	NULL
.	NULL

The	NULL
3296	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
)	NULL
34	NULL
-	NULL
38	NULL
AMINO	NULL
ACIDS	NULL
LWQFLLELL	NULL
NKPKMNYDKLSRALRYYY	NULL
x	NULL
p	NULL
SRTN	NULL
T	NULL
E	NULL
MA	NULL
G	NULL
N	NULL
G	NULL
o	NULL
K	NULL
o	NULL
wo	NULL
g	NULL
F	NULL
L	NULL
LOE	NULL
p	NULL
Ko	NULL
M	NULL
N	NULL
Y	NULL
D	NULL
K	NULL
o	NULL
N	NULL
E	NULL
lel	NULL
B	NULL
)	NULL
PRIMER	NULL
A	NULL
5	NULL
'	NULL
~GCTAGCGGCCGCTGGCAATTTTTNTTNCA-3	NULL
'	NULL
PRIMER	NULL
C	NULL
3'-TTNTACTTAATACTNTTCAGCTGAGG-5	NULL
'	NULL
s	NULL
ccoc	NULL
@	NULL
c	NULL
c	NULL
Sall	NULL
NotI	NULL
6	NULL
E	NULL
Lak	NULL
P5	NULL
Ko	NULL
M	NULL
T	NULL
Y	NULL
D	NULL
K	NULL
N	NULL
E	NULL
ld	NULL
lel	NULL
PRIMER	NULL
B	NULL
5	NULL
'	NULL
~GCTAGCGGCCGCTATCAATTTTTNTTNCA-3	NULL
'	NULL
PRIMER	NULL
D	NULL
-	NULL
3'-TTNTACTGNATACTNTTCAGCTGAGG-5	NULL
'	NULL
>	NULL
h	NULL
ce	NULL
NotI	NULL
C_	NULL
e	NULL
Sall	NULL
C	NULL
)	NULL
PRIMERS	NULL
AD	NULL
AC	NULL
BD	NULL
BC	NULL
DMSO	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
4+	NULL
-	NULL
MW	NULL
~170-180	NULL
bp	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Amplification	NULL
of	NULL
ets-related	NULL
cDNAs	NULL
with	NULL
degenerate	NULL
oligonucleotide	NULL
primers	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Conserved	NULL
regions	NULL
within	NULL
ETS	NULL
domains	NULL
.	NULL

Blocks	NULL
of	NULL
amino	NULL
acids	NULL
(	NULL
in	NULL
one-letter	NULL
code	NULL
)	NULL
conserved	NULL
within	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
all	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
are	NULL
boxed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Degenerate	NULL
PCR	NULL
primers	NULL
derived	NULL
from	NULL
consensus	NULL
sequences	NULL
conserved	NULL
within	NULL
ETS	NULL
domains	NULL
.	NULL

Degeneracies	NULL
are	NULL
indicated	NULL
,	NULL
with	NULL
N	NULL
denoting	NULL
all	NULL
four	NULL
deoxynucleotides	NULL
.	NULL

In	NULL
order	NULL
to	NULL
decrease	NULL
degeneracy	NULL
,	NULL
two	NULL
sets	NULL
of	NULL
primers	NULL
differing	NULL
in	NULL
one	NULL
amino	NULL
acid	NULL
each	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
were	NULL
derived	NULL
.	NULL

Restriction	NULL
sites	NULL
for	NULL
NofI	NULL
and	NULL
Sa/l	NULL
are	NULL
flanking	NULL
the	NULL
amino	NULL
acid-encoding	NULL
nucleotides	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gel	NULL
electrophoresis	NULL
of	NULL
amplified	NULL
efs-related	NULL
sequences	NULL
.	NULL

Ethidium	NULL
bromide-stained	NULL
agarose	NULL
gel	NULL
of	NULL
PCR	NULL
products	NULL
with	NULL
the	NULL
pre-B-cell	NULL
,	NULL
BASC6C2	NULL
,	NULL
cDNA	NULL
as	NULL
a	NULL
template	NULL
.	NULL

Primer	NULL
pairs	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
gel	NULL
.	NULL

Dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
was	NULL
used	NULL
in	NULL
the	NULL
PCR	NULL
where	NULL
indicated	NULL
(	NULL
+	NULL
)	NULL
.	NULL

The	NULL
expected	NULL
170-	NULL
to	NULL
180-bp	NULL
amplification	NULL
product	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
(	NULL
MW	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

remaining	NULL
clone	NULL
did	NULL
not	NULL
show	NULL
any	NULL
sequence	NULL
homology	NULL
to	NULL
ets-related	NULL
genes	NULL
and	NULL
might	NULL
represent	NULL
a	NULL
PCR	NULL
artifact	NULL
.	NULL

Two	NULL
clones	NULL
were	NULL
identical	NULL
to	NULL
Ets-1	NULL
(	NULL
99	NULL
)	NULL
,	NULL
and	NULL
two	NULL
clones	NULL
corresponded	NULL
to	NULL
the	NULL
Ets-2	NULL
gene	NULL
(	NULL
99	NULL
)	NULL
.	NULL

However	NULL
,	NULL
10	NULL
clones	NULL
encoded	NULL
the	NULL
same	NULL
apparently	NULL
novel	NULL
ets-related	NULL
protein	NULL
with	NULL
the	NULL
highest	NULL
homology	NULL
to	NULL
ELK-1	NULL
(	NULL
68	NULL
)	NULL
and	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
,	NULL
a	NULL
subgroup	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
both	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
sequences	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
gene	NULL
,	NULL
whereas	NULL
our	NULL
gene	NULL
was	NULL
of	NULL
murine	NULL
origin	NULL
,	NULL
we	NULL
had	NULL
to	NULL
make	NULL
sure	NULL
that	NULL
our	NULL
gene	NULL
was	NULL
indeed	NULL
a	NULL
new	NULL
gene	NULL
and	NULL
not	NULL
the	NULL
murine	NULL
counterpart	NULL
of	NULL
ELK-1	NULL
or	NULL
SAP-1	NULL
.	NULL

We	NULL
designed	NULL
two	NULL
additional	NULL
degenerate	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
based	NULL
on	NULL
conserved	NULL
regions	NULL
A	NULL
and	NULL
C	NULL
present	NULL
in	NULL
both	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
.	NULL

PCR	NULL
amplification	NULL
using	NULL
primers	NULL
E	NULL
and	NULL
F	NULL
and	NULL
cDNA	NULL
derived	NULL
from	NULL
BASC6C2	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
~900-bp	NULL
amplification	NULL
product	NULL
.	NULL

Upon	NULL
sequencing	NULL
,	NULL
this	NULL
900-bp	NULL
DNA	NULL
fragment	NULL
gave	NULL
us	NULL
a	NULL
predicted	NULL
open	NULL
reading	NULL
frame	NULL
which	NULL
confirmed	NULL
the	NULL
similarity	NULL
to	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
in	NULL
regions	NULL
A	NULL
to	NULL
C	NULL
as	NULL
well	NULL
as	NULL
the	NULL
striking	NULL
divergence	NULL
from	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
in	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cDNA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
relatedness	NULL
of	NULL
our	NULL
gene	NULL
to	NULL
the	NULL
ets	NULL
family	NULL
,	NULL
we	NULL
named	NULL
it	NULL
ERP	NULL
(	NULL
ets-related	NULL
protein	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
ERP	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
5	NULL
'	NULL
RACE	NULL
method	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
primer	NULL
G	NULL
close	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
our	NULL
cDNA	NULL
for	NULL
priming	NULL
and	NULL
primer	NULL
H	NULL
further	NULL
5	NULL
of	NULL
primer	NULL
G	NULL
together	NULL
with	NULL
an	NULL
oligo	NULL
(	NULL
dG	NULL
)	NULL
anchor	NULL
primer	NULL
for	NULL
PCR	NULL
amplification	NULL
.	NULL

We	NULL
obtained	NULL
several	NULL
5	NULL
cDNA	NULL
clones	NULL
which	NULL
upon	NULL
sequencing	NULL
were	NULL
found	NULL
to	NULL
lie	NULL
within	NULL
200	NULL
bp	NULL
from	NULL
each	NULL
other	NULL
,	NULL
suggesting	NULL
the	NULL
possibility	NULL
of	NULL
multiple	NULL
transcription	NULL
start	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
has	NULL
C	NULL
A	NULL
B	NULL
a	NULL
)	NULL
C	NULL
--	NULL
EC	NULL
NOM	NULL
N	NULL
Y	NULL
D	NULL
K	NULL
B	NULL
)	NULL
PRIMER	NULL
E	NULL
5	NULL
'	NULL
-GCTAGCGGCCGCAATATGAATTATCATAA-3	NULL
'	NULL
C	NULL
c	NULL
c	NULL
c	NULL
NotI	NULL
my	NULL
|	NULL
--	NULL
I	NULL
HOF	NULL
W	NULL
s	NULL
T	NULL
PRIMER	NULL
F	NULL
-	NULL
3'-TAAGTAAAAACCTGNTGCGCCGGCGATCG-5	NULL
'	NULL
G	NULL
c	NULL
G	NULL
AC	NULL
T	NULL
NotI	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Homology	NULL
regions	NULL
within	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
.	NULL

Domains	NULL
A	NULL
to	NULL
C	NULL
denote	NULL
regions	NULL
of	NULL
homology	NULL
.	NULL

Blocks	NULL
of	NULL
amino	NULL
acids	NULL
(	NULL
in	NULL
one-letter	NULL
code	NULL
)	NULL
conserved	NULL
within	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
and	NULL
ELK-1	NULL
(	NULL
68	NULL
)	NULL
are	NULL
shown	NULL
below	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Degenerate	NULL
PCR	NULL
primers	NULL
derived	NULL
from	NULL
consensus	NULL
sequences	NULL
conserved	NULL
within	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
.	NULL

Degeneracies	NULL
are	NULL
indicated	NULL
,	NULL
with	NULL
N	NULL
denoting	NULL
all	NULL
four	NULL
deoxynucleotides	NULL
.	NULL

Restriction	NULL
sites	NULL
for	NULL
NotI	NULL
are	NULL
flanking	NULL
the	NULL
amino	NULL
acid-encoding	NULL
nucleotides	NULL
.	NULL

Vou	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
ets	NULL
FAMILY	NULL
3297	NULL
5	NULL
'	NULL
~AAAAGCCTGTTTACACAGACTGCACACCGCCTGGGGAATAATGCAGTAAAGGAAGTGAGCGGGC	NULL
88	NULL
we	NULL
we	NULL
te	NULL
w	NULL
#	NULL
t	NULL
oie	NULL
#	NULL
GCTCTCACACACACCAGAGGAGGGGGGGGGGGGAAGAGAAAAAAAAAAGAGGAGCGAGAGAAAGAAAAAAAAGAGGGGGGAAAATCAGGATCTCATTACAAGA	NULL
191	NULL
294	NULL
373	NULL
1	NULL
45	NULL
!	NULL

A	NULL
(	NULL
ETS	NULL
)	NULL
25	NULL
529	NULL
51	NULL
|K	NULL
.	NULL

I	NULL
.	NULL

dog	NULL
.	NULL

GTC	NULL
TCT	NULL
TIC	NULL
CTG	NULL
AAA	NULL
ATG	NULL
GAT	NULL
CCT	NULL
CAC	NULL
GCG	NULL
GTA	NULL
GAG	NULL
ATC	NULL
AGC	NULL
CGG	NULL
607	NULL
77	NULL
|G	NULL
v	NULL
8	NULL
F	NULL
L	NULL
K	NULL
M	NULL
D	NULL
P	NULL
K	NULL
A	NULL
v	NULL
E	NULL
I	NULL
8	NULL
R	NULL
GAG	NULL
GAC	NULL
TGT	NULL
AAG	NULL
GTG	NULL
GAA	NULL
GGC	NULL
CGA	NULL
GAG	NULL
GTC	NULL
CAC	NULL
AGG	NULL
CAC	NULL
GGC	NULL
TTG	NULL
TCC	NULL
TCC	NULL
685	NULL
103	NULL
R	NULL
D	NULL
C	NULL
K	NULL
v	NULL
E	NULL
G	NULL
R	NULL
E	NULL
v	NULL
id	NULL
R	NULL
H	NULL
G	NULL
L	NULL
8	NULL
S	NULL
CTC	NULL
TAC	NULL
CTC	NULL
CAC	NULL
TCG	NULL
GGC	NULL
CTC	NULL
TAC	NULL
TCG	NULL
TCC	NULL
TTC	NULL
ACC	NULL
ATC	NULL
Aac	NULL
TCC	NULL
Cre	NULL
AAC	NULL
GCT	NULL
763	NULL
B	NULL
129	NULL
L	NULL
Y	NULL
L	NULL
)	NULL
8	NULL
G	NULL
T	NULL
Y	NULL
8	NULL
B	NULL
4	NULL
T	NULL
I	NULL
N	NULL
j	NULL
L	NULL
[	NULL
+	NULL
]	NULL
N	NULL
A	NULL
CCA	NULL
ACG	NULL
GAG	NULL
AAG	NULL
CTG	NULL
GAG	NULL
GAG	NULL
CCC	NULL
TGT	NULL
GAT	NULL
GAC	NULL
AGC	NULL
CCC	NULL
CCT	NULL
GTG	NULL
GAA	NULL
GAA	NULL
GTC	NULL
AGG	NULL
841	NULL
155	NULL
P	NULL
T	NULL
E	NULL
K	NULL
L	NULL
E	NULL
E	NULL
P	NULL
C	NULL
D	NULL
D	NULL
8	NULL
P	NULL
P	NULL
v	NULL
E	NULL
E	NULL
v	NULL
R	NULL
ACT	NULL
AAA	NULL
ACC	NULL
GAC	NULL
AAG	NULL
CAC	NULL
ATC	NULL
ACC	NULL
AGG	NULL
CCT	NULL
GTG	NULL
ATG|TCC	NULL
CTG	NULL
CCT	NULL
TCC	NULL
ACA	NULL
TCC	NULL
GaG|	NULL
s19	NULL
181	NULL
T	NULL
K	NULL
T	NULL
D	NULL
K	NULL
H	NULL
I	NULL
T	NULL
R	NULL
P	NULL
v	NULL
M	NULL
J	NULL
L	NULL
P	NULL
8	NULL
T	NULL
3	NULL
E	NULL
ER	NULL
acc	NULL
TTC	NULL
CTG	NULL
GCC	NULL
TCA	NULL
TCP	NULL
GTC	NULL
TCA	NULL
GCC	NULL
AAG	NULL
ATC	NULL
TCC	NULL
TCT	NULL
TTA	NULL
ATG	NULL
TPG	NULL
CCA	NULL
AAT	NULL
QCT|	NULL
997	NULL
RICH	NULL
207|	NULL
T	NULL
Â¥	NULL
L	NULL
A	NULL
8	NULL
8	NULL
v	NULL
8	NULL
A	NULL
K	NULL
I	NULL
8	NULL
8	NULL
L	NULL
x	NULL
L	NULL
P	NULL
N	NULL
A	NULL
acc	NULL
mmmmmmwï¬'mmmmmmmmmmmnn	NULL
233|	NULL
A	NULL
8	NULL
8	NULL
8	NULL
R	NULL
8	NULL
P	NULL
8	NULL
L	NULL
8	NULL
P	NULL
D	NULL
8	NULL
P	NULL
L	NULL
P	NULL
8	NULL
E	NULL
H	NULL
AGA	NULL
TGC	NULL
CAT	NULL
GAG	NULL
TCG	NULL
GAT	NULL
TCT	NULL
CTG	NULL
GAG	NULL
CCC	NULL
CTG	NULL
AAT	NULL
CTG	NULL
TCA	NULL
TCG	NULL
GGC	NULL
TCC	NULL
AAA	NULL
ACC	NULL
1153	NULL
259	NULL
R	NULL
C	NULL
H	NULL
E	NULL
8	NULL
D	NULL
8	NULL
L	NULL
E	NULL
P	NULL
L	NULL
N	NULL
L	NULL
S	NULL
8	NULL
G	NULL
8	NULL
K	NULL
T	NULL
AAG	NULL
GGC	NULL
AAA	NULL
AAA	NULL
CCC	NULL
AAA	NULL
GGC	NULL
TTG	NULL
GAA	NULL
ATC	NULL
TCT	NULL
GCA	NULL
CCC	NULL
CAA	NULL
CTG	NULL
TTG	NULL
CTC	NULL
TCC	NULL
GGC	NULL
1231	NULL
285	NULL
K	NULL
G	NULL
K	NULL
K	NULL
P	NULL
K	NULL
G	NULL
L	NULL
E	NULL
I	NULL
8	NULL
A	NULL
P	NULL
Q	NULL
L	NULL
L	NULL
L	NULL
8	NULL
G	NULL
#	NULL
000	NULL
e	NULL
00	NULL
e	NULL
e	NULL
c+	NULL
ACC	NULL
AAC	NULL
AGC	NULL
CCA	NULL
GCC	NULL
CTC	NULL
CCC	NULL
TCA	NULL
GGA	NULL
TCC	NULL
CTC	NULL
ACT	NULL
CCA	NULL
GCC	NULL
TTC	NULL
TTC	NULL
ACC	NULL
GCA	NULL
CAG	NULL
1309	NULL
311	NULL
T	NULL
N	NULL
8	NULL
P	NULL
A	NULL
L	NULL
P	NULL
8	NULL
G	NULL
8	NULL
L	NULL
T	NULL
P	NULL
A	NULL
F	NULL
F	NULL
T	NULL
A	NULL
[	NULL
el	NULL
ACA	NULL
AGT	NULL
CCG	NULL
CTG	NULL
CTG	NULL
CCC	NULL
AGC	NULL
ATA	NULL
CAC	NULL
TTC	NULL
TGG	NULL
AGC	NULL
AGC	NULL
CTT	NULL
AGT	NULL
CCG	NULL
GTC	NULL
GCC|1387	NULL
337	NULL
T	NULL
8	NULL
S	NULL
P	NULL
L	NULL
L	NULL
P	NULL
8	NULL
I	NULL
A	NULL
Â®	NULL
w	NULL
S	NULL
8	NULL
L	NULL
8	NULL
P	NULL
v	NULL
A	NULL
CCA	NULL
GGG	NULL
CCG	NULL
AAC	NULL
ACA	NULL
CTT	NULL
TTC	NULL
CAG	NULL
TTC	NULL
CCC	NULL
)	NULL
ACA	NULL
CTG	NULL
CTC	NULL
AAC	NULL
GGT	NULL
CAC	NULL
ATG	NULL
CCG	NULL
GTG	NULL
1465	NULL
c	NULL
363	NULL
)	NULL
P	NULL
G	NULL
P	NULL
N	NULL
T	NULL
L	NULL
F	NULL
[	NULL
+	NULL
]	NULL
F	NULL
P	NULL
T	NULL
L	NULL
L	NULL
N	NULL
G	NULL
H	NULL
M	NULL
P	NULL
v	NULL
CCG	NULL
CCA	NULL
TCC	NULL
CCA	NULL
GTP	NULL
CTG	NULL
CTG	NULL
TCC	NULL
CCC	NULL
AGC	NULL
TCT	NULL
CAG	NULL
AAA	NULL
TCC	NULL
TGA	NULL
TGATGGGCCACCAAC	NULL
1546	NULL
389	NULL
P	NULL
P	NULL
8	NULL
P	NULL
v	NULL
L	NULL
L	NULL
8	NULL
P	NULL
8	NULL
8	NULL
Q	NULL
K	NULL
8	NULL
#	NULL
#	NULL
#	NULL
TGTCACTGTCATCAACTAAGGACTCAGAACAGATGACGGATGATGCCAGTTTGTCCCCATGGGCTAGTTTACCTGTGTCATGAGAAGGACATTGTGAAACCTG	NULL
1649	NULL
GTTCATTTGGTTTGCACTTTTCGTAACATGGATAATCTAGATGTATGTTAGCATTTTAAAACAAAAGTTTTGTCTTTTTATATATATATATATATATTCAGCT	NULL
1752	NULL
CTCTATAAAAGTCTGTTTCGCATTCAGTGAATTTTAATGTTTGTGTTTTTTTTTAATCTTGTTAGCTCTGGAGTGTTGAACACTGCCAGGGAGGAGCCTTTCT	NULL
1855	NULL
TAATGTTTTCAATGTAACTAATGAGGATGTGAAGCCTTTTATTGCTTTAACTCTACATATGCTGAACTCCGCTTGCATACACGATGTAACCAGCTGTGCCTTC	NULL
1958	NULL
CTTTGCATTTAGTGTTATATGTACATGAATTTATGTATTTCTAGTATTGAGAGGAACTGTTTGAAGGACACCTTGSCATCCAACTGCTCTCTGTAGAGGGTTA	NULL
2061	NULL
TTTTCTCACGTAGACACGTTCAAGTGAACCTCCATCGCGGTAAGAACTGCCTTAGGACCTCTTTGGAACTGAAATCCAGTAATGTCCAAGTGATGGGTTTTTA	NULL
2164	NULL
TATAAGAATGAACGAAGCCATATTTAGACAATAAACATTGTTTAAAG-3	NULL
'	NULL
2211	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
and	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
ERP	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
murine	NULL
ERP	NULL
,	NULL
with	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
(	NULL
one-letter	NULL
code	NULL
)	NULL
of	NULL
the	NULL
major	NULL
open	NULL
reading	NULL
frame	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

Nucleotides	NULL
are	NULL
numbered	NULL
on	NULL
the	NULL
right	NULL
;	NULL
amino	NULL
acids	NULL
are	NULL
numbered	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Peptide	NULL
sequences	NULL
underlined	NULL
with	NULL
a	NULL
dashed	NULL
line	NULL
denote	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
degenerate	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
for	NULL
the	NULL
original	NULL
PCR	NULL
amplification	NULL
.	NULL

Domains	NULL
A	NULL
(	NULL
ETS	NULL
domain	NULL
)	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
which	NULL
are	NULL
homologous	NULL
to	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
alanine-serine-rich	NULL
domain	NULL
,	NULL
are	NULL
shaded	NULL
and	NULL
labeled	NULL
on	NULL
the	NULL
right	NULL
.	NULL

The	NULL
termination	NULL
codons	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
reading	NULL
frame	NULL
upstream	NULL
and	NULL
downstream	NULL
are	NULL
indicated	NULL
by	NULL
asterisks	NULL
.	NULL

A	NULL
putative	NULL
nuclear	NULL
localization	NULL
sequence	NULL
is	NULL
marked	NULL
by	NULL
filled	NULL
circles	NULL
.	NULL

The	NULL
putative	NULL
polyadenylation	NULL
sequence	NULL
,	NULL
AATAAA	NULL
,	NULL
close	NULL
to	NULL
the	NULL
polyadenylated	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
mRNA	NULL
is	NULL
doubly	NULL
underlined	NULL
.	NULL

The	NULL
ATTTA	NULL
motifs	NULL
involved	NULL
in	NULL
mRNA	NULL
turnover	NULL
are	NULL
underlined	NULL
.	NULL

Arrows	NULL
,	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
different	NULL
cDNAs	NULL
.	NULL

confirmed	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
transcription	NULL
start	NULL
sites	NULL
(	NULL
data	NULL
brary	NULL
with	NULL
the	NULL
900-bp	NULL
ERP	NULL
PCR-amplified	NULL
fragment	NULL
.	NULL

We	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

isolated	NULL
six	NULL
positive	NULL
clones	NULL
,	NULL
which	NULL
were	NULL
all	NULL
sequenced	NULL
in	NULL
their	NULL
To	NULL
obtain	NULL
the	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
ERP	NULL
,	NULL
we	NULL
screened	NULL
entirety	NULL
.	NULL

One	NULL
clone	NULL
containing	NULL
a	NULL
~2-kb	NULL
insert	NULL
was	NULL
almost	NULL
full	NULL
a	NULL
random-primed-oligo	NULL
(	NULL
dT	NULL
)	NULL
-primed	NULL
murine	NULL
lung	NULL
cDNA	NULL
li-	NULL
length	NULL
starting	NULL
with	NULL
a	NULL
3	NULL
'	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
and	NULL
encoding	NULL
the	NULL
whole	NULL
3298	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

Cec	NULL
.	NULL

BioL	NULL
.	NULL

ETS	NULL
DOMAIN	NULL
(	NULL
DOMAIN	NULL
A	NULL
)	NULL
SAP-1	NULL
EAP	NULL
ELK	NULL
SAP-1	NULL
--	NULL
--	NULL
9u	NULL
~af	NULL
@	NULL
f1	NULL
--	NULL
--	NULL
-	NULL
n	NULL
xsmrsx-J	NULL
sssxnv	NULL
:	NULL
nsnxnxnopc	NULL
ERP	NULL
â	NULL
Hf	NULL
â	NULL
LLLQ	NULL
--	NULL
--	NULL
--	NULL
--	NULL
iprcrÂ®Â¥urnG-	NULL
--	NULL
--	NULL
LsS	NULL
ELK-1	NULL
nvaccsuncnqr	NULL
viyt	NULL
mpuvnumummvxcncrpxamu-dares	NULL
SAP-1	NULL
paguuuslqipnsmgx	NULL
;	NULL
Fe	NULL
ERP	NULL
Â®	NULL
f	NULL
1eiip	NULL
-	NULL
con	NULL
ELK-1	NULL
i	NULL
it	NULL
7	NULL
8	NULL
porn	NULL
--	NULL
--	NULL
--	NULL
HPRPAVVLPNAAPAGAAAP	NULL
--	NULL
--	NULL
--	NULL
--	NULL
psosrsis	NULL
#	NULL
sr	NULL
SAP-1	NULL
ATIBIGPSISPSSEETIQAQBTLWPILPQBA	NULL
â	NULL
T	NULL
ignvu'muTwrrxisxluqxnn'wsrins	NULL
!	NULL

HPD	NULL
ERP	NULL
--	NULL
HSBPSTSETXAARASAPhASSï¬ï¬htls	NULL
mtÂ¥in	NULL
--	NULL
--	NULL
vssns	NULL
!	NULL

ssinsbit	NULL
.	NULL

--	NULL
--	NULL
-ELK~1	NULL
LEACKLE	NULL
--	NULL
--	NULL
~	NULL
IEBIGLPLQVILTPPEAPN	NULL
â	NULL
KSBBLNVBPGLGRALPï¬IVKVBGPKBELEVAGERGFVPQTTK	NULL
SAP-1	NULL
mmxnsvnsopnlnvxmnspinqnsvï¬uxnxvu	NULL
ssr	NULL
ERP	NULL
}	NULL
ELKT	NULL
_	NULL
AEPEVPPORGVPARLBAVVNDTAGQAGGHAASSPEISQÂ®	NULL
sap	NULL
thr	NULL
ERP	NULL
scnrï¬a	NULL
ELK	NULL
7	NULL
snnp'ru'rnrrnvnm	NULL
[	NULL
SARQUDLLS	NULL
@	NULL
TDI	NULL
--	NULL
GsSIALNBPA	NULL
IUPLSPSLLGGPGPERTPGSGSGSG	NULL
vÃ©ssnerrtts	NULL
SAP-1	NULL
GWHDL	NULL
!	NULL

PLAHFPQTYRRHNLCTCGHRBï¬RNBB	NULL
â	NULL
I'DIQHDCI	NULL
EAP	NULL
--	NULL
Â¥PEÂ¥BEpRrapsp	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-ELK1	NULL
_	NULL
--	NULL
vHIÂ¥8ISv	NULL
--	NULL
--	NULL
--	NULL
-	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
ERP	NULL
with	NULL
those	NULL
of	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
.	NULL

The	NULL
optimal	NULL
alignment	NULL
of	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
ERP	NULL
,	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
ELK-1	NULL
(	NULL
68	NULL
)	NULL
,	NULL
using	NULL
the	NULL
Seqapp	NULL
and	NULL
Clustal	NULL
programs	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
four	NULL
major	NULL
homology	NULL
regions-the	NULL
ETS	NULL
domain	NULL
(	NULL
domain	NULL
A	NULL
)	NULL
and	NULL
domains	NULL
B	NULL
to	NULL
D-are	NULL
boxed	NULL
.	NULL

Regions	NULL
of	NULL
amino	NULL
acid	NULL
identity	NULL
with	NULL
ERP	NULL
are	NULL
shaded	NULL
.	NULL

open	NULL
reading	NULL
frame	NULL
.	NULL

The	NULL
other	NULL
clones	NULL
between	NULL
900	NULL
bp	NULL
and	NULL
1.3	NULL
kb	NULL
in	NULL
length	NULL
contained	NULL
overlapping	NULL
portions	NULL
of	NULL
either	NULL
the	NULL
3	NULL
'	NULL
end	NULL
or	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
ERP	NULL
cDNA	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
lung	NULL
ERP	NULL
cDNA	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
BASC6C2	NULL
pre-B-cell	NULL
line	NULL
ERP	NULL
cDNA	NULL
,	NULL
two	NULL
nucleotide	NULL
differences	NULL
(	NULL
C-466-T-466	NULL
and	NULL
C-469-T-469	NULL
)	NULL
were	NULL
observed	NULL
without	NULL
resulting	NULL
in	NULL
a	NULL
change	NULL
of	NULL
the	NULL
encoded	NULL
amino	NULL
acids	NULL
.	NULL

This	NULL
suggests	NULL
a	NULL
polymorphism	NULL
for	NULL
these	NULL
two	NULL
nucleotides	NULL
in	NULL
the	NULL
murine	NULL
ERP	NULL
gene	NULL
rather	NULL
than	NULL
a	NULL
PCR	NULL
artifact	NULL
,	NULL
since	NULL
sequencing	NULL
of	NULL
several	NULL
independent	NULL
PCR	NULL
amplification	NULL
products	NULL
resulted	NULL
in	NULL
the	NULL
same	NULL
sequence	NULL
.	NULL

The	NULL
combined	NULL
length	NULL
of	NULL
the	NULL
cDNA	NULL
clones	NULL
equaled	NULL
2,211	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
ERP	NULL
.	NULL

Both	NULL
strands	NULL
of	NULL
the	NULL
2.2-kb	NULL
ERP	NULL
cDNA	NULL
were	NULL
sequenced	NULL
entirely	NULL
by	NULL
double-stranded	NULL
dideoxy	NULL
sequencing	NULL
using	NULL
M13	NULL
sequencing	NULL
primers	NULL
,	NULL
T7	NULL
and	NULL
T3	NULL
polymerase	NULL
sequencing	NULL
primers	NULL
,	NULL
and	NULL
ERP-specific	NULL
primers	NULL
based	NULL
on	NULL
partial	NULL
DNA	NULL
sequencing	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
ERP	NULL
cDNA	NULL
revealed	NULL
a	NULL
1,227-nucleotide	NULL
open	NULL
reading	NULL
frame	NULL
encoding	NULL
a	NULL
409-amino-acid	NULL
protein	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
mass	NULL
of	NULL
44.5	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
starting	NULL
with	NULL
an	NULL
ATG	NULL
at	NULL
position	NULL
302	NULL
and	NULL
terminating	NULL
with	NULL
a	NULL
TGA	NULL
at	NULL
position	NULL
1529	NULL
.	NULL

The	NULL
ATG	NULL
initiator	NULL
codon	NULL
partially	NULL
conforms	NULL
to	NULL
the	NULL
consensus	NULL
eukaryotic	NULL
translation	NULL
initiation	NULL
sequence	NULL
(	NULL
33	NULL
)	NULL
with	NULL
a	NULL
G	NULL
at	NULL
position	NULL
+4	NULL
and	NULL
a	NULL
G	NULL
at	NULL
position	NULL
-3	NULL
.	NULL

There	NULL
are	NULL
several	NULL
reasons	NULL
to	NULL
believe	NULL
that	NULL
this	NULL
ATG	NULL
is	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
.	NULL

No	NULL
additional	NULL
ATG	NULL
is	NULL
found	NULL
in	NULL
frame	NULL
,	NULL
and	NULL
an	NULL
in-frame	NULL
termination	NULL
codon	NULL
is	NULL
found	NULL
228	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
ERP	NULL
is	NULL
compared	NULL
with	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
all	NULL
three	NULL
contain	NULL
the	NULL
initiator	NULL
methionine	NULL
at	NULL
the	NULL
same	NULL
position	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
ATG	NULL
is	NULL
the	NULL
true	NULL
translation	NULL
initiation	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
deletion	NULL
of	NULL
all	NULL
the	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
does	NULL
not	NULL
alter	NULL
the	NULL
size	NULL
of	NULL
the	NULL
protein	NULL
product	NULL
,	NULL
when	NULL
the	NULL
product	NULL
is	NULL
translated	NULL
in	NULL
vitro	NULL
(	NULL
62	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
translation	NULL
of	NULL
ERP	NULL
starts	NULL
at	NULL
a	NULL
codon	NULL
different	NULL
from	NULL
ATG	NULL
.	NULL

The	NULL
ERP	NULL
cDNA	NULL
contains	NULL
a	NULL
long	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
starting	NULL
at	NULL
position	NULL
2211	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
which	NULL
is	NULL
preceded	NULL
by	NULL
a	NULL
classical	NULL
polyadenylation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
at	NULL
an	NULL
appropriate	NULL
distance	NULL
.	NULL

Three	NULL
ATTTA	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
rapid	NULL
mRNA	NULL
turnover	NULL
(	NULL
1	NULL
,	NULL
73	NULL
,	NULL
82	NULL
)	NULL
,	NULL
are	NULL
found	NULL
in	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
,	NULL
suggesting	NULL
a	NULL
low	NULL
stability	NULL
of	NULL
ERP	NULL
mRNA	NULL
.	NULL

A	NULL
hydropathicity	NULL
plot	NULL
of	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
reveals	NULL
a	NULL
hydrophobic	NULL
amino	NULL
terminus	NULL
(	NULL
~15	NULL
amino	NULL
acids	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
~285-amino-acid	NULL
primarily	NULL
hydrophilic	NULL
domain	NULL
and	NULL
a	NULL
carboxy-terminal	NULL
hydrophobic	NULL
domain	NULL
of	NULL
~110	NULL
amino	NULL
acids	NULL
.	NULL

The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
ERP	NULL
predicts	NULL
a	NULL
protein	NULL
rich	NULL
in	NULL
proline	NULL
(	NULL
9	NULL
%	NULL
)	NULL
,	NULL
serine	NULL
(	NULL
16	NULL
%	NULL
)	NULL
,	NULL
leucine	NULL
(	NULL
14	NULL
%	NULL
)	NULL
,	NULL
and	NULL
lysine	NULL
(	NULL
7	NULL
%	NULL
)	NULL
.	NULL

The	NULL
middle	NULL
of	NULL
ERP	NULL
,	NULL
spanning	NULL
from	NULL
around	NULL
amino	NULL
acid	NULL
200	NULL
down	NULL
to	NULL
around	NULL
amino	NULL
acid	NULL
250	NULL
,	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
high	NULL
abundance	NULL
of	NULL
alanine	NULL
and	NULL
serine	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Of	NULL
57	NULL
amino	NULL
acids	NULL
,	NULL
21	NULL
(	NULL
37	NULL
%	NULL
)	NULL
represent	NULL
serine	NULL
and	NULL
11	NULL
(	NULL
19	NULL
%	NULL
)	NULL
represent	NULL
alanine	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
cluster	NULL
of	NULL
five	NULL
alanines	NULL
is	NULL
found	NULL
in	NULL
amino	NULL
acids	NULL
208	NULL
to	NULL
212	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
serines	NULL
appear	NULL
to	NULL
form	NULL
short	NULL
clusters	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
amino-terminal	NULL
half	NULL
,	NULL
which	NULL
contains	NULL
most	NULL
of	NULL
the	NULL
basic	NULL
and	NULL
acidic	NULL
amino	NULL
acids	NULL
,	NULL
the	NULL
carboxy-terminal	NULL
half	NULL
contains	NULL
very	NULL
few	NULL
acidic	NULL
or	NULL
basic	NULL
amino	NULL
acid	NULL
residues	NULL
but	NULL
is	NULL
proline	NULL
rich	NULL
,	NULL
with	NULL
27	NULL
(	NULL
17	NULL
%	NULL
)	NULL
prolines	NULL
out	NULL
of	NULL
163	NULL
amino	NULL
acids	NULL
.	NULL

Serine-	NULL
and	NULL
proline-rich	NULL
domains	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
have	NULL
been	NULL
implicated	NULL
previously	NULL
in	NULL
transactivation	NULL
(	NULL
67	NULL
,	NULL
84	NULL
,	NULL
101	NULL
)	NULL
.	NULL

Interest	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
eis	NULL
FAMILY	NULL
3299	NULL
+14	NULL
,	NULL
IDENTITY	NULL
*	NULL
%	NULL
ERP	NULL
-	NULL
cur	NULL
si	NULL
5	NULL
o	NULL
-	NULL
(	NULL
â¬	NULL
]	NULL
-	NULL
-r	NULL
x	NULL
1	NULL
Â®	NULL
Â®	NULL
v	NULL
A	NULL
K	NULL
L	NULL
w	NULL
0	NULL
L	NULL
Â®	NULL
Â®	NULL
)	NULL
-	NULL
M	NULL
K	NULL
T	NULL
m	NULL
M	NULL
N	NULL
Y	NULL
DKC	NULL
5	NULL
R	NULL
A	NULL
5	NULL
R	NULL
Y	NULL
Y	NULL
Y	NULL
DK	NULL
H	NULL
I	NULL
1	NULL
}	NULL
-x	NULL
k	NULL
vira	NULL
-/o	NULL
x	NULL
r	NULL
v	NULL
v	NULL
x	NULL
r	NULL
sap-1	NULL
-	NULL
-	NULL
ir	NULL
our	NULL
sana	NULL
-	NULL
o	NULL
-	NULL
-/r	NULL
xn	NULL
clola	NULL
n	NULL
av	NULL
aleln	NULL
w	NULL
Â®	NULL
)	NULL
-n	NULL
o	NULL
x	NULL
n	NULL
e	NULL
n	NULL
a	NULL
oir	NULL
iv	NULL
r	NULL
a	NULL
1	NULL
]	NULL
-n	NULL
ic	NULL
-lorxryyx	NULL
Â®	NULL
Â»	NULL
81	NULL
ELE-1	NULL
a	NULL
-	NULL
-	NULL
=	NULL
olg	NULL
)	NULL
-	NULL
-|rxzfvolazeyv	NULL
-nurlul	NULL
!	NULL

nxnsnanxrrrnxl	NULL
;	NULL
-	NULL
Rix	NULL
visle	NULL
-lo	NULL
xr	NULL
v	NULL
v	NULL
Â®	NULL
r	NULL
,	NULL
78	NULL
vas	NULL
|	NULL
ortls	NULL
sohc	NULL
o	NULL
xx	NULL
s	NULL
oÂ£	NULL
c	NULL
r	NULL
[	NULL
pft	NULL
ov	NULL
-	NULL
-le	NULL
x2	NULL
vor	NULL
aG	NULL
c	NULL
shay	NULL
oxfids	NULL
r	NULL
a	NULL
nav	NULL
v	NULL
e	NULL
1ft	NULL
.	NULL

-	NULL
ale	NULL
viola	NULL
-	NULL
Â®	NULL
Â®	NULL
a	NULL
c/xfol	NULL
as	NULL
RG	NULL
siple	NULL
a	NULL
w	NULL
a	NULL
s	NULL
-	NULL
-	NULL
ciriniwis	NULL
o	NULL
-	NULL
rm	NULL
of-	NULL
-Ir	NULL
xin	NULL
r	NULL
op	NULL
viev	NULL
Jero	NULL
Y	NULL
DK	NULL
L	NULL
8	NULL
R	NULL
AL	NULL
RY	NULL
YY	NULL
DX	NULL
H	NULL
tin	NULL
-	NULL
Tk	NULL
Visgl-	NULL
x	NULL
rv	NULL
aly	NULL
Â®	NULL
9	NULL
so	NULL
ror-1	NULL
s	NULL
ANA	NULL
s	NULL
-	NULL
-	NULL
C	NULL
so	NULL
-	NULL
T	NULL
Â»	NULL
oin	NULL
r	NULL
o	NULL
p	NULL
Dev	NULL
PINNEY	NULL
DXL	NULL
S	NULL
RA	NULL
LRYYY	NULL
DEN	NULL
-	NULL
KR	NULL
YAY	NULL
Er	NULL
so	NULL
p-ers	NULL
plc	NULL
x	NULL
[	NULL
8	NULL
)	NULL
7	NULL
n	NULL
-	NULL
-	NULL
-	NULL
r	NULL
Â®	NULL
-r	NULL
xr	NULL
D	NULL
p	NULL
D	NULL
Rv	NULL
wa	NULL
yizlxosranÂ®y	NULL
yy	NULL
bo	NULL
b	NULL
sig-	NULL
x	NULL
x	NULL
xc	NULL
rf	NULL
56	NULL
casp-	NULL
o	NULL
lx	NULL
o	NULL
a	NULL
Â®	NULL
p	NULL
-	NULL
~	NULL
clzistulv	NULL
a	NULL
[	NULL
ols	NULL
of-	NULL
-/	NULL
x	NULL
tim	NULL
o	NULL
aw	NULL
viz	NULL
sr	NULL
anry	NULL
ry	NULL
beb	NULL
old-	NULL
x	NULL
rir	NULL
vv	NULL
Â®	NULL
r	NULL
,	NULL
J	NULL
EATFi-60	NULL
DK	NULL
D	NULL
A	NULL
R	NULL
D	NULL
-	NULL
-	NULL
CJT	NULL
vG	NULL
-	NULL
-	NULL
~|F	NULL
K	NULL
LH	NULL
Q	NULL
ine	NULL
80	NULL
KL	NULL
S	NULL
RA	NULL
LRYYYDG	NULL
D	NULL
q	NULL
-	NULL
x	NULL
R	NULL
[	NULL
F	NULL
V	NULL
Y	NULL
Â®	NULL
#	NULL
)	NULL
60	NULL
ER71	NULL
ajsizntiofble	NULL
a	NULL
r	NULL
s	NULL
s	NULL
-	NULL
-	NULL
clzlriw	NULL
tio	NULL
-	NULL
us	NULL
-	NULL
~|ngue	NULL
oro	NULL
ev	NULL
s	NULL
r	NULL
18	NULL
NGLRYTYYRÂ®R	NULL
s	NULL
q	NULL
-	NULL
56	NULL
ET8-1	NULL
\	NULL
it	NULL
:	NULL
t	NULL
pir	NULL
s	NULL
cos	NULL
-	NULL
-	NULL
riz	NULL
-	NULL
-|FERIS	NULL
D	NULL
P	NULL
Dey	NULL
NYEKTL	NULL
S	NULL
RGLRYYYDENT	NULL
I	NULL
-	NULL
sgt	NULL
aG	NULL
-	NULL
x	NULL
Â®	NULL
Â®	NULL
62	NULL
Ers-2	NULL
't	NULL
sxscosnr	NULL
:	NULL
u	NULL
a	NULL
-	NULL
~	NULL
[	NULL
FEÂ®IA	NULL
D	NULL
?	NULL

DEV	NULL
oa	NULL
y	NULL
[	NULL
zix	NULL
6	NULL
s	NULL
Rolo	NULL
rr	NULL
tv	NULL
sig-	NULL
x	NULL
Â®	NULL
viv	NULL
Â¥	NULL
}	NULL
n	NULL
62	NULL
c-zrs-2	NULL
lu	NULL
s	NULL
c	NULL
os	NULL
-	NULL
-	NULL
ritls|	NULL
\	NULL
-	NULL
D	NULL
Â»	NULL
DEV	NULL
a	NULL
18	NULL
I-	NULL
mgt	NULL
sig-	NULL
xr	NULL
Â®	NULL
62	NULL
uUrinkEDÂ®	NULL
t	NULL
cos	NULL
-	NULL
-	NULL
riz	NULL
-	NULL
D	NULL
P	NULL
DBV	NULL
hon	NULL
vizie	NULL
o	NULL
s	NULL
ax	NULL
v	NULL
x	NULL
prom	NULL
I	NULL
x	NULL
)	NULL
mixt	NULL
alg	NULL
-	NULL
x	NULL
Â®	NULL
viv	NULL
vinlr	NULL
63	NULL
ETS-3	NULL
I	NULL
~ASNNAS-âCI	NULL
I0	NULL
TN	NULL
-	NULL
~|FEIT	NULL
D	NULL
P	NULL
DEV	NULL
MHY	NULL
DRL	NULL
8	NULL
RAL	NULL
.	NULL

59	NULL
ET8~4	NULL
uta	NULL
s	NULL
-T	NULL
I	NULL
DR	NULL
SK	NULL
GI	NULL
-	NULL
31	NULL
Â®	NULL
D	NULL
s	NULL
v	NULL
RV	NULL
ery	NULL
ox	NULL
u	NULL
s	NULL
(	NULL
z	NULL
Â®	NULL
Â®	NULL
uly	NULL
vir	NULL
as	NULL
Â®rs-6	NULL
taiols	NULL
s	NULL
w	NULL
aw	NULL
-	NULL
-	NULL
o	NULL
-	NULL
o	NULL
s	NULL
of	NULL
-	NULL
-	NULL
I	NULL
o	NULL
p	NULL
oE	NULL
v	NULL
afr	NULL
re	NULL
NHYDEKLSRALRYYYDRN	NULL
-	NULL
KRY	NULL
AYEY	NULL
so	NULL
E74	NULL
REYCPR	NULL
-	NULL
F	NULL
[	NULL
IRNENRERGV	NULL
-	NULL
-	NULL
V	NULL
D	NULL
8	NULL
K	NULL
I-TITHGIALIYY	NULL
!	NULL

QRG	NULL
-R	NULL
Â¥	NULL
47	NULL
ELEF-1	NULL
KATCP-~-EYEKWTQREKRGTI-	NULL
-	NULL
v	NULL
D	NULL
8	NULL
K	NULL
N	NULL
T	NULL
M	NULL
GIR	NULL
A	NULL
LR	NULL
YY	NULL
Yio	NULL
R	NULL
G	NULL
-	NULL
GR	NULL
Â¥	NULL
46	NULL
ERrei	NULL
-	NULL
819	NULL
s	NULL
p	NULL
s	NULL
u	NULL
s	NULL
[	NULL
Fabe	NULL
uR-	NULL
-	NULL
-|rx	NULL
31	NULL
Â®	NULL
p	NULL
how	NULL
x	NULL
bX	NULL
cs	NULL
Â®	NULL
slu	NULL
a	NULL
v	NULL
v	NULL
v	NULL
]	NULL
zhd	NULL
of	NULL
-	NULL
ER	NULL
YIV	NULL
YE	NULL
FI	NULL
se	NULL
reas	NULL
@	NULL
uonworuy	NULL
prx	NULL
``	NULL
111130	NULL
â	NULL
-	NULL
-|FEII	NULL
EP	NULL
aa	NULL
x	NULL
ox	NULL
o	NULL
s	NULL
Â®	NULL
sls	NULL
r	NULL
x	NULL
v	NULL
yieln	NULL
-	NULL
ERYVYEKF	NULL
eo	NULL
Spi-1/pu.1	NULL
.	NULL

KTR	NULL
r	NULL
5	NULL
o	NULL
puXÂ®	NULL
p	NULL
-	NULL
-	NULL
o	NULL
xfolx	NULL
a	NULL
r	NULL
r	NULL
oiris	NULL
a	NULL
x	NULL
a	NULL
sig	NULL
miviolsix	NULL
aln	NULL
a	NULL
t	NULL
ciH-rcl	NULL
mung	NULL
â	NULL
:	NULL
39	NULL
Spi-B	NULL
KL	NULL
TRGDMRE	NULL
--	NULL
CVNMMVEPGAGVFr	NULL
8	NULL
S	NULL
KH	NULL
Bg	NULL
TY	NULL
)	NULL
[	NULL
.	NULL

RA	NULL
L	NULL
A	NULL
GET	NULL
K-	NULL
~-	NULL
L	NULL
TIX	NULL
o	NULL
[	NULL
)	NULL
36	NULL
CONSENSUS	NULL
-	NULL
IQLWQRLLELL-D	NULL
--	NULL
--	NULL
-~-~	NULL
--	NULL
I-WTG-DG-E	NULL
--	NULL
FKL-DP-EVAR-W	NULL
@	NULL
-RE-NKP-MNYDKLSRALRYYYDKNI	NULL
--	NULL
-ERV-G-KR-vy-E	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
ERP	NULL
with	NULL
those	NULL
of	NULL
all	NULL
known	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Percent	NULL
identity	NULL
with	NULL
ERP	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Amino	NULL
acids	NULL
identical	NULL
to	NULL
those	NULL
in	NULL
ERP	NULL
are	NULL
shaded	NULL
.	NULL

Gaps	NULL
are	NULL
introduced	NULL
to	NULL
optimize	NULL
alignment	NULL
.	NULL

A	NULL
derived	NULL
consensus	NULL
sequence	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Amino	NULL
acids	NULL
conserved	NULL
among	NULL
all	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
are	NULL
underlined	NULL
.	NULL

References	NULL
:	NULL
SAP-1	NULL
,	NULL
14	NULL
;	NULL
ELK-1	NULL
,	NULL
68	NULL
;	NULL
YAN	NULL
,	NULL
37	NULL
;	NULL
ERG	NULL
,	NULL
76	NULL
;	NULL
Fli-1	NULL
,	NULL
65	NULL
;	NULL
D-ELG	NULL
,	NULL
66	NULL
;	NULL
GABPa	NULL
,	NULL
38	NULL
;	NULL
E4TF1-60	NULL
,	NULL
98	NULL
;	NULL
ER71	NULL
,	NULL
10	NULL
;	NULL
Ets-1	NULL
,	NULL
12	NULL
,	NULL
23	NULL
,	NULL
43	NULL
,	NULL
74	NULL
,	NULL
99	NULL
;	NULL
Ets-2	NULL
,	NULL
99	NULL
;	NULL
C-Ets-2	NULL
,	NULL
8	NULL
;	NULL
D-Ets-2	NULL
,	NULL
66	NULL
;	NULL
Ets-3	NULL
,	NULL
13	NULL
;	NULL
Ets-4	NULL
,	NULL
13	NULL
;	NULL
Ets-6	NULL
,	NULL
13	NULL
;	NULL
E74	NULL
,	NULL
11	NULL
;	NULL
ELF-1	NULL
,	NULL
41	NULL
;	NULL
ER81	NULL
,	NULL
10	NULL
;	NULL
PEA3	NULL
,	NULL
103	NULL
;	NULL
Spi-1/Pu.1	NULL
,	NULL
30	NULL
;	NULL
Spi-B	NULL
,	NULL
72.	NULL
ingly	NULL
,	NULL
alanine-rich	NULL
regions	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
transcriptional	NULL
repression	NULL
functions	NULL
(	NULL
50	NULL
)	NULL
.	NULL

A	NULL
potential	NULL
nuclear	NULL
localization	NULL
sequence	NULL
,	NULL
KGKKPK	NULL
,	NULL
is	NULL
located	NULL
between	NULL
amino	NULL
acids	NULL
292	NULL
and	NULL
297	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Several	NULL
potential	NULL
glycosylation	NULL
sites	NULL
,	NULL
NKTN	NULL
,	NULL
NKTD	NULL
,	NULL
and	NULL
NLSS	NULL
,	NULL
as	NULL
well	NULL
as	NULL
seven	NULL
putative	NULL
protein	NULL
kinase	NULL
C	NULL
phosphorylation	NULL
sites	NULL
,	NULL
five	NULL
casein	NULL
kinase	NULL
II	NULL
phosphorylation	NULL
sites	NULL
,	NULL
a	NULL
edc2	NULL
kinase	NULL
phosphorylation	NULL
site	NULL
,	NULL
and	NULL
a	NULL
tyrosine	NULL
kinase	NULL
phosphorylation	NULL
site	NULL
are	NULL
present	NULL
in	NULL
ERP	NULL
(	NULL
29	NULL
,	NULL
35	NULL
,	NULL
81	NULL
,	NULL
92	NULL
)	NULL
.	NULL

The	NULL
predicted	NULL
ERP	NULL
protein	NULL
sequence	NULL
reveals	NULL
,	NULL
furthermore	NULL
,	NULL
15	NULL
potential	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
phosphorylation	NULL
sites	NULL
(	NULL
S/TP	NULL
)	NULL
,	NULL
two	NULL
of	NULL
them	NULL
containing	NULL
the	NULL
optimal	NULL
PX	NULL
(	NULL
S/T	NULL
)	NULL
P	NULL
sequence	NULL
(	NULL
3	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Several	NULL
of	NULL
the	NULL
putative	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
sites	NULL
are	NULL
present	NULL
in	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
as	NULL
well	NULL
(	NULL
14	NULL
,	NULL
56	NULL
,	NULL
68	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
sites	NULL
for	NULL
the	NULL
biological	NULL
function	NULL
of	NULL
ELK-1	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
(	NULL
56	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
at	NULL
least	NULL
some	NULL
of	NULL
these	NULL
putative	NULL
sites	NULL
might	NULL
be	NULL
functionally	NULL
relevant	NULL
for	NULL
ERP	NULL
as	NULL
well	NULL
.	NULL

We	NULL
observed	NULL
also	NULL
that	NULL
the	NULL
antisense	NULL
DNA	NULL
strand	NULL
to	NULL
ERP	NULL
contains	NULL
another	NULL
209-amino-acid	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
homology	NULL
to	NULL
any	NULL
known	NULL
protein	NULL
was	NULL
found	NULL
when	NULL
the	NULL
data	NULL
base	NULL
was	NULL
searched	NULL
for	NULL
this	NULL
potential	NULL
protein	NULL
.	NULL

We	NULL
have	NULL
no	NULL
evidence	NULL
as	NULL
to	NULL
whether	NULL
the	NULL
complementary	NULL
DNA	NULL
strand	NULL
is	NULL
indeed	NULL
transcribed	NULL
.	NULL

Sequence	NULL
comparison	NULL
of	NULL
ERP	NULL
with	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
ERP	NULL
with	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
revealed	NULL
the	NULL
highest	NULL
homology	NULL
to	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
and	NULL
ELK-1	NULL
(	NULL
68	NULL
)	NULL
,	NULL
a	NULL
subgroup	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
homology	NULL
of	NULL
ERP	NULL
with	NULL
SAP-1	NULL
is	NULL
46	NULL
%	NULL
,	NULL
and	NULL
that	NULL
of	NULL
ERP	NULL
with	NULL
ELK-1	NULL
is	NULL
36	NULL
%	NULL
.	NULL

Homologies	NULL
are	NULL
clustered	NULL
in	NULL
three	NULL
primary	NULL
regions	NULL
,	NULL
the	NULL
amino-terminal	NULL
domain	NULL
A	NULL
,	NULL
a	NULL
smaller	NULL
domain	NULL
B	NULL
slightly	NULL
further	NULL
down-stream	NULL
,	NULL
and	NULL
domain	NULL
C	NULL
close	NULL
to	NULL
the	NULL
carboxy	NULL
terminus	NULL
.	NULL

An	NULL
additional	NULL
short	NULL
stretch	NULL
of	NULL
homology	NULL
,	NULL
domain	NULL
D	NULL
,	NULL
contains	NULL
potential	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

All	NULL
three	NULL
proteins	NULL
apparently	NULL
start	NULL
at	NULL
the	NULL
same	NULL
methionine	NULL
,	NULL
with	NULL
the	NULL
highly	NULL
conserved	NULL
ETS	NULL
domain	NULL
(	NULL
domain	NULL
A	NULL
)	NULL
directly	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
.	NULL

Spacing	NULL
between	NULL
regions	NULL
A	NULL
and	NULL
B	NULL
,	NULL
as	NULL
well	NULL
as	NULL
between	NULL
regions	NULL
B	NULL
and	NULL
C	NULL
,	NULL
appears	NULL
not	NULL
to	NULL
be	NULL
conserved	NULL
.	NULL

The	NULL
regions	NULL
in	NULL
between	NULL
the	NULL
conserved	NULL
domains	NULL
show	NULL
only	NULL
limited	NULL
homology	NULL
to	NULL
each	NULL
other	NULL
.	NULL

Alignment	NULL
of	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
ERP	NULL
with	NULL
that	NULL
of	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
revealed	NULL
highest	NULL
homology	NULL
to	NULL
SAP-1	NULL
(	NULL
81	NULL
%	NULL
)	NULL
and	NULL
ELK-1	NULL
(	NULL
78	NULL
%	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Sequence	NULL
identity	NULL
to	NULL
most	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
was	NULL
~60	NULL
%	NULL
.	NULL

ERP	NULL
is	NULL
least	NULL
related	NULL
to	NULL
Pu.l/Spi-1	NULL
(	NULL
39	NULL
%	NULL
)	NULL
(	NULL
31	NULL
)	NULL
and	NULL
Spi-B	NULL
(	NULL
36	NULL
%	NULL
)	NULL
(	NULL
72	NULL
)	NULL
.	NULL

Homology	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
ETS	NULL
domain	NULL
which	NULL
is	NULL
involved	NULL
in	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
short	NULL
stretches	NULL
of	NULL
similarity	NULL
between	NULL
ERP	NULL
and	NULL
E74A	NULL
or	NULL
E74B	NULL
(	NULL
11	NULL
)	NULL
exist	NULL
in	NULL
the	NULL
alanine-serine-rich	NULL
region	NULL
of	NULL
ERP	NULL
,	NULL
which	NULL
is	NULL
divergent	NULL
from	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
between	NULL
ERP	NULL
and	NULL
Ets-1	NULL
(	NULL
99	NULL
)	NULL
in	NULL
a	NULL
region	NULL
homologous	NULL
to	NULL
SAP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
pattern	NULL
of	NULL
ERP	NULL
in	NULL
murine	NULL
tissues	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
ERP	NULL
and	NULL
the	NULL
sizes	NULL
of	NULL
the	NULL
ERP	NULL
transcripts	NULL
,	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNAs	NULL
derived	NULL
from	NULL
various	NULL
mouse	NULL
tissues	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
using	NULL
ERP	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

To	NULL
control	NULL
for	NULL
RNA	NULL
quality	NULL
and	NULL
quantity	NULL
,	NULL
we	NULL
rehybridized	NULL
the	NULL
Northern	NULL
blots	NULL
with	NULL
a	NULL
B-actin	NULL
probe	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
three	NULL
predominant	NULL
transcripts	NULL
of	NULL
approximately	NULL
4.4	NULL
,	NULL
2.2	NULL
,	NULL
and	NULL
1.9	NULL
kb	NULL
and	NULL
a	NULL
minor	NULL
transcript	NULL
of	NULL
5.9	NULL
kb	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
ERP	NULL
gene	NULL
was	NULL
expressed	NULL
in	NULL
all	NULL
tissues	NULL
tested	NULL
with	NULL
significant	NULL
variation	NULL
in	NULL
abundance	NULL
.	NULL

Lung	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
heart	NULL
tissues	NULL
expressed	NULL
the	NULL
largest	NULL
amounts	NULL
of	NULL
ERP	NULL
.	NULL

Moderate	NULL
levels	NULL
of	NULL
ERP	NULL
were	NULL
found	NULL
in	NULL
kidney	NULL
and	NULL
skeletal	NULL
muscle	NULL
.	NULL

Very	NULL
low	NULL
levels	NULL
of	NULL
ERP	NULL
mRNA	NULL
were	NULL
observed	NULL
in	NULL
brain	NULL
,	NULL
liver	NULL
,	NULL
and	NULL
testis	NULL
tissues	NULL
.	NULL

The	NULL
5.9-kb	NULL
transcript	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
mRNA	NULL
derived	NULL
from	NULL
the	NULL
heart	NULL
.	NULL

The	NULL
4.4-	NULL
and	NULL
2.2-kb	NULL
transcripts	NULL
were	NULL
expressed	NULL
in	NULL
all	NULL
tissues	NULL
in	NULL
approximately	NULL
equ1valent	NULL
amounts	NULL
.	NULL

The	NULL
results	NULL
suggest	NULL
that	NULL
ERP	NULL
is	NULL
expressed	NULL
to	NULL
various	NULL
degrees	NULL
in	NULL
many	NULL
tissues	NULL
.	NULL

Our	NULL
cDNA	NULL
appears	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
the	NULL
2.2-kb	NULL
transcript	NULL
.	NULL

The	NULL
different	NULL
transcripts	NULL
might	NULL
be	NULL
due	NULL
to	NULL
either	NULL
3300	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

LJ	NULL
wd	NULL
O	NULL
W	NULL
>	NULL
a	NULL
Â«	NULL
ad	NULL
z	NULL
m	NULL
>	NULL
k-	NULL
u	NULL
LW	NULL
0	NULL
Â©	NULL
Z1	NULL
o	NULL
o	NULL
2	NULL
4	NULL
<	NULL
4	NULL
u	NULL
2	NULL
W	NULL
wu	NULL
&	NULL
w	NULL
C	NULL
a	NULL
35	NULL
2	NULL
Â¥	NULL
8	NULL
uw	NULL
IT	NULL
M	NULL
@	NULL
_J	NULL
J	NULL
(	NULL
Â¥	NULL
}	NULL
9.5	NULL
Kb	NULL
I*	NULL
im	NULL
=-5.9	NULL
Kb	NULL
44	NULL
_-	NULL
==	NULL
4.4	NULL
ERP	NULL
24	NULL
\	NULL
%	NULL
s	NULL
==	NULL
2.2	NULL
-1.9	NULL
1.35	NULL
w=	NULL
2	NULL
-1s	NULL
-	NULL
B-ACTIN	NULL
102	NULL
304	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Expression	NULL
of	NULL
ERP	NULL
in	NULL
different	NULL
mouse	NULL
tissues	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNAs	NULL
from	NULL
the	NULL
indicated	NULL
mouse	NULL
tissues	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
sequentially	NULL
probed	NULL
with	NULL
a	NULL
900-bp	NULL
ERP	NULL
cDNA	NULL
probe	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
a	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
under	NULL
stringent	NULL
conditions	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
major	NULL
mRNA	NULL
bands	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
;	NULL
the	NULL
sizes	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
(	NULL
RNA	NULL
ladder	NULL
;	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

alternative	NULL
splicing	NULL
,	NULL
cross-hybridization	NULL
with	NULL
transcripts	NULL
derived	NULL
from	NULL
related	NULL
genes	NULL
,	NULL
or	NULL
transcription	NULL
from	NULL
the	NULL
DNA	NULL
strand	NULL
opposite	NULL
to	NULL
that	NULL
encoding	NULL
the	NULL
ERP	NULL
transcripts	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
1.9-kb	NULL
transcript	NULL
is	NULL
similar	NULL
in	NULL
size	NULL
to	NULL
the	NULL
SAP-1	NULL
transcript	NULL
.	NULL

Further	NULL
detailed	NULL
analysis	NULL
will	NULL
clarify	NULL
the	NULL
origins	NULL
of	NULL
the	NULL
different	NULL
transcripts	NULL
.	NULL

Southern	NULL
blot	NULL
hybridization	NULL
analysis	NULL
of	NULL
genomic	NULL
DNAs	NULL
isolated	NULL
from	NULL
different	NULL
species	NULL
suggests	NULL
that	NULL
the	NULL
ERP	NULL
gene	NULL
is	NULL
highly	NULL
conserved	NULL
during	NULL
evolution	NULL
but	NULL
might	NULL
be	NULL
absent	NULL
in	NULL
flies	NULL
and	NULL
yeasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
pattern	NULL
of	NULL
ERP	NULL
in	NULL
murine	NULL
B-cell	NULL
lines	NULL
representing	NULL
different	NULL
developmental	NULL
stages	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insight	NULL
into	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
ERP	NULL
gene	NULL
during	NULL
B-cell	NULL
differentiation	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
hybridization	NULL
analysis	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNAs	NULL
derived	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
murine	NULL
B-cell	NULL
lines	NULL
representing	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
ERP	NULL
mRNAs	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
pre-B-cell	NULL
lines	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
representing	NULL
later	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
including	NULL
mature	NULL
B-cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
and	NULL
myeloma	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
11	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
expressed	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
ERP	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ERP	NULL
gene	NULL
appears	NULL
to	NULL
be	NULL
expressed	NULL
primarily	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
might	NULL
play	NULL
a	NULL
role	NULL
in	NULL
early	NULL
B-cell	NULL
development	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

Interestingly	NULL
,	NULL
approximately	NULL
equal	NULL
amounts	NULL
of	NULL
the	NULL
4.4-	NULL
and	NULL
2.2-kb	NULL
ERP	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
pre-B-cell	NULL
lines	NULL
,	NULL
whereas	NULL
the	NULL
1.9-kb	NULL
ERP	NULL
transcript	NULL
was	NULL
detectable	NULL
only	NULL
in	NULL
some	NULL
of	NULL
the	NULL
pre-B-cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Significant	NULL
expression	NULL
of	NULL
the	NULL
ERP	NULL
gene	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
the	NULL
EL.4	NULL
T-cell	NULL
line	NULL
,	NULL
PuS5-1.8	NULL
monocyte/macrophage	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

However	NULL
,	NULL
no	NULL
expression	NULL
of	NULL
ERP	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
line	NULL
P19	NULL
,	NULL
while	NULL
upon	NULL
differentiation	NULL
of	NULL
P19	NULL
cells	NULL
Mor	NULL
.	NULL

BioL	NULL
.	NULL

a	NULL
3	NULL
3	NULL
Be	NULL
e	NULL
:	NULL
Â£	NULL
B	NULL
s	NULL
$	NULL
m	NULL
!	NULL

5	NULL
o	NULL
mi	NULL
fi	NULL
Ã©	NULL
re	NULL
5	NULL
$	NULL
I	NULL
o	NULL
g	NULL
=	NULL
0	NULL
2	NULL
3	NULL
<	NULL
a	NULL
{	NULL
u	NULL
a	NULL
2	NULL
o	NULL
a	NULL
Â§	NULL
ma	NULL
x	NULL
a	NULL
Z	NULL
3	NULL
<	NULL
a	NULL
5	NULL
S	NULL
a	NULL
i	NULL
a.	NULL
Ra	NULL
ma	NULL
mae	NULL
dis	NULL
oils	NULL
-	NULL
4.4	NULL
Kb	NULL
ERP	NULL
#	NULL
p	NULL
M	NULL
-	NULL
2.2	NULL
B0	NULL
-	NULL
#	NULL
=	NULL
:	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Expression	NULL
of	NULL
ERP	NULL
in	NULL
various	NULL
mouse	NULL
cell	NULL
lines	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNAs	NULL
from	NULL
various	NULL
mouse	NULL
cell	NULL
lines	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
sequentially	NULL
probed	NULL
with	NULL
a	NULL
900-bp	NULL
ERP	NULL
cDNA	NULL
probe	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
a	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
under	NULL
stringent	NULL
conditions	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
major	NULL
mRNA	NULL
bands	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

RA	NULL
,	NULL
retinoic	NULL
acid	NULL
.	NULL

8	NULL
9	NULL
10111213	NULL
14	NULL
15	NULL
16	NULL
by	NULL
retinoic	NULL
acid	NULL
into	NULL
glial	NULL
and	NULL
neuronal	NULL
cells	NULL
(	NULL
63	NULL
)	NULL
low	NULL
levels	NULL
of	NULL
ERP	NULL
transcripts	NULL
became	NULL
visible	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
ERP	NULL
expression	NULL
is	NULL
regulated	NULL
upon	NULL
B-cell	NULL
and	NULL
teratocarcinoma	NULL
differentiation	NULL
.	NULL

Chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
ERP	NULL
gene	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
chromosome	NULL
location	NULL
of	NULL
the	NULL
ERP	NULL
locus	NULL
in	NULL
the	NULL
human	NULL
genome	NULL
we	NULL
performed	NULL
Southern	NULL
blot	NULL
hybridization	NULL
analysis	NULL
using	NULL
Pvull-digested	NULL
genomic	NULL
DNA	NULL
derived	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
hamster-human	NULL
somatic	NULL
cell	NULL
hybrids	NULL
carrying	NULL
overlapping	NULL
subsets	NULL
of	NULL
human	NULL
chromosomes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
human	NULL
ERP	NULL
-specific	NULL
band	NULL
correlates	NULL
only	NULL
with	NULL
hybrids	NULL
containing	NULL
human	NULL
chromosome	NULL
12	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
ERP	NULL
gene	NULL
is	NULL
located	NULL
on	NULL
human	NULL
chromosome	NULL
12	NULL
,	NULL
where	NULL
no	NULL
other	NULL
known	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
has	NULL
been	NULL
found	NULL
.	NULL

ERP	NULL
contains	NULL
a	NULL
carboxy-terminal	NULL
negative	NULL
regulatory	NULL
domain	NULL
which	NULL
inhibits	NULL
autonomous	NULL
DNA	NULL
binding	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
ERP	NULL
can	NULL
bind	NULL
sequence	NULL
specifically	NULL
to	NULL
DNA	NULL
and	NULL
to	NULL
delineate	NULL
the	NULL
domains	NULL
of	NULL
ERP	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
we	NULL
created	NULL
a	NULL
series	NULL
of	NULL
different	NULL
carboxy-terminal-deletion	NULL
mutants	NULL
of	NULL
ERP	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

9a	NULL
.	NULL

In	NULL
vitro-transcribed	NULL
RNAs	NULL
encoding	NULL
either	NULL
full-length	NULL
ERP	NULL
or	NULL
the	NULL
different	NULL
deletion	NULL
mutants	NULL
were	NULL
translated	NULL
into	NULL
Erotein	NULL
in	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
.	NULL

SDS-PAGE	NULL
analysis	NULL
of	NULL
the	NULL
[	NULL
*Â°S	NULL
}	NULL
methionine-labeled	NULL
in	NULL
vitro	NULL
translation	NULL
reaction	NULL
mixtures	NULL
revealed	NULL
as	NULL
the	NULL
major	NULL
products	NULL
proteins	NULL
of	NULL
the	NULL
expected	NULL
molecular	NULL
weights	NULL
(	NULL
Fig	NULL
.	NULL

9b	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Small	NULL
amounts	NULL
of	NULL
additional	NULL
faster-migrating	NULL
proteins	NULL
were	NULL
visible	NULL
as	NULL
well	NULL
in	NULL
some	NULL
of	NULL
the	NULL
reaction	NULL
mixtures	NULL
because	NULL
of	NULL
either	NULL
partial	NULL
proteolysis	NULL
,	NULL
premature	NULL
translational	NULL
termination	NULL
,	NULL
or	NULL
alternative	NULL
internal	NULL
initiation	NULL
codons	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
a	NULL
-	NULL
HAMSTER	NULL
ERP	NULL
--	NULL
HUMAN	NULL
ERP	NULL
12	NULL
%	NULL
A5	NULL
``	NULL
6Â°	NULL
7	NULL
``	NULL
s	NULL
``	NULL
o	NULL
10	NULL
11	NULL
b	NULL
HUMAN	NULL
CHROMOSOMES	NULL
_	NULL
nyBRID|	NULL
1	NULL
]	NULL
2	NULL
]	NULL
3	NULL
]	NULL
4	NULL
]	NULL
5	NULL
]	NULL
6	NULL
]	NULL
7	NULL
]	NULL
s	NULL
|	NULL
a	NULL
10	NULL
]	NULL
u	NULL
[	NULL
12	NULL
]	NULL
13	NULL
]	NULL
14	NULL
]	NULL
15	NULL
]	NULL
16	NULL
]	NULL
17	NULL
[	NULL
is	NULL
]	NULL
19	NULL
]	NULL
20	NULL
]	NULL
21	NULL
]	NULL
22	NULL
]	NULL
x	NULL
|	NULL
Y	NULL
ERP	NULL
3B	NULL
TCH	NULL
T	NULL
T	NULL
@	NULL
W	NULL
F1	NULL
111	NULL
3	NULL
324	NULL
423	NULL
web	NULL
|-	NULL
|-	NULL
1	NULL
3	NULL
a	NULL
+	NULL
3s	NULL
TT	NULL
H	NULL
ï¬i	NULL
â	NULL
f	NULL
7	NULL
I	NULL
Fl	NULL
|	NULL
734	NULL
1	NULL
|	NULL
(	NULL
esl	NULL
AML	NULL
rse	NULL
(	NULL
TT	NULL
]	NULL
T	NULL
J_	NULL
[	NULL
|	NULL
E	NULL
,	NULL
l	NULL
[	NULL
L	NULL
l	NULL
|	NULL
â	NULL
l	NULL
j	NULL
}	NULL
}	NULL
7â7	NULL
a	NULL
_	NULL
B	NULL
756	NULL
|	NULL
|	NULL
ooke	NULL
a	NULL
[	NULL
C08	NULL
[	NULL
(	NULL
(	NULL
1s	NULL
_	NULL
|	NULL
|	NULL
wks	NULL
|	NULL
|-	NULL
}	NULL
i	NULL
'	NULL
l	NULL
â	NULL
l	NULL
â	NULL
|	NULL
|	NULL
1	NULL
}	NULL
9m	NULL
|	NULL
-In	NULL
L	NULL
--	NULL
ss2	NULL
|_	NULL
[	NULL
1	NULL
1	NULL
.	NULL

|	NULL
Jel	NULL
{	NULL
ollo	NULL
L	NULL
LLL	NULL
_L	NULL
-	NULL
sl	NULL
B	NULL
nec	NULL
Gt	NULL
BSH	NULL
[	NULL
â¬	NULL
862	NULL
ik	NULL
3	NULL
ier	NULL
.	NULL

het-	NULL
-	NULL
--	NULL
-|-	NULL
(	NULL
3	NULL
if	NULL
Â»	NULL
;	NULL
|	NULL
K	NULL
|	NULL
|	NULL
5	NULL
,	NULL
â	NULL
â	NULL
EL	NULL
|	NULL
q	NULL
we	NULL
1-11	NULL
]	NULL
|	NULL
~	NULL
fe	NULL
2	NULL
mi	NULL
|	NULL
|-	NULL
]	NULL
ast	NULL
(	NULL
@	NULL
]	NULL
|	NULL
Cm	NULL
E	NULL
[	NULL
|	NULL
1	NULL
(	NULL
%	NULL
s	NULL
940	NULL
|	NULL
|	NULL
i	NULL
w	NULL
)	NULL
-|-	NULL
!	NULL

|	NULL
|	NULL
967	NULL
|	NULL
|	NULL
|	NULL
323	NULL
{	NULL
51-1	NULL
A	NULL
â	NULL
;	NULL
j	NULL
|	NULL
F3	NULL
PFF	NULL
|_	NULL
FS	NULL
|	NULL
-	NULL
]	NULL
983	NULL
E|	NULL
|	NULL
C5	NULL
1006	NULL
-|	NULL
Cie	NULL
|	NULL
[	NULL
|	NULL
C	NULL
|	NULL
Mek	NULL
1049	NULL
z	NULL
mo	NULL
||	NULL
(	NULL
aa	NULL
_	NULL
k	NULL
lm	NULL
-	NULL
-	NULL
-e	NULL
C-	NULL
'm~	NULL
alles	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
ERP	NULL
gene	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Southern	NULL
blot	NULL
hybridization	NULL
analysis	NULL
of	NULL
26	NULL
hamster-human	NULL
somatic	NULL
cell	NULL
hybrids	NULL
.	NULL

Genomic	NULL
DNAs	NULL
of	NULL
hamster-human	NULL
somatic	NULL
cell	NULL
hybrids	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
10	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
human	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
hamster	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
control	NULL
DNAs	NULL
,	NULL
were	NULL
digested	NULL
with	NULL
Pvull	NULL
and	NULL
subjected	NULL
to	NULL
Southern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
panel	NULL
blots	NULL
were	NULL
obtained	NULL
from	NULL
Bios	NULL
Corp	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
the	NULL
ERP	NULL
cDNA	NULL
probe	NULL
under	NULL
stringent	NULL
conditions	NULL
.	NULL

Informative	NULL
hybrids	NULL
and	NULL
controls	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Chromosomal	NULL
localization	NULL
analysis	NULL
of	NULL
26	NULL
hamster-human	NULL
somatic	NULL
cell	NULL
hybrids	NULL
.	NULL

The	NULL
number	NULL
of	NULL
the	NULL
hamster-human	NULL
somatic	NULL
cell	NULL
hybrid	NULL
line	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Shaded	NULL
box	NULL
,	NULL
presence	NULL
of	NULL
the	NULL
chromosome	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
;	NULL
open	NULL
box	NULL
,	NULL
absence	NULL
of	NULL
the	NULL
chromosome	NULL
;	NULL
black	NULL
box	NULL
,	NULL
presence	NULL
of	NULL
both	NULL
the	NULL
chromosome	NULL
and	NULL
the	NULL
human	NULL
ERP	NULL
gene	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
retention	NULL
(	NULL
+	NULL
)	NULL
of	NULL
the	NULL
human	NULL
ERP	NULL
gene	NULL
in	NULL
the	NULL
hybrids	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

To	NULL
evaluate	NULL
whether	NULL
ERP	NULL
can	NULL
specifically	NULL
interact	NULL
with	NULL
canonical	NULL
ets-related	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
in	NULL
vitro-translated	NULL
full-length	NULL
or	NULL
truncated	NULL
ERP	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Drosophila	NULL
E74	NULL
binding	NULL
site	NULL
(	NULL
11	NULL
)	NULL
which	NULL
has	NULL
previously	NULL
been	NULL
demonstrated	NULL
to	NULL
bind	NULL
several	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
including	NULL
the	NULL
highly	NULL
related	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
(	NULL
28	NULL
,	NULL
70	NULL
,	NULL
71	NULL
,	NULL
90	NULL
)	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
abilities	NULL
of	NULL
wheat	NULL
germ	NULL
extracts	NULL
containing	NULL
the	NULL
different-length	NULL
ERP	NULL
proteins	NULL
and	NULL
of	NULL
unprimed	NULL
wheat	NULL
germ	NULL
extracts	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
the	NULL
E74	NULL
DNA	NULL
motif	NULL
in	NULL
EMSAs	NULL
.	NULL

To	NULL
ensure	NULL
equivalent	NULL
amounts	NULL
of	NULL
in	NULL
vitro-translated	NULL
protein	NULL
in	NULL
each	NULL
EMSA	NULL
reaction	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
amount	NULL
of	NULL
[	NULL
Â°Â°S	NULL
)	NULL
methionine	NULL
incorporation	NULL
and	NULL
adjusted	NULL
for	NULL
the	NULL
number	NULL
of	NULL
methionines	NULL
present	NULL
in	NULL
the	NULL
different	NULL
ERP	NULL
proteins	NULL
.	NULL

Molar	NULL
equivalents	NULL
of	NULL
each	NULL
ERP	NULL
protein	NULL
were	NULL
used	NULL
for	NULL
EMSAs	NULL
.	NULL

The	NULL
E74	NULL
oligonucleotide	NULL
formed	NULL
several	NULL
complexes	NULL
with	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
ERP	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

9b	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
which	NULL
were	NULL
not	NULL
formed	NULL
by	NULL
the	NULL
control	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

9b	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Some	NULL
additional	NULL
weaker	NULL
complexes	NULL
were	NULL
formed	NULL
by	NULL
the	NULL
control	NULL
as	NULL
well	NULL
as	NULL
all	NULL
the	NULL
other	NULL
extracts	NULL
.	NULL

Strikingly	NULL
,	NULL
both	NULL
full-length	NULL
ERP	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
eis	NULL
FAMILY	NULL
3301	NULL
and	NULL
the	NULL
ERPAC396	NULL
deletion	NULL
mutant	NULL
formed	NULL
much	NULL
weaker	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

9b	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
than	NULL
more	NULL
extensive	NULL
carboxy-terminal-deletion	NULL
mutants	NULL
of	NULL
ERP	NULL
(	NULL
ERPAC298	NULL
,	NULL
ERPACZ222	NULL
,	NULL
and	NULL
ERPACI106	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

9b	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
potential	NULL
negative	NULL
regulatory	NULL
domain	NULL
at	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
ERP	NULL
located	NULL
between	NULL
amino	NULL
acids	NULL
298	NULL
and	NULL
396	NULL
which	NULL
encompasses	NULL
domain	NULL
C	NULL
and	NULL
contains	NULL
several	NULL
putative	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
sites	NULL
.	NULL

DNA	NULL
binding	NULL
was	NULL
the	NULL
strongest	NULL
in	NULL
ERP	NULL
AC106	NULL
,	NULL
which	NULL
contains	NULL
primarily	NULL
the	NULL
amino-terminal	NULL
ETS	NULL
domain	NULL
.	NULL

Further	NULL
deletion	NULL
to	NULL
amino	NULL
acid	NULL
61	NULL
(	NULL
ERPAC61	NULL
)	NULL
within	NULL
the	NULL
ETS	NULL
domain	NULL
completely	NULL
abolished	NULL
the	NULL
DNA-binding	NULL
capacity	NULL
of	NULL
ERP	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
ERP	NULL
maps	NULL
indeed	NULL
to	NULL
the	NULL
ETS	NULL
domain	NULL
and	NULL
is	NULL
sufficient	NULL
for	NULL
specific	NULL
DNA	NULL
binding	NULL
.	NULL

No	NULL
protein-DNA	NULL
complex	NULL
formation	NULL
was	NULL
observed	NULL
when	NULL
a	NULL
mutant	NULL
E74	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

9c	NULL
)	NULL
,	NULL
verifying	NULL
the	NULL
sequence	NULL
specificity	NULL
of	NULL
ERP	NULL
interaction	NULL
with	NULL
the	NULL
E74	NULL
DNA	NULL
motif	NULL
.	NULL

ERPAC298	NULL
,	NULL
ERPAC222	NULL
,	NULL
and	NULL
ERPAC106	NULL
formed	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
mobilities	NULL
in	NULL
the	NULL
EMSA	NULL
consistent	NULL
with	NULL
their	NULL
relative	NULL
molecular	NULL
weights	NULL
.	NULL

However	NULL
,	NULL
the	NULL
most	NULL
slowly	NULL
migrating	NULL
complexes	NULL
formed	NULL
with	NULL
full-length	NULL
ERP	NULL
or	NULL
ERPAC39Y6	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
their	NULL
expected	NULL
relative	NULL
molecular	NULL
masses	NULL
and	NULL
appeared	NULL
to	NULL
be	NULL
of	NULL
similar	NULL
size	NULL
as	NULL
ERPAC298	NULL
,	NULL
which	NULL
is	NULL
100	NULL
amino	NULL
acids	NULL
smaller	NULL
,	NULL
raising	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
these	NULL
bands	NULL
may	NULL
be	NULL
due	NULL
to	NULL
complex	NULL
formation	NULL
with	NULL
smaller	NULL
translation	NULL
products	NULL
rather	NULL
than	NULL
the	NULL
full-length	NULL
proteins	NULL
.	NULL

There	NULL
was	NULL
a	NULL
weak	NULL
smear	NULL
(	NULL
C1	NULL
)	NULL
above	NULL
this	NULL
complex	NULL
which	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
ERPAC298	NULL
and	NULL
most	NULL
likely	NULL
represents	NULL
a	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
by	NULL
full-length	NULL
ERP	NULL
with	NULL
lower	NULL
affinity	NULL
than	NULL
the	NULL
other	NULL
complexes	NULL
.	NULL

To	NULL
analyze	NULL
in	NULL
more	NULL
detail	NULL
which	NULL
protein-DNA	NULL
complex	NULL
is	NULL
formed	NULL
by	NULL
which	NULL
translation	NULL
product	NULL
,	NULL
in	NULL
vitro	NULL
translation	NULL
reaction	NULL
mixtures	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Slices	NULL
representing	NULL
different	NULL
molecular	NULL
weight	NULL
regions	NULL
were	NULL
cut	NULL
out	NULL
of	NULL
the	NULL
gel	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
eluted	NULL
,	NULL
denatured	NULL
,	NULL
and	NULL
renatured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
urea	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
renatured	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
for	NULL
the	NULL
presence	NULL
and	NULL
the	NULL
size	NULL
of	NULL
in	NULL
vitro-translated	NULL
ERP	NULL
proteins	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
lower	NULL
panel	NULL
.	NULL

A	NULL
second	NULL
equivalent	NULL
of	NULL
renatured	NULL
proteins	NULL
was	NULL
used	NULL
for	NULL
EMSAs	NULL
using	NULL
the	NULL
E74	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Single	NULL
,	NULL
strong	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
formed	NULL
by	NULL
renatured	NULL
proteins	NULL
recovered	NULL
from	NULL
the	NULL
ERPAC298	NULL
,	NULL
ERPAC222	NULL
,	NULL
and	NULL
ERPAC106	NULL
in	NULL
vitro	NULL
translations	NULL
(	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
lanes	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
which	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
single	NULL
[	NULL
*S	NULL
]	NULL
methionine-labeled	NULL
proteins	NULL
in	NULL
SDS-PAGE	NULL
and	NULL
corresponded	NULL
to	NULL
the	NULL
molecular	NULL
weights	NULL
expected	NULL
for	NULL
the	NULL
particular	NULL
deletion	NULL
mutants	NULL
.	NULL

Renatured	NULL
protein	NULL
recovered	NULL
from	NULL
full-length	NULL
ERP	NULL
translations	NULL
,	NULL
however	NULL
,	NULL
gave	NULL
rise	NULL
to	NULL
only	NULL
very	NULL
weak	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
fraction	NULL
containing	NULL
the	NULL
apparent	NULL
full-length	NULL
44-kDa	NULL
ERP	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
formed	NULL
only	NULL
a	NULL
very	NULL
weak	NULL
complex	NULL
.	NULL

This	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
comigrated	NULL
with	NULL
a	NULL
complex	NULL
formed	NULL
by	NULL
renatured	NULL
protein	NULL
from	NULL
the	NULL
equivalent	NULL
molecular	NULL
weight	NULL
region	NULL
of	NULL
the	NULL
ERPAC298	NULL
translation	NULL
(	NULL
Fig	NULL
.	NULL

9d	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
no	NULL
[	NULL
**Â°S	NULL
)	NULL
methionine-labeled	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
this	NULL
fraction	NULL
of	NULL
the	NULL
ERPAC298	NULL
translation	NULL
.	NULL

These	NULL
denaturation-renaturation	NULL
experiments	NULL
most	NULL
vividly	NULL
demonstrate	NULL
that	NULL
the	NULL
full-length	NULL
ERP	NULL
protein	NULL
expresses	NULL
negligible	NULL
DNA-binding	NULL
activity	NULL
by	NULL
itself	NULL
and	NULL
that	NULL
,	NULL
upon	NULL
removal	NULL
of	NULL
an	NULL
apparent	NULL
carboxy-terminal	NULL
negative	NULL
regulatory	NULL
domain	NULL
,	NULL
DNA-binding	NULL
capacity	NULL
is	NULL
recovered	NULL
.	NULL

ERP	NULL
binds	NULL
to	NULL
functionally	NULL
important	NULL
efs-related	NULL
binding	NULL
sites	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
including	NULL
the	NULL
pre-B-specific	NULL
IgH	NULL
enhancer	NULL
#	NULL
site	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
DNA	NULL
sequence	NULL
requirements	NULL
3302	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

a	NULL
MUTANT	NULL
PROTEIN	NULL
DNA	NULL
BINDING	NULL
A	NULL
B	NULL
ALA/SER	NULL
D	NULL
C	NULL
7	NULL
S	NULL
--	NULL
RM	NULL
|	NULL
_	NULL
]	NULL
_	NULL
+	NULL
j/	NULL
&	NULL
\	NULL
+l	NULL
1	NULL
409	NULL
ERPAC396	NULL
+/-ERPAC298	NULL
++	NULL
ERP	NULL
AC222	NULL
++	NULL
ERPac106	NULL
++	NULL
ERPAcC6Ã©1	NULL
~	NULL
w	NULL
Â©	NULL
a	NULL
w	NULL
Â®	NULL
Â®	NULL
n	NULL
O	NULL
b	NULL
$	NULL
Â§	NULL
Â§	NULL
8	NULL
;	NULL
C	NULL
3	NULL
8	NULL
8	NULL
o	NULL
8	NULL
d	NULL
_	NULL
err	NULL
ERPac2zgs	NULL
-	NULL
ERPac2az2	NULL
ERMPacio6	NULL
o	NULL
o	NULL
o	NULL
o	NULL
o	NULL
Â£6	NULL
Cok	NULL
4	NULL
.	NULL

4	NULL
4	NULL
34	NULL
3	NULL
a	NULL
&	NULL
0.	NULL
a	NULL
``	NULL
LC	NULL
&	NULL
Â£	NULL
/L	NULL
5	NULL
&	NULL
&	NULL
KE	NULL
G	NULL
&	NULL
.	NULL

C	NULL
E74	NULL
E74	NULL
E74	NULL
E74	NULL
C	NULL
C	NULL
C	NULL
C	NULL
C	NULL
&	NULL
C	NULL
P	NULL
wo	NULL
wou	NULL
w	NULL
w	NULL
row	NULL
i	NULL
i	NULL
dj	NULL
w	NULL
ous	NULL
|	NULL
|	NULL
|	NULL
|	NULL
fe	NULL
I	NULL
|	NULL
|	NULL
A	NULL
E74	NULL
MUT	NULL
.	NULL

t	NULL
.	NULL

|	NULL
f	NULL
C1	NULL
-	NULL
Â»	NULL
C2	NULL
-	NULL
Â»	NULL
C	NULL
--	NULL
C4	NULL
-	NULL
Â»	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Delineation	NULL
of	NULL
protein	NULL
domains	NULL
involved	NULL
in	NULL
DNA	NULL
binding	NULL
of	NULL
ERP	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
structures	NULL
and	NULL
DNA-binding	NULL
abilities	NULL
of	NULL
full-length	NULL
and	NULL
deletion	NULL
mutants	NULL
of	NULL
ERP	NULL
.	NULL

Carboxy-terminal-deletion	NULL
mutants	NULL
of	NULL
ERP	NULL
are	NULL
denoted	NULL
by	NULL
AC	NULL
and	NULL
the	NULL
number	NULL
of	NULL
the	NULL
last	NULL
amino	NULL
acid	NULL
.	NULL

The	NULL
409-amino-acid	NULL
open	NULL
reading	NULL
frame	NULL
is	NULL
represented	NULL
by	NULL
a	NULL
box	NULL
.	NULL

Amino-terminal	NULL
and	NULL
carboxy-terminal	NULL
residues	NULL
are	NULL
indicated	NULL
for	NULL
each	NULL
translation	NULL
product	NULL
.	NULL

The	NULL
SAP-1/ELK-1	NULL
homology	NULL
domains	NULL
A	NULL
to	NULL
C	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
alanine-serine-rich	NULL
region	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
relative	NULL
abilities	NULL
of	NULL
the	NULL
full-length	NULL
protein	NULL
and	NULL
deletion	NULL
mutants	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
E74-binding	NULL
site	NULL
in	NULL
EMSA	NULL
as	NULL
shown	NULL
in	NULL
panels	NULL
b	NULL
and	NULL
d	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

(	NULL
b	NULL
)	NULL
(	NULL
Upper	NULL
panel	NULL
)	NULL
DNA	NULL
binding	NULL
of	NULL
full-length	NULL
ERP	NULL
and	NULL
deletion	NULL
mutants	NULL
in	NULL
an	NULL
EMSA	NULL
using	NULL
synthetic	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
E74	NULL
site	NULL
.	NULL

The	NULL
full-length	NULL
and	NULL
carboxy	NULL
terminus-truncated	NULL
ERP	NULL
constructs	NULL
in	NULL
panel	NULL
a	NULL
were	NULL
transcribed	NULL
in	NULL
vitro	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
ERP	NULL
,	NULL
we	NULL
designed	NULL
oligonucleotides	NULL
encoding	NULL
a	NULL
whole	NULL
spectrum	NULL
of	NULL
different	NULL
functionally	NULL
relevant	NULL
binding	NULL
sites	NULL
for	NULL
ets-related	NULL
factors	NULL
including	NULL
sites	NULL
of	NULL
several	NULL
B-	NULL
or	NULL
T-lymphoid-specific	NULL
genes	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

10a	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
binding	NULL
affinity	NULL
and	NULL
specificity	NULL
of	NULL
ERP	NULL
for	NULL
these	NULL
sites	NULL
were	NULL
compared	NULL
with	NULL
its	NULL
affinity	NULL
for	NULL
the	NULL
E74	NULL
site	NULL
in	NULL
competition	NULL
experiments	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
wild-type	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
in	NULL
EMSA	NULL
with	NULL
equal	NULL
amounts	NULL
of	NULL
ERPAC222	NULL
in	NULL
vitro-translated	NULL
protein	NULL
and	NULL
the	NULL
E74	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
E74	NULL
oligonucleotide	NULL
competed	NULL
effectively	NULL
with	NULL
complexes	NULL
formed	NULL
by	NULL
ERPAC222	NULL
,	NULL
whereas	NULL
the	NULL
mutant	NULL
E74	NULL
oligonucleotide	NULL
was	NULL
unable	NULL
to	NULL
inhibit	NULL
binding	NULL
of	NULL
ERPAC222	NULL
even	NULL
at	NULL
high	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Ten	NULL
nanograms	NULL
of	NULL
wild-type	NULL
competitor	NULL
completely	NULL
abolished	NULL
binding	NULL
of	NULL
ERPAC222	NULL
to	NULL
the	NULL
E74	NULL
probe	NULL
.	NULL

None	NULL
of	NULL
the	NULL
other	NULL
ets-related-binding-site	NULL
oligonucleotides	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
the	NULL
E74	NULL
oligonucleotide	NULL
in	NULL
competing	NULL
for	NULL
ERPAC222	NULL
.	NULL

Only	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
(	NULL
HSV	NULL
)	NULL
ICP4	NULL
oligonucleotide	NULL
encoding	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
GA-binding	NULL
protein	NULL
(	NULL
GABP	NULL
)	NULL
in	NULL
the	NULL
HSV	NULL
ICP4	NULL
gene	NULL
expressed	NULL
an	NULL
affinity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
E74	NULL
site	NULL
for	NULL
ERPAC222	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
but	NULL
it	NULL
might	NULL
contain	NULL
actually	NULL
two	NULL
ets-binding	NULL
sites	NULL
.	NULL

Oligonucleotides	NULL
encoding	NULL
the	NULL
IgH	NULL
enhancer	NULL
t	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
34	NULL
and	NULL
35	NULL
)	NULL
,	NULL
the	NULL
polyomavirus	NULL
PEA3	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
28	NULL
and	NULL
29	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Ick	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
26	NULL
and	NULL
27	NULL
)	NULL
still	NULL
competed	NULL
efficiently	NULL
with	NULL
ERPAC222	NULL
,	NULL
showing	NULL
at	NULL
least	NULL
partial	NULL
competition	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
oligonucleotide	NULL
.	NULL

Other	NULL
sites	NULL
including	NULL
the	NULL
urokinase	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
,	NULL
the	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
,	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
LTR	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
14	NULL
and	NULL
15	NULL
)	NULL
,	NULL
the	NULL
murine	NULL
sarcoma	NULL
virus	NULL
(	NULL
MSV	NULL
)	NULL
LTR	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
18	NULL
and	NULL
19	NULL
)	NULL
,	NULL
the	NULL
c-fos	NULL
promoter	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
20	NULL
and	NULL
21	NULL
)	NULL
,	NULL
the	NULL
stromelysin	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
30	NULL
and	NULL
31	NULL
)	NULL
,	NULL
and	NULL
the	NULL
vpreB	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
competed	NULL
only	NULL
weakly	NULL
,	NULL
leading	NULL
to	NULL
partial	NULL
competition	NULL
only	NULL
at	NULL
100	NULL
ng	NULL
of	NULL
oligonucleotide	NULL
.	NULL

Interestingly	NULL
,	NULL
virtually	NULL
no	NULL
competition	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
3	NULL
'	NULL
enhancer	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
and	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
16	NULL
and	NULL
17	NULL
)	NULL
,	NULL
which	NULL
bind	NULL
Pu.1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
the	NULL
IL-2	NULL
promoter	NULL
IL-2B	NULL
and	NULL
NF-AT	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
22	NULL
to	NULL
25	NULL
)	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
ELF-1	NULL
,	NULL
and	NULL
the	NULL
T-cell	NULL
receptor	NULL
Â«	NULL
a	NULL
enhancer	NULL
Ta2	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10b	NULL
,	NULL
lanes	NULL
32	NULL
and	NULL
33	NULL
)	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
Ets-1	NULL
or	NULL
ELF-1	NULL
.	NULL

Figure	NULL
10a	NULL
summarizes	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
this	NULL
competition	NULL
analysis	NULL
,	NULL
indicating	NULL
the	NULL
relative	NULL
binding	NULL
affinities	NULL
of	NULL
the	NULL
different	NULL
sites	NULL
for	NULL
ERPAC222	NULL
and	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
binding	NULL
core	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
this	NULL
experiment	NULL
,	NULL
we	NULL
have	NULL
compiled	NULL
a	NULL
putative	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
ERP	NULL
(	NULL
Fig	NULL
.	NULL

10a	NULL
)	NULL
which	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
consensus	NULL
recognition	NULL
sequences	NULL
for	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
GABPa	NULL
,	NULL
Fli-1	NULL
,	NULL
and	NULL
E74	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
30	NULL
,	NULL
61	NULL
,	NULL
91	NULL
,	NULL
102	NULL
)	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
eis	NULL
FAMILY	NULL
3303	NULL
but	NULL
divergent	NULL
from	NULL
the	NULL
Pu.1	NULL
and	NULL
ELF-1	NULL
consensus	NULL
sequences	NULL
(	NULL
64	NULL
,	NULL
94	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
in	NULL
more	NULL
detail	NULL
the	NULL
interaction	NULL
of	NULL
ERP	NULL
with	NULL
some	NULL
of	NULL
the	NULL
ets-related	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
with	NULL
ERPAC222	NULL
and	NULL
the	NULL
control	NULL
translation	NULL
using	NULL
several	NULL
of	NULL
the	NULL
ets-related	NULL
binding	NULL
sites	NULL
as	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

11a	NULL
)	NULL
.	NULL

The	NULL
E74	NULL
oligonucleotide	NULL
formed	NULL
the	NULL
strongest	NULL
protein-DNA	NULL
complex	NULL
,	NULL
which	NULL
comigrated	NULL
with	NULL
a	NULL
similar	NULL
strong	NULL
complex	NULL
formed	NULL
by	NULL
the	NULL
HSV	NULL
ICP4	NULL
oligonucleotide	NULL
and	NULL
was	NULL
absent	NULL
in	NULL
the	NULL
control	NULL
reaction	NULL
.	NULL

A	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
with	NULL
similar	NULL
migration	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
ERPACZ222	NULL
but	NULL
not	NULL
the	NULL
control	NULL
translation	NULL
when	NULL
the	NULL
IgH	NULL
enhancer	NULL
#	NULL
site	NULL
,	NULL
the	NULL
MSV	NULL
LTR	NULL
ets	NULL
site	NULL
,	NULL
or	NULL
the	NULL
Ick	NULL
promoter	NULL
ets	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
even	NULL
though	NULL
the	NULL
quantity	NULL
was	NULL
much	NULL
less	NULL
than	NULL
with	NULL
the	NULL
E74	NULL
probe	NULL
.	NULL

Virtually	NULL
no	NULL
specific	NULL
complex	NULL
formation	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
site	NULL
and	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
ets	NULL
site	NULL
.	NULL

A	NULL
strong	NULL
,	NULL
slowly	NULL
migrating	NULL
nonspecific	NULL
complex	NULL
which	NULL
was	NULL
much	NULL
weaker	NULL
in	NULL
experiments	NULL
for	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
10	NULL
was	NULL
visible	NULL
in	NULL
all	NULL
reactions	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
.	NULL

The	NULL
EMSA	NULL
of	NULL
Fig	NULL
.	NULL

11	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
different	NULL
batch	NULL
of	NULL
in	NULL
vitro	NULL
transcription-in	NULL
vitro	NULL
translation	NULL
reaction	NULL
mixture	NULL
and	NULL
had	NULL
to	NULL
be	NULL
exposed	NULL
for	NULL
longer	NULL
periods	NULL
than	NULL
those	NULL
of	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
10	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
fresh	NULL
in	NULL
vitro	NULL
translation	NULL
reaction	NULL
was	NULL
not	NULL
as	NULL
efficient	NULL
as	NULL
the	NULL
previous	NULL
one	NULL
.	NULL

The	NULL
results	NULL
correlate	NULL
relatively	NULL
well	NULL
with	NULL
the	NULL
affinities	NULL
determined	NULL
in	NULL
the	NULL
competition	NULL
analysis	NULL
.	NULL

Sequence	NULL
specificities	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
the	NULL
IgH	NULL
#	NULL
site	NULL
and	NULL
the	NULL
Ick	NULL
ets	NULL
site	NULL
were	NULL
,	NULL
furthermore	NULL
,	NULL
confirmed	NULL
by	NULL
competition	NULL
analysis	NULL
with	NULL
either	NULL
wild-type	NULL
or	NULL
mutant	NULL
IgH	NULL
1	NULL
site	NULL
and	NULL
Ick	NULL
ets	NULL
site	NULL
oligonucleotides	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

11b	NULL
)	NULL
.	NULL

Wild-type	NULL
but	NULL
not	NULL
mutant	NULL
IgH	NULL
1	NULL
site	NULL
and	NULL
Ick	NULL
ets	NULL
site	NULL
oligonucleotides	NULL
competed	NULL
efficiently	NULL
with	NULL
the	NULL
specific	NULL
complex	NULL
.	NULL

An	NULL
additional	NULL
complex	NULL
which	NULL
was	NULL
formed	NULL
with	NULL
both	NULL
the	NULL
ERPAC222	NULL
and	NULL
the	NULL
control	NULL
translation	NULL
product	NULL
competed	NULL
with	NULL
both	NULL
the	NULL
wild-type	NULL
and	NULL
the	NULL
mutant	NULL
oligonucleotides	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
protein	NULL
binds	NULL
to	NULL
sequences	NULL
not	NULL
directly	NULL
overlapping	NULL
the	NULL
IgH	NULL
1	NULL
or	NULL
the	NULL
Ick	NULL
ets	NULL
site	NULL
.	NULL

Interestingly	NULL
,	NULL
competition	NULL
with	NULL
the	NULL
mutant	NULL
oligonucleotides	NULL
actually	NULL
increased	NULL
formation	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
,	NULL
most	NULL
likely	NULL
because	NULL
of	NULL
competition	NULL
with	NULL
the	NULL
other	NULL
unrelated	NULL
protein	NULL
which	NULL
might	NULL
bind	NULL
with	NULL
higher	NULL
affinity	NULL
to	NULL
an	NULL
overlapping	NULL
site	NULL
.	NULL

Results	NULL
from	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
ERP	NULL
interacts	NULL
with	NULL
various	NULL
,	NULL
but	NULL
not	NULL
all	NULL
functionally	NULL
relevant	NULL
,	NULL
efs-related	NULL
binding	NULL
sites	NULL
,	NULL
although	NULL
with	NULL
different	NULL
affinities	NULL
.	NULL

In	NULL
this	NULL
context	NULL
it	NULL
is	NULL
particularly	NULL
interesting	NULL
that	NULL
ERP	NULL
binds	NULL
to	NULL
the	NULL
IgH	NULL
enhancer	NULL
t	NULL
site	NULL
which	NULL
is	NULL
active	NULL
primarily	NULL
during	NULL
early	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
coinciding	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
ERP	NULL
in	NULL
the	NULL
B-cell	NULL
lineage	NULL
.	NULL

Future	NULL
experiments	NULL
will	NULL
clarify	NULL
whether	NULL
ERP	NULL
is	NULL
indeed	NULL
the	NULL
natural	NULL
activator	NULL
of	NULL
the	NULL
IgH	NULL
#	NULL
site	NULL
.	NULL

DISCUSSION	NULL
In	NULL
our	NULL
search	NULL
for	NULL
transcriptional	NULL
regulators	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
and	NULL
cloned	NULL
a	NULL
gene	NULL
for	NULL
a	NULL
novel	NULL
Equal	NULL
amounts	NULL
of	NULL
the	NULL
translation	NULL
products	NULL
as	NULL
assayed	NULL
by	NULL
SDS-PAGE	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
E74	NULL
oligonucleotide	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
unprogrammed	NULL
(	NULL
-	NULL
)	NULL
wheat	NULL
germ	NULL
extract	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
,	NULL
wheat	NULL
germ	NULL
extracts	NULL
programmed	NULL
with	NULL
the	NULL
ERP	NULL
RNAs	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
and	NULL
illustrated	NULL
in	NULL
panel	NULL
a.	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
Lower	NULL
panel	NULL
)	NULL
SDS-PAGE	NULL
analysis	NULL
of	NULL
the	NULL
corresponding	NULL
in	NULL
vitro	NULL
translation	NULL
products	NULL
.	NULL

The	NULL
apparent	NULL
sizes	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

(	NULL
c	NULL
)	NULL
DNA	NULL
binding	NULL
of	NULL
full-length	NULL
ERP	NULL
and	NULL
deletion	NULL
mutants	NULL
in	NULL
an	NULL
EMSA	NULL
using	NULL
synthetic	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
a	NULL
mutant	NULL
(	NULL
MUT	NULL
)	NULL
E74	NULL
site	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
the	NULL
full-length	NULL
and	NULL
carboxy	NULL
terminus-truncated	NULL
ERP	NULL
translation	NULL
products	NULL
as	NULL
assayed	NULL
by	NULL
SDS-PAGE	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
mutant	NULL
E74	NULL
oligonucleotide	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
unprogrammed	NULL
(	NULL
-	NULL
)	NULL
wheat	NULL
germ	NULL
extract	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
,	NULL
wheat	NULL
germ	NULL
extracts	NULL
programmed	NULL
with	NULL
the	NULL
ERP	NULL
RNAs	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
and	NULL
illustrated	NULL
in	NULL
panel	NULL
a	NULL
.	NULL

(	NULL
d	NULL
)	NULL
DNA	NULL
binding	NULL
of	NULL
renatured	NULL
translation	NULL
products	NULL
of	NULL
ERP	NULL
in	NULL
an	NULL
EMSA	NULL
using	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
E74	NULL
site	NULL
.	NULL

The	NULL
full-length	NULL
and	NULL
carboxy	NULL
terminus-truncated	NULL
ERP	NULL
constructs	NULL
in	NULL
panel	NULL
a	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
.	NULL

The	NULL
translation	NULL
products	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
followed	NULL
by	NULL
excision	NULL
of	NULL
different	NULL
molecular	NULL
weight	NULL
regions	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
elution	NULL
,	NULL
and	NULL
renaturation	NULL
.	NULL

Renatured	NULL
proteins	NULL
from	NULL
different	NULL
molecular	NULL
weight	NULL
fractions	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
and	NULL
in	NULL
an	NULL
EMSA	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
using	NULL
the	NULL
labeled	NULL
E74	NULL
oligonucleotide	NULL
.	NULL

Lanes	NULL
I	NULL
to	NULL
3	NULL
,	NULL
renatured	NULL
proteins	NULL
from	NULL
the	NULL
full-length	NULL
ERP	NULL
translation	NULL
;	NULL
lanes	NULL
4	NULL
to	NULL
12	NULL
,	NULL
renatured	NULL
proteins	NULL
from	NULL
the	NULL
deletion	NULL
mutant	NULL
translations	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
.	NULL

The	NULL
apparent	NULL
sizes	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

3304	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
ENHANCER	NULL
BINDING	NULL
SITE	NULL
ERPFAo333	NULL
E74	NULL
AACCGGAAGTAA	NULL
+++	NULL
HSV	NULL
ICP4	NULL
GAACGGAAGCGG	NULL
++*	NULL
LCK	NULL
Prom	NULL
.	NULL

GGCAGGAAGCTT	NULL
++	NULL
Polyoma	NULL
PEA3	NULL
AGCAGGAAGTGA	NULL
++	NULL
IgH	NULL
Enh	NULL
.	NULL

x	NULL
site	NULL
GGCAGGAAGCAG	NULL
++	NULL
UROKINASE	NULL
Prom	NULL
.	NULL

AGGAGGAAATGA	NULL
+	NULL
STROMELYSIN	NULL
Prom	NULL
.	NULL

AGCAGGAAGCAT	NULL
*	NULL
vpreB	NULL
Prom	NULL
.	NULL

GGGAGGAAGCAC	NULL
+	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
GACAGGAACAGC	NULL
+	NULL
HTLV-1	NULL
LTR	NULL
GGGAGGAAATGG	NULL
+	NULL
MSV	NULL
LTR	NULL
GAGCGGAAGCGC	NULL
+	NULL
FOS	NULL
SRE	NULL
CACAGGATGTCC	NULL
+	NULL
IL-2	NULL
NF-AT	NULL
AGGAGGAAAAAC	NULL
+/=	NULL
TCR	NULL
Â«	NULL
Enh	NULL
.	NULL

To2	NULL
CAGAGGATGTGG	NULL
+/-Igx	NULL
3	NULL
'	NULL
Enh	NULL
.	NULL

TTGAGGAACTGA	NULL
+/-IL-2	NULL
IL-2B	NULL
AAGAGGAAAAAT	NULL
at	NULL
MHC	NULL
class	NULL
II	NULL
Prom	NULL
.	NULL

GTGAGGAACCAA	NULL
g	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

FIG	NULL
.	NULL

10	NULL
.	NULL

Interaction	NULL
of	NULL
ERP	NULL
with	NULL
functionally	NULL
relevant	NULL
regulatory	NULL
sites	NULL
in	NULL
different	NULL
genes	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
relative	NULL
binding	NULL
affinities	NULL
of	NULL
ERP	NULL
for	NULL
ets-binding	NULL
sites	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
of	NULL
different	NULL
genes	NULL
.	NULL

Sequences	NULL
present	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
various	NULL
genes	NULL
that	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
efs-related	NULL
factors	NULL
or	NULL
that	NULL
correspond	NULL
to	NULL
the	NULL
consensus	NULL
efs-binding	NULL
site	NULL
including	NULL
E74	NULL
(	NULL
91	NULL
)	NULL
,	NULL
HSV	NULL
ICP4	NULL
(	NULL
89	NULL
)	NULL
,	NULL
Ick	NULL
promoter	NULL
(	NULL
Prom	NULL
.	NULL
)	NULL

(	NULL
44	NULL
)	NULL
,	NULL
polyomavirus	NULL
PEA3	NULL
(	NULL
95	NULL
)	NULL
,	NULL
IgH	NULL
enhancer	NULL
(	NULL
Enh	NULL
.	NULL
)	NULL

1	NULL
site	NULL
(	NULL
47	NULL
)	NULL
,	NULL
urokinase	NULL
promoter	NULL
(	NULL
60	NULL
)	NULL
,	NULL
stromelysin	NULL
promoter	NULL
(	NULL
96	NULL
)	NULL
,	NULL
vpreB	NULL
promoter	NULL
(	NULL
34	NULL
)	NULL
,	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
(	NULL
41	NULL
)	NULL
,	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
21	NULL
)	NULL
,	NULL
MSV	NULL
LTR	NULL
(	NULL
23	NULL
)	NULL
,	NULL
c-fos	NULL
SRE	NULL
(	NULL
14	NULL
,	NULL
25	NULL
)	NULL
,	NULL
IL-2	NULL
NF-AT	NULL
(	NULL
88	NULL
)	NULL
,	NULL
T-cell	NULL
receptor	NULL
Â«	NULL
enhancer	NULL
Ta2	NULL
(	NULL
26	NULL
)	NULL
,	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
3	NULL
'	NULL
enhancer	NULL
(	NULL
64	NULL
)	NULL
,	NULL
IL-2	NULL
IL-2B	NULL
(	NULL
88	NULL
)	NULL
,	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
(	NULL
31	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
relative	NULL
DNA-binding	NULL
affinity	NULL
of	NULL
the	NULL
ERPAC222	NULL
deletion	NULL
mutant	NULL
towards	NULL
each	NULL
site	NULL
as	NULL
determined	NULL
by	NULL
EMSA	NULL
(	NULL
see	NULL
panel	NULL
b	NULL
)	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

A	NULL
potential	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
ERP	NULL
based	NULL
on	NULL
this	NULL
analysis	NULL
is	NULL
summarized	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Nucleotides	NULL
at	NULL
high-affinity	NULL
binding	NULL
sites	NULL
are	NULL
uppercased	NULL
;	NULL
nucleotides	NULL
at	NULL
lower-affinity	NULL
binding	NULL
sites	NULL
are	NULL
lowercased	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Relative	NULL
censsusus	NULL
ï¬gmï¬	NULL
â	NULL
jim	NULL
DNA-binding	NULL
activities	NULL
of	NULL
ERP	NULL
for	NULL
different	NULL
ets-binding	NULL
sites	NULL
in	NULL
an	NULL
c	NULL
g	NULL
ca	NULL
EMSA	NULL
using	NULL
synthetic	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
E74	NULL
site	NULL
.	NULL

ERPAC222	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
E74	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
no	NULL
competitor	NULL
.	NULL

MUT	NULL
,	NULL
mutant	NULL
;	NULL
HSV	NULL
,	NULL
HSV	NULL
ICP4	NULL
;	NULL
URO	NULL
,	NULL
urokinase	NULL
promoter	NULL
;	NULL
HIV-2	NULL
,	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
;	NULL
Igk	NULL
,	NULL
Ig	NULL
(	NULL
k	NULL
)	NULL
3	NULL
'	NULL
en-hancer	NULL
;	NULL
HTLV-1	NULL
,	NULL
HTLV-I	NULL
LTR	NULL
;	NULL
MHC	NULL
II	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
;	NULL
MSV	NULL
,	NULL
MSV	NULL
LTR	NULL
;	NULL
STROM	NULL
,	NULL
stromelysin	NULL
promoter	NULL
;	NULL
TCR	NULL
a	NULL
,	NULL
T-cell	NULL
receptor	NULL
enhancer	NULL
To2	NULL
.	NULL

Arrow	NULL
on	NULL
the	NULL
left	NULL
,	NULL
specific	NULL
complex	NULL
.	NULL

b	NULL
g	NULL
o	NULL
in	NULL
vitro	NULL
&	NULL
TRANSLATED	NULL
PROTEIN	NULL
5	NULL
*	NULL
ProBE	NULL
E74	NULL
a-COMPETITOR	NULL
E74	NULL
-	NULL
E74	NULL
mUT	NULL
-	NULL
HSV	NULL
URO	NULL
HIV-2	NULL
igx	NULL
HTLV-1	NULL
MHC	NULL
II	NULL
MSV	NULL
FOS	NULL
SRE	NULL
IL-2B	NULL
NF-AT	NULL
-	NULL
LCK	NULL
PEA3	NULL
STROM	NULL
TCR	NULL
Â«	NULL
-	NULL
IgH	NULL
x	NULL
(	NULL
ng	NULL
)	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
7T	NULL
``	NULL
#	NULL
og	NULL
19	NULL
H	NULL
12	NULL
042	NULL
44	NULL
4s	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
transcription	NULL
factor/oncoprotein	NULL
family	NULL
,	NULL
ERP	NULL
.	NULL

ERP	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
;	NULL
however	NULL
,	NULL
within	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
ERP	NULL
is	NULL
transcribed	NULL
primarily	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
,	NULL
and	NULL
expression	NULL
drastically	NULL
declines	NULL
upon	NULL
B-cell	NULL
maturation	NULL
.	NULL

This	NULL
expression	NULL
pattern	NULL
correlates	NULL
with	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
#	NULL
site	NULL
,	NULL
and	NULL
ERP	NULL
is	NULL
indeed	NULL
able	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
this	NULL
enhancer	NULL
element	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
an	NULL
involvement	NULL
of	NULL
ERP	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
B-cell	NULL
differentiation	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
in	NULL
IgH	NULL
gene	NULL
expression	NULL
as	NULL
well	NULL
.	NULL

ERP	NULL
interaction	NULL
with	NULL
DNA	NULL
appears	NULL
to	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
carboxy-terminal	NULL
negative	NULL
regulatory	NULL
domain	NULL
,	NULL
indicating	NULL
the	NULL
role	NULL
of	NULL
putative	NULL
posttranslational	NULL
modifications	NULL
and/or	NULL
protein-protein	NULL
interactions	NULL
in	NULL
the	NULL
control	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
ERP	NULL
.	NULL

ERP	NULL
was	NULL
isolated	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
homology	NULL
to	NULL
the	NULL
ETS	NULL
domain	NULL
which	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
all	NULL
ets-related	NULL
proteins	NULL
and	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
55	NULL
,	NULL
61	NULL
,	NULL
85	NULL
,	NULL
94	NULL
)	NULL
.	NULL

ets-related	NULL
proteins	NULL
can	NULL
be	NULL
further	NULL
grouped	NULL
into	NULL
subclasses	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
additional	NULL
homologous	NULL
protein	NULL
domains	NULL
which	NULL
are	NULL
30	NULL
31	NULL
32	NULL
33	NULL
34	NULL
35	NULL
unique	NULL
for	NULL
particular	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
55	NULL
,	NULL
61	NULL
,	NULL
85	NULL
,	NULL
and	NULL
94	NULL
)	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
comparison	NULL
demonstrates	NULL
that	NULL
ERP	NULL
shows	NULL
the	NULL
highest	NULL
homology	NULL
to	NULL
a	NULL
particular	NULL
subgroup	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
with	NULL
distinctive	NULL
features	NULL
which	NULL
includes	NULL
SAP-1	NULL
(	NULL
14	NULL
)	NULL
and	NULL
ELK-1	NULL
(	NULL
68	NULL
)	NULL
.	NULL

Both	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
are	NULL
able	NULL
to	NULL
form	NULL
a	NULL
ternary	NULL
complex	NULL
with	NULL
the	NULL
SRF	NULL
and	NULL
bind	NULL
to	NULL
the	NULL
SRE	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
in	NULL
an	NULL
SRF-dependent	NULL
manner	NULL
(	NULL
14	NULL
,	NULL
25	NULL
,	NULL
28	NULL
,	NULL
71	NULL
,	NULL
90	NULL
)	NULL
.	NULL

Protein-protein	NULL
interactions	NULL
appear	NULL
to	NULL
be	NULL
common	NULL
mechanisms	NULL
for	NULL
the	NULL
function	NULL
of	NULL
most	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
efs-related	NULL
proteins	NULL
.	NULL

Pu.1	NULL
,	NULL
for	NULL
example	NULL
,	NULL
cooperates	NULL
with	NULL
a	NULL
second	NULL
factor	NULL
,	NULL
NF-EMS	NULL
(	NULL
64	NULL
)	NULL
,	NULL
and	NULL
GABPa	NULL
binds	NULL
to	NULL
GABPLB	NULL
(	NULL
38	NULL
,	NULL
89	NULL
)	NULL
.	NULL

Similarly	NULL
to	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
,	NULL
ERP	NULL
contains	NULL
the	NULL
three	NULL
homology	NULL
regions	NULL
A	NULL
to	NULL
C.	NULL
Domain	NULL
A	NULL
,	NULL
the	NULL
ETS	NULL
domain	NULL
,	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
DNA	NULL
binding	NULL
and	NULL
is	NULL
the	NULL
region	NULL
which	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
all	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
(	NULL
55	NULL
,	NULL
61	NULL
,	NULL
85	NULL
,	NULL
94	NULL
)	NULL
.	NULL

Domain	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
interaction	NULL
of	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
with	NULL
SRF	NULL
and	NULL
has	NULL
been	NULL
found	NULL
only	NULL
in	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
(	NULL
14	NULL
,	NULL
28	NULL
,	NULL
71	NULL
,	NULL
90	NULL
)	NULL
.	NULL

Since	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
a	NULL
a	NULL
a	NULL
&	NULL
8	NULL
&	NULL
&	NULL
a	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
s	NULL
)	NULL
..	NULL

IN	NULL
vitro	NULL
a.	NULL
a.	NULL
a	NULL
a.	NULL
a	NULL
a.	NULL
a	NULL
TRANsLatepprotem	NULL
.oÂ§6	NULL
.	NULL

Â§	NULL
.	NULL

Â§	NULL
.	NULL

Â§	NULL
Â°.Â°Â§	NULL
.	NULL

Â§	NULL
ProBE	NULL
E74	NULL
-	NULL
igh	NULL
x	NULL
-	NULL
HSV	NULL
_	NULL
HIV-2	NULL
-	NULL
MSV	NULL
_	NULL
LCK	NULL
_	NULL
MHC	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
1Â°	NULL
59	NULL
``	NULL
is	NULL
Mug	NULL
ig	NULL
ug	NULL
recs	NULL
IN	NULL
VITRO	NULL
TRANSLATED	NULL
PROTEIN	NULL
prose	NULL
E74	NULL
LCK	NULL
igh	NULL
x	NULL
ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
ets	NULL
FAMILY	NULL
3305	NULL
ERPaC222	NULL
ERPAC222	NULL
ERPAC222	NULL
competitor	NULL
(	NULL
wt	NULL
mut	NULL
u	NULL
wt	NULL
mut	NULL
II	NULL
wr	NULL
mut	NULL
(	NULL
ng	NULL
)	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
10	NULL
100	NULL
1	NULL
2103	NULL
}	NULL
ip	NULL
``	NULL
``	NULL
gle	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

ERP	NULL
interacts	NULL
specifically	NULL
with	NULL
the	NULL
ick	NULL
promoter	NULL
ets	NULL
site	NULL
and	NULL
the	NULL
IgH	NULL
enhancer	NULL
m	NULL
site	NULL
.	NULL

(	NULL
a	NULL
)	NULL
DNA	NULL
binding	NULL
of	NULL
ERP	NULL
to	NULL
various	NULL
ets-binding	NULL
sites	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
the	NULL
unprogrammed	NULL
(	NULL
-	NULL
)	NULL
and	NULL
ERPAC222	NULL
in	NULL
vitro	NULL
translation	NULL
products	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
oligonucleotide	NULL
probes	NULL
encoding	NULL
the	NULL
E74	NULL
,	NULL
IgH	NULL
enhancer	NULL
#	NULL
,	NULL
HSV	NULL
ICP4	NULL
,	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
,	NULL
MSV	NULL
LTR	NULL
,	NULL
ick	NULL
promoter	NULL
ets	NULL
,	NULL
and	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
sites	NULL
.	NULL

(	NULL
b	NULL
)	NULL
ERP	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
Ick	NULL
ets	NULL
site	NULL
and	NULL
the	NULL
IgH	NULL
enhancer	NULL
#	NULL
site	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

ERPAC222	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
E74	NULL
,	NULL
ick	NULL
,	NULL
or	NULL
IgH	NULL
enhancer	NULL
r	NULL
site	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
7	NULL
,	NULL
and	NULL
13	NULL
,	NULL
DNA-binding	NULL
reactions	NULL
with	NULL
unprogrammed	NULL
(	NULL
-	NULL
)	NULL
in	NULL
vitro	NULL
translation	NULL
products	NULL
and	NULL
E74	NULL
,	NULL
ick	NULL
,	NULL
or	NULL
IgH	NULL
enhancer	NULL
#	NULL
site	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

Lanes	NULL
2	NULL
,	NULL
8	NULL
,	NULL
and	NULL
14	NULL
,	NULL
no	NULL
competitor	NULL
.	NULL

WT	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
MUT	NULL
,	NULL
mutant	NULL
.	NULL

Arrow	NULL
on	NULL
the	NULL
left	NULL
,	NULL
specific	NULL
complex	NULL
.	NULL

ERP	NULL
contains	NULL
a	NULL
region	NULL
of	NULL
similarity	NULL
to	NULL
domain	NULL
B	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
ERP	NULL
binds	NULL
to	NULL
SRF	NULL
as	NULL
well	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
testing	NULL
this	NULL
possibility	NULL
,	NULL
but	NULL
we	NULL
were	NULL
so	NULL
far	NULL
unable	NULL
to	NULL
detect	NULL
any	NULL
ternary	NULL
complex	NULL
formation	NULL
with	NULL
SRF	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Domain	NULL
C	NULL
contains	NULL
phosphorylation	NULL
sites	NULL
for	NULL
MAP	NULL
kinase	NULL
and	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
regulation	NULL
by	NULL
growth	NULL
factors	NULL
and	NULL
transactivation	NULL
(	NULL
56	NULL
,	NULL
90	NULL
)	NULL
.	NULL

ERP	NULL
contains	NULL
putative	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
sites	NULL
homologous	NULL
to	NULL
the	NULL
sites	NULL
in	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
,	NULL
suggesting	NULL
a	NULL
potential	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ERP	NULL
activity	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
an	NULL
additional	NULL
shorter	NULL
region	NULL
of	NULL
homology	NULL
,	NULL
domain	NULL
D	NULL
,	NULL
that	NULL
might	NULL
encode	NULL
a	NULL
nuclear	NULL
localization	NULL
signal	NULL
for	NULL
ERP	NULL
,	NULL
ELK-1	NULL
,	NULL
and	NULL
SAP-1	NULL
.	NULL

While	NULL
domains	NULL
A	NULL
to	NULL
D	NULL
are	NULL
highly	NULL
conserved	NULL
,	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
ERP	NULL
protein	NULL
reveals	NULL
only	NULL
limited	NULL
similarity	NULL
to	NULL
SAP-1	NULL
or	NULL
ELK-1	NULL
,	NULL
even	NULL
though	NULL
there	NULL
are	NULL
some	NULL
short	NULL
stretches	NULL
with	NULL
similarity	NULL
to	NULL
SAP-1	NULL
,	NULL
while	NULL
other	NULL
regions	NULL
are	NULL
similar	NULL
to	NULL
ELK-1	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
these	NULL
homologies	NULL
for	NULL
the	NULL
biological	NULL
function	NULL
of	NULL
ERP	NULL
,	NULL
SAP-1	NULL
,	NULL
or	NULL
ELK-1	NULL
has	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

The	NULL
small	NULL
stretches	NULL
of	NULL
similarity	NULL
and	NULL
the	NULL
divergent	NULL
regions	NULL
in	NULL
the	NULL
remainder	NULL
of	NULL
these	NULL
proteins	NULL
suggest	NULL
that	NULL
each	NULL
of	NULL
these	NULL
ets-related	NULL
proteins	NULL
has	NULL
unique	NULL
features	NULL
whether	NULL
or	NULL
not	NULL
it	NULL
is	NULL
through	NULL
interaction	NULL
with	NULL
particular	NULL
binding	NULL
sites	NULL
,	NULL
interaction	NULL
with	NULL
particular	NULL
secondary	NULL
factors	NULL
,	NULL
unique	NULL
posttranslational	NULL
modifications	NULL
,	NULL
or	NULL
other	NULL
undetermined	NULL
func-tions	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
these	NULL
unique	NULL
domains	NULL
play	NULL
crucial	NULL
roles	NULL
in	NULL
the	NULL
diverse	NULL
functions	NULL
of	NULL
ERP	NULL
,	NULL
SAP-1	NULL
,	NULL
and	NULL
ELK-1	NULL
.	NULL

Overall	NULL
,	NULL
ERP	NULL
has	NULL
a	NULL
slightly	NULL
higher	NULL
sequence	NULL
identity	NULL
to	NULL
SAP-1	NULL
(	NULL
46	NULL
%	NULL
)	NULL
than	NULL
to	NULL
ELK-1	NULL
(	NULL
36	NULL
%	NULL
)	NULL
.	NULL

A	NULL
few	NULL
short	NULL
amino	NULL
acid	NULL
stretches	NULL
in	NULL
ERP	NULL
which	NULL
are	NULL
not	NULL
conserved	NULL
in	NULL
SAP-1	NULL
or	NULL
ELK-1	NULL
are	NULL
conserved	NULL
in	NULL
another	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
,	NULL
E74	NULL
(	NULL
11	NULL
)	NULL
,	NULL
which	NULL
otherwise	NULL
shows	NULL
very	NULL
little	NULL
homology	NULL
to	NULL
ERP	NULL
,	NULL
SAP-1	NULL
,	NULL
or	NULL
ELK-1	NULL
outside	NULL
the	NULL
ETS	NULL
domain	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
this	NULL
region	NULL
for	NULL
the	NULL
function	NULL
of	NULL
E74	NULL
is	NULL
not	NULL
known	NULL
.	NULL

Both	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
are	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
DNA	NULL
independently	NULL
of	NULL
SRF	NULL
as	NULL
well	NULL
(	NULL
28	NULL
,	NULL
71	NULL
,	NULL
90	NULL
)	NULL
.	NULL

The	NULL
E74A-binding	NULL
site	NULL
of	NULL
the	NULL
Drosophila	NULL
ecdysone-inducible	NULL
E74A	NULL
gene	NULL
,	NULL
for	NULL
example	NULL
,	NULL
binds	NULL
to	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
(	NULL
28	NULL
,	NULL
70	NULL
,	NULL
71	NULL
,	NULL
90	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
the	NULL
ets-related	NULL
protein	NULL
E74	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
(	NULL
28	NULL
,	NULL
70	NULL
,	NULL
71	NULL
,	NULL
90	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
by	NULL
EMSAs	NULL
that	NULL
ERP	NULL
interacts	NULL
with	NULL
the	NULL
E74A	NULL
site	NULL
as	NULL
well	NULL
.	NULL

However	NULL
,	NULL
significant	NULL
sequence-specific	NULL
DNA-binding	NULL
activity	NULL
is	NULL
detected	NULL
only	NULL
upon	NULL
deletion	NULL
of	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
ERP	NULL
,	NULL
which	NULL
contains	NULL
domain	NULL
C	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
domain	NULL
in	NULL
that	NULL
region	NULL
.	NULL

A	NULL
protein-DNA	NULL
complex	NULL
with	NULL
full-length	NULL
ERP	NULL
is	NULL
observed	NULL
in	NULL
our	NULL
experiments	NULL
,	NULL
but	NULL
deletion	NULL
mutant	NULL
analysis	NULL
and	NULL
denaturation-renaturation	NULL
studies	NULL
indicate	NULL
that	NULL
this	NULL
complex	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
the	NULL
expected	NULL
mobility	NULL
and	NULL
most	NULL
likely	NULL
represents	NULL
an	NULL
early	NULL
termination	NULL
or	NULL
degradation	NULL
product	NULL
of	NULL
ERP	NULL
.	NULL

ERP	NULL
might	NULL
have	NULL
to	NULL
interact	NULL
with	NULL
other	NULL
proteins	NULL
in	NULL
vivo	NULL
and/or	NULL
might	NULL
have	NULL
to	NULL
be	NULL
posttranslationally	NULL
modified	NULL
,	NULL
leading	NULL
to	NULL
derepression	NULL
and	NULL
increased	NULL
affinity	NULL
of	NULL
ERP	NULL
for	NULL
DNA	NULL
.	NULL

Negative	NULL
regulatory	NULL
domains	NULL
have	NULL
been	NULL
found	NULL
in	NULL
several	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
including	NULL
ELK-1	NULL
and	NULL
Ets-1	NULL
(	NULL
52	NULL
,	NULL
71	NULL
,	NULL
97	NULL
)	NULL
as	NULL
well	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
carboxy-terminal	NULL
truncation	NULL
of	NULL
ERP	NULL
which	NULL
eliminates	NULL
the	NULL
conserved	NULL
domain	NULL
C	NULL
reconstitutes	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Domain	NULL
C	NULL
and	NULL
the	NULL
surrounding	NULL
regions	NULL
contain	NULL
several	NULL
putative	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
sites	NULL
which	NULL
are	NULL
conserved	NULL
in	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
as	NULL
well	NULL
and	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
growth	NULL
factor-regulated	NULL
transactivation	NULL
by	NULL
ELK-1	NULL
(	NULL
56	NULL
)	NULL
.	NULL

A	NULL
possible	NULL
model	NULL
predicts	NULL
that	NULL
the	NULL
carboxy	NULL
terminus	NULL
represses	NULL
DNA	NULL
binding	NULL
of	NULL
ERP	NULL
by	NULL
an	NULL
intramolecular	NULL
mechanism	NULL
in	NULL
which	NULL
the	NULL
carboxy	NULL
terminus	NULL
masks	NULL
the	NULL
amino-terminal	NULL
ETS	NULL
domain	NULL
.	NULL

Phosphorylation	NULL
of	NULL
certain	NULL
amino	NULL
acid	NULL
residues	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
region	NULL
of	NULL
ERP	NULL
might	NULL
affect	NULL
the	NULL
DNA-binding	NULL
ability	NULL
of	NULL
ERP	NULL
by	NULL
conformational	NULL
modification	NULL
of	NULL
the	NULL
carboxy	NULL
terminus	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
9	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Another	NULL
possible	NULL
mechanism	NULL
might	NULL
involve	NULL
the	NULL
interaction	NULL
of	NULL
ERP	NULL
with	NULL
a	NULL
second	NULL
protein	NULL
either	NULL
at	NULL
the	NULL
carboxy	NULL
terminus	NULL
or	NULL
at	NULL
domain	NULL
B	NULL
which	NULL
might	NULL
relieve	NULL
the	NULL
negative	NULL
constraint	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

Our	NULL
deletion	NULL
analysis	NULL
of	NULL
ERP	NULL
,	NULL
furthermore	NULL
,	NULL
confirms	NULL
that	NULL
the	NULL
highly	NULL
conserved	NULL
ETS	NULL
domain	NULL
constitutes	NULL
the	NULL
DNA-binding	NULL
domain	NULL
.	NULL

This	NULL
domain	NULL
A	NULL
is	NULL
sufficient	NULL
to	NULL
bind	NULL
sequence	NULL
specifically	NULL
to	NULL
DNA	NULL
.	NULL

The	NULL
DNA-binding	NULL
domains	NULL
of	NULL
ERP	NULL
,	NULL
ELK-1	NULL
,	NULL
and	NULL
SAP-1	NULL
are	NULL
remarkably	NULL
similar	NULL
.	NULL

Nevertheless	NULL
,	NULL
a	NULL
region	NULL
of	NULL
6	NULL
amino	NULL
acids	NULL
close	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
is	NULL
unique	NULL
in	NULL
each	NULL
of	NULL
these	NULL
three	NULL
proteins	NULL
,	NULL
and	NULL
there	NULL
are	NULL
several	NULL
other	NULL
amino	NULL
acid	NULL
differences	NULL
which	NULL
could	NULL
affect	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

All	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
share	NULL
a	NULL
common	NULL
recognition	NULL
sequence	NULL
,	NULL
5-GGA	NULL
(	NULL
A/T	NULL
)	NULL
-3	NULL
'	NULL
(	NULL
55	NULL
,	NULL
61	NULL
,	NULL
85	NULL
,	NULL
94	NULL
)	NULL
,	NULL
which	NULL
is	NULL
located	NULL
in	NULL
the	NULL
middle	NULL
3306	NULL
LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

of	NULL
the	NULL
DNA-binding	NULL
site	NULL
,	NULL
whereas	NULL
the	NULL
flanking	NULL
sequences	NULL
are	NULL
divergent	NULL
for	NULL
different	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
.	NULL

Differences	NULL
in	NULL
the	NULL
ETS	NULL
domain	NULL
between	NULL
ERP	NULL
and	NULL
SAP-1	NULL
or	NULL
ELK-1	NULL
could	NULL
therefore	NULL
influence	NULL
the	NULL
precise	NULL
recognition	NULL
sequence	NULL
for	NULL
ERP	NULL
,	NULL
which	NULL
might	NULL
be	NULL
slightly	NULL
different	NULL
from	NULL
those	NULL
of	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
.	NULL

Whereas	NULL
full-length	NULL
ERP	NULL
expresses	NULL
only	NULL
negligible	NULL
DNA-binding	NULL
activity	NULL
towards	NULL
a	NULL
variety	NULL
of	NULL
ets-binding	NULL
sites	NULL
,	NULL
carboxy	NULL
terminus-deleted	NULL
ERP	NULL
interacts	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
functionally	NULL
relevant	NULL
ets-binding	NULL
sites	NULL
with	NULL
different	NULL
affinities	NULL
including	NULL
the	NULL
HSV	NULL
ICP4	NULL
GABP	NULL
site	NULL
(	NULL
89	NULL
)	NULL
,	NULL
the	NULL
IgH	NULL
enhancer	NULL
t	NULL
site	NULL
(	NULL
47	NULL
)	NULL
,	NULL
the	NULL
polyomavirus	NULL
PEA3	NULL
site	NULL
(	NULL
95	NULL
)	NULL
,	NULL
the	NULL
Ick	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
44	NULL
)	NULL
,	NULL
the	NULL
urokinase	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
60	NULL
)	NULL
,	NULL
the	NULL
HIV-2	NULL
LTR	NULL
CD3R	NULL
site	NULL
(	NULL
94	NULL
)	NULL
,	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
ets	NULL
site	NULL
(	NULL
21	NULL
)	NULL
,	NULL
the	NULL
MSV	NULL
LTR	NULL
ets	NULL
site	NULL
(	NULL
61	NULL
)	NULL
,	NULL
the	NULL
c-fos	NULL
promoter	NULL
SRE	NULL
site	NULL
(	NULL
14	NULL
,	NULL
25	NULL
)	NULL
,	NULL
the	NULL
stromelysin	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
96	NULL
)	NULL
,	NULL
and	NULL
the	NULL
vpreB	NULL
promoter	NULL
ets	NULL
site	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ERP	NULL
is	NULL
another	NULL
candidate	NULL
factor	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

An	NULL
approximate	NULL
consensus	NULL
high-affinity	NULL
binding	NULL
site	NULL
for	NULL
ERP	NULL
is	NULL
similar	NULL
to	NULL
recognition	NULL
sequences	NULL
for	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
ERG	NULL
,	NULL
Fli-1	NULL
,	NULL
PEA3	NULL
,	NULL
GABP	NULL
,	NULL
E74	NULL
,	NULL
and	NULL
ELK-1	NULL
(	NULL
10	NULL
,	NULL
19	NULL
,	NULL
25	NULL
,	NULL
30	NULL
,	NULL
61	NULL
,	NULL
64	NULL
,	NULL
70	NULL
,	NULL
71	NULL
,	NULL
75	NULL
,	NULL
91	NULL
,	NULL
94	NULL
,	NULL
102	NULL
,	NULL
103	NULL
)	NULL
.	NULL

However	NULL
,	NULL
ERP	NULL
displays	NULL
very	NULL
low	NULL
or	NULL
no	NULL
affinity	NULL
towards	NULL
binding	NULL
sites	NULL
for	NULL
two	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
,	NULL
Pu.1	NULL
and	NULL
ELF-1	NULL
,	NULL
which	NULL
recognize	NULL
more	NULL
divergent	NULL
DNA	NULL
motifs	NULL
than	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
family	NULL
(	NULL
31	NULL
,	NULL
64	NULL
,	NULL
88	NULL
,	NULL
94	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
unlikely	NULL
that	NULL
the	NULL
slight	NULL
differences	NULL
in	NULL
DNA-binding	NULL
affinities	NULL
among	NULL
the	NULL
majority	NULL
of	NULL
ets-related	NULL
factors	NULL
towards	NULL
highly	NULL
related	NULL
recognition	NULL
sequences	NULL
will	NULL
determine	NULL
which	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
will	NULL
interact	NULL
with	NULL
a	NULL
particular	NULL
site	NULL
in	NULL
different	NULL
genes	NULL
.	NULL

We	NULL
anticipate	NULL
that	NULL
the	NULL
specific	NULL
arrangement	NULL
and	NULL
combination	NULL
of	NULL
different	NULL
regulatory	NULL
sites	NULL
surrounding	NULL
an	NULL
ets-binding	NULL
site	NULL
in	NULL
a	NULL
particular	NULL
gene	NULL
will	NULL
favor	NULL
the	NULL
selection	NULL
of	NULL
a	NULL
specific	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
due	NULL
to	NULL
specific	NULL
protein-protein	NULL
interactions	NULL
and	NULL
potential	NULL
posttranslational	NULL
modifications	NULL
.	NULL

At	NULL
least	NULL
four	NULL
mRNA	NULL
transcripts	NULL
are	NULL
detected	NULL
on	NULL
Northern	NULL
blots	NULL
hybridizing	NULL
to	NULL
ERP	NULL
cDNA	NULL
probes	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
the	NULL
transcripts	NULL
,	NULL
however	NULL
,	NULL
vary	NULL
in	NULL
different	NULL
tissues	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
2.2-kb	NULL
transcript	NULL
appears	NULL
to	NULL
encode	NULL
the	NULL
ERP	NULL
cDNA	NULL
which	NULL
we	NULL
have	NULL
cloned	NULL
.	NULL

It	NULL
contains	NULL
a	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
,	NULL
and	NULL
preliminary	NULL
primer	NULL
extension	NULL
analysis	NULL
indicates	NULL
the	NULL
existence	NULL
of	NULL
two	NULL
main	NULL
transcription	NULL
start	NULL
sites	NULL
within	NULL
100	NULL
nucleotides	NULL
from	NULL
each	NULL
other	NULL
,	NULL
similar	NULL
or	NULL
identical	NULL
to	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
our	NULL
cDNAs	NULL
.	NULL

The	NULL
other	NULL
mRNA	NULL
species	NULL
might	NULL
encode	NULL
either	NULL
alternative	NULL
splice	NULL
products	NULL
of	NULL
ERP	NULL
,	NULL
transcripts	NULL
of	NULL
ERP	NULL
genes	NULL
,	NULL
or	NULL
antisense	NULL
transcripts	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
antisense	NULL
strand	NULL
of	NULL
the	NULL
ERP	NULL
cDNA	NULL
encodes	NULL
another	NULL
long	NULL
open	NULL
reading	NULL
frame	NULL
for	NULL
a	NULL
putative	NULL
polypeptide	NULL
of	NULL
209	NULL
amino	NULL
acids	NULL
.	NULL

No	NULL
homology	NULL
to	NULL
any	NULL
known	NULL
protein	NULL
is	NULL
apparent	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
at	NULL
the	NULL
moment	NULL
whether	NULL
this	NULL
protein	NULL
really	NULL
exists	NULL
.	NULL

Nevertheless	NULL
,	NULL
at	NULL
least	NULL
one	NULL
other	NULL
ets-related	NULL
gene	NULL
isolated	NULL
from	NULL
drosophila	NULL
,	NULL
D-elg	NULL
,	NULL
encodes	NULL
an	NULL
antisense	NULL
transcript	NULL
for	NULL
an	NULL
unidentified	NULL
protein	NULL
whose	NULL
expression	NULL
is	NULL
coregulated	NULL
with	NULL
the	NULL
D-elg	NULL
gene	NULL
(	NULL
66	NULL
)	NULL
.	NULL

We	NULL
are	NULL
now	NULL
in	NULL
the	NULL
process	NULL
of	NULL
verifying	NULL
,	NULL
using	NULL
cRNA	NULL
probes	NULL
,	NULL
whether	NULL
any	NULL
of	NULL
the	NULL
other	NULL
transcripts	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
antisense	NULL
strand	NULL
of	NULL
ERP	NULL
.	NULL

Recent	NULL
data	NULL
from	NULL
several	NULL
laboratories	NULL
suggest	NULL
that	NULL
ets-related	NULL
proteins	NULL
are	NULL
essential	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
many	NULL
T-cell-specific	NULL
genes	NULL
including	NULL
T-cell	NULL
receptors	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
8	NULL
,	NULL
IL-2	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
CD3	NULL
(	NULL
26	NULL
,	NULL
40	NULL
,	NULL
57	NULL
,	NULL
88	NULL
,	NULL
94	NULL
)	NULL
,	NULL
and	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
ets-related	NULL
proteins	NULL
play	NULL
a	NULL
role	NULL
in	NULL
B-cell	NULL
gene	NULL
regulation	NULL
and	NULL
differentiation	NULL
as	NULL
well	NULL
(	NULL
18	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
53	NULL
,	NULL
64	NULL
,	NULL
72	NULL
,	NULL
80	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
Pu.1	NULL
factor	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
B-cell-specific	NULL
expression	NULL
of	NULL
both	NULL
IgH	NULL
(	NULL
2	NULL
)	NULL
and	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
genes	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
Pu.1	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
IgH	NULL
intronic	NULL
enhancer	NULL
(	NULL
2	NULL
,	NULL
59	NULL
)	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
B-cell-specific	NULL
activation	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
(	NULL
2	NULL
,	NULL
49	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
Pu.1-binding	NULL
site	NULL
in	NULL
the	NULL
3	NULL
'	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
enhancer	NULL
is	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

important	NULL
for	NULL
B-cell-specific	NULL
activation	NULL
of	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
enhancer	NULL
,	NULL
and	NULL
Pu.1	NULL
interacts	NULL
with	NULL
a	NULL
second	NULL
B-cell-specific	NULL
nuclear	NULL
factor	NULL
which	NULL
binds	NULL
to	NULL
an	NULL
adjacent	NULL
site	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Another	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
,	NULL
Ets-1	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
,	NULL
and	NULL
ligation	NULL
of	NULL
membrane	NULL
Ig	NULL
leads	NULL
to	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
Ets-1	NULL
,	NULL
suggesting	NULL
that	NULL
Ets-1	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
B-cell	NULL
gene	NULL
regulation	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
third	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
,	NULL
Spi-B	NULL
,	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
might	NULL
bind	NULL
to	NULL
similar	NULL
sites	NULL
as	NULL
Pu.1	NULL
(	NULL
72	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Fli-1	NULL
and	NULL
ERG-3	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
differentially	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
IgH	NULL
gene	NULL
regulation	NULL
(	NULL
80	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ERP	NULL
and	NULL
several	NULL
other	NULL
ets-related	NULL
genes	NULL
are	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
analogously	NULL
to	NULL
the	NULL
apparent	NULL
role	NULL
of	NULL
ets-related	NULL
factors	NULL
in	NULL
the	NULL
control	NULL
of	NULL
T-cell-specific	NULL
gene	NULL
expression	NULL
,	NULL
efs-related	NULL
proteins	NULL
might	NULL
regulate	NULL
B-cell-specific	NULL
gene	NULL
expression	NULL
as	NULL
well	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
ERP	NULL
suggests	NULL
a	NULL
widespread	NULL
tissue	NULL
distribution	NULL
of	NULL
ERP	NULL
,	NULL
though	NULL
to	NULL
different	NULL
degrees	NULL
in	NULL
the	NULL
tissues	NULL
analyzed	NULL
.	NULL

Nevertheless	NULL
,	NULL
in	NULL
the	NULL
B-cell	NULL
lineage	NULL
it	NULL
appears	NULL
that	NULL
ERP	NULL
is	NULL
highly	NULL
expressed	NULL
primarily	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
and	NULL
expression	NULL
is	NULL
down-regulated	NULL
upon	NULL
maturation	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
the	NULL
function	NULL
of	NULL
ERP	NULL
in	NULL
B-cell	NULL
development	NULL
or	NULL
gene	NULL
regulation	NULL
.	NULL

However	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
ERP	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
early	NULL
B-cell	NULL
development	NULL
and	NULL
gene	NULL
regulation	NULL
,	NULL
since	NULL
expression	NULL
of	NULL
ERP	NULL
drastically	NULL
decreases	NULL
upon	NULL
B-cell	NULL
maturation	NULL
.	NULL

Interestingly	NULL
,	NULL
expression	NULL
of	NULL
ERP	NULL
in	NULL
these	NULL
B-cell	NULL
lines	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
#	NULL
enhancer	NULL
element	NULL
which	NULL
we	NULL
have	NULL
identified	NULL
in	NULL
the	NULL
IgH	NULL
enhancer	NULL
and	NULL
which	NULL
we	NULL
have	NULL
shown	NULL
to	NULL
be	NULL
primarily	NULL
active	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
#	NULL
enhancer	NULL
element	NULL
contains	NULL
a	NULL
functionally	NULL
crucial	NULL
5-GGAA-3	NULL
'	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
site	NULL
similar	NULL
to	NULL
other	NULL
recognition	NULL
sites	NULL
for	NULL
ets-related	NULL
factors	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
including	NULL
Ets-1	NULL
,	NULL
Fli-1	NULL
,	NULL
and	NULL
ERG-3	NULL
were	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
IgH	NULL
1	NULL
site	NULL
and	NULL
to	NULL
activate	NULL
it	NULL
when	NULL
overexpressed	NULL
(	NULL
59	NULL
,	NULL
80	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
ERP	NULL
is	NULL
also	NULL
able	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
IgH	NULL
r	NULL
site	NULL
.	NULL

Expression	NULL
of	NULL
ERG-3	NULL
and	NULL
ERP	NULL
,	NULL
but	NULL
not	NULL
Ets-1	NULL
or	NULL
Fli-1	NULL
,	NULL
correlates	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
1	NULL
site	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
either	NULL
of	NULL
these	NULL
two	NULL
factors	NULL
in	NULL
IgH	NULL
gene	NULL
regulation	NULL
(	NULL
47	NULL
,	NULL
59	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Several	NULL
other	NULL
putative	NULL
target	NULL
genes	NULL
for	NULL
ERP	NULL
which	NULL
are	NULL
transcriptionally	NULL
active	NULL
exclusively	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
include	NULL
vpreB	NULL
(	NULL
5	NULL
)	NULL
,	NULL
A5	NULL
(	NULL
34	NULL
)	NULL
,	NULL
TdT	NULL
(	NULL
53	NULL
,	NULL
78	NULL
)	NULL
,	NULL
and	NULL
mb-1	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
regions	NULL
of	NULL
all	NULL
these	NULL
pre-B-cell-specific	NULL
genes	NULL
contain	NULL
DNA	NULL
sequences	NULL
related	NULL
to	NULL
ets-binding	NULL
sites	NULL
and	NULL
might	NULL
represent	NULL
targets	NULL
for	NULL
ERP	NULL
.	NULL

Furthermore	NULL
,	NULL
several	NULL
other	NULL
B-cell-specific	NULL
genes	NULL
including	NULL
IgH	NULL
(	NULL
2	NULL
,	NULL
22	NULL
)	NULL
,	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
(	NULL
64	NULL
)	NULL
,	NULL
and	NULL
FcesRIla	NULL
(	NULL
77	NULL
)	NULL
contain	NULL
apparent	NULL
binding	NULL
sites	NULL
for	NULL
ets-related	NULL
proteins	NULL
in	NULL
their	NULL
regulatory	NULL
regions	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
some	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
ERP	NULL
.	NULL

Preliminary	NULL
results	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
ERP	NULL
is	NULL
indeed	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
vpreB	NULL
ets-binding	NULL
site	NULL
but	NULL
not	NULL
with	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
ets	NULL
site	NULL
.	NULL

Since	NULL
protein-protein	NULL
interactions	NULL
and	NULL
posttranslational	NULL
modifications	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
DNA-binding	NULL
capacity	NULL
and	NULL
transactivation	NULL
of	NULL
most	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
including	NULL
the	NULL
highly	NULL
related	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
and	NULL
since	NULL
ERP	NULL
binds	NULL
to	NULL
DNA	NULL
only	NULL
upon	NULL
deletion	NULL
of	NULL
the	NULL
carboxy	NULL
terminus	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
that	NULL
the	NULL
actual	NULL
target	NULL
sites	NULL
for	NULL
ERP	NULL
are	NULL
different	NULL
from	NULL
the	NULL
sequences	NULL
determined	NULL
in	NULL
our	NULL
analysis	NULL
.	NULL

Southern	NULL
blot	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
ERP	NULL
gene	NULL
is	NULL
highly	NULL
conserved	NULL
during	NULL
evolution	NULL
,	NULL
since	NULL
we	NULL
can	NULL
detect	NULL
specifically	NULL
hybridizing	NULL
bands	NULL
in	NULL
all	NULL
mammalian	NULL
,	NULL
bird	NULL
,	NULL
and	NULL
frog	NULL
DNAs	NULL
and	NULL
weaker	NULL
bands	NULL
in	NULL
nematode	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
hybridization	NULL
to	NULL
fly	NULL
or	NULL
yeast	NULL
DNA	NULL
,	NULL
suggesting	NULL
either	NULL
that	NULL
these	NULL
organisms	NULL
do	NULL
not	NULL
contain	NULL
any	NULL
gene	NULL
closely	NULL
related	NULL
to	NULL
ERP	NULL
or	NULL
that	NULL
our	NULL
hybridization	NULL
conditions	NULL
were	NULL
too	NULL
stringent	NULL
.	NULL

We	NULL
have	NULL
mapped	NULL
the	NULL
gene	NULL
for	NULL
ERP	NULL
to	NULL
human	NULL
chromosome	NULL
12	NULL
.	NULL

No	NULL
other	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
has	NULL
been	NULL
located	NULL
to	NULL
this	NULL
VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
chromosome	NULL
yet	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
clusters	NULL
of	NULL
ets-related	NULL
genes	NULL
located	NULL
on	NULL
human	NULL
chromosomes	NULL
11	NULL
and	NULL
21	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
65	NULL
,	NULL
69	NULL
,	NULL
100	NULL
)	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
tumorigenesis	NULL
has	NULL
only	NULL
recently	NULL
received	NULL
more	NULL
attention	NULL
,	NULL
when	NULL
it	NULL
was	NULL
observed	NULL
that	NULL
many	NULL
of	NULL
the	NULL
oncogenes	NULL
and	NULL
tumor	NULL
suppressor	NULL
genes	NULL
indeed	NULL
encode	NULL
transcription	NULL
factors	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Chromosomal	NULL
translocations	NULL
involving	NULL
transcription	NULL
factor	NULL
genes	NULL
appear	NULL
to	NULL
be	NULL
especially	NULL
frequent	NULL
in	NULL
human	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
(	NULL
32	NULL
,	NULL
87	NULL
,	NULL
93	NULL
)	NULL
.	NULL

At	NULL
least	NULL
two	NULL
ets-related	NULL
genes	NULL
,	NULL
F/i-1	NULL
(	NULL
65	NULL
)	NULL
and	NULL
ERG	NULL
(	NULL
86	NULL
)	NULL
,	NULL
have	NULL
been	NULL
directly	NULL
implicated	NULL
in	NULL
human	NULL
tumor	NULL
formation	NULL
.	NULL

Human	NULL
chromosome	NULL
12	NULL
is	NULL
involved	NULL
in	NULL
translocations	NULL
in	NULL
acute	NULL
myeloid	NULL
and	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
79	NULL
)	NULL
and	NULL
in	NULL
several	NULL
other	NULL
neoplasms	NULL
.	NULL

Further	NULL
analysis	NULL
will	NULL
determine	NULL
whether	NULL
the	NULL
ERP	NULL
gene	NULL
is	NULL
involved	NULL
in	NULL
translocations	NULL
of	NULL
chromosome	NULL
12	NULL
and	NULL
whether	NULL
ERP	NULL
may	NULL
act	NULL
as	NULL
an	NULL
oncogene	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
established	NULL
ERP	NULL
as	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
with	NULL
significant	NULL
sequence	NULL
homology	NULL
to	NULL
SAP-1	NULL
and	NULL
ELK-1	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
ERP	NULL
is	NULL
developmentally	NULL
regulated	NULL
during	NULL
B-cell	NULL
and	NULL
possibly	NULL
teratocarcinoma	NULL
differentiation	NULL
.	NULL

Since	NULL
ERP	NULL
is	NULL
expressed	NULL
in	NULL
several	NULL
different	NULL
tissues	NULL
and	NULL
cell	NULL
types	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
ERP	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
a	NULL
whole	NULL
set	NULL
of	NULL
genes	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
ERP	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
pre-B	NULL
cells	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
IgH	NULL
r	NULL
site	NULL
,	NULL
and	NULL
is	NULL
downregulated	NULL
upon	NULL
B-cell	NULL
maturation	NULL
warrants	NULL
further	NULL
studies	NULL
as	NULL
to	NULL
its	NULL
involvement	NULL
in	NULL
B-cell	NULL
differentiation	NULL
and	NULL
gene	NULL
regulation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Lori	NULL
Wirth	NULL
for	NULL
help	NULL
in	NULL
DNA	NULL
sequencing	NULL
and	NULL
Dave	NULL
Gonzalez	NULL
for	NULL
synthesis	NULL
of	NULL
the	NULL
oligonucleotides	NULL
.	NULL

We	NULL
acknowledge	NULL
fruitful	NULL
discussions	NULL
with	NULL
T.	NULL
B.	NULL
Strom	NULL
,	NULL
R.	NULL
Kapeller	NULL
,	NULL
and	NULL
K.	NULL
LeClair	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grant	NULL
AVCA33211-01	NULL
ALY	NULL
to	NULL
TAL	NULL
.	NULL

M.L	NULL
.	NULL

and	NULL
P.O	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aharon	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Schneider	NULL
,	NULL
1993	NULL
.	NULL

Selective	NULL
destabilization	NULL
of	NULL
short-lived	NULL
mRNAs	NULL
with	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
AU-rich	NULL
3	NULL
'	NULL
noncoding	NULL
region	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
cotranslational	NULL
mechanism	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1971-1980	NULL
.	NULL

2	NULL
.	NULL

Akbarali	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
P.	NULL
Octtgen	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Libermann	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

3	NULL
.	NULL

Alvarez	NULL
,	NULL
E.	NULL
,	NULL
I.	NULL
C.	NULL
Northwood	NULL
,	NULL
F.	NULL
A.	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
Latour	NULL
,	NULL
A.	NULL
Seth	NULL
,	NULL
C.	NULL
Abate	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1991	NULL
.	NULL

Pro-Leu-Ser/	NULL
Thr-Pro	NULL
is	NULL
a	NULL
consensus	NULL
for	NULL
substrate	NULL
protein	NULL
phosphorylation	NULL
:	NULL
characterization	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
c-myc	NULL
and	NULL
c-jun	NULL
proteins	NULL
by	NULL
an	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
threonine	NULL
669	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:15277-15285	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

5	NULL
.	NULL

Bauer	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
A.	NULL
Kudo	NULL
,	NULL
and	NULL
F.	NULL
Melchers	NULL
.	NULL

1988	NULL
.	NULL

Structure	NULL
and	NULL
pre-B	NULL
lymphocyte	NULL
restricted	NULL
expression	NULL
of	NULL
the	NULL
VpreB	NULL
in	NULL
humans	NULL
and	NULL
conservation	NULL
of	NULL
its	NULL
structure	NULL
in	NULL
other	NULL
mammalian	NULL
species	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:111-116	NULL
.	NULL

6	NULL
.	NULL

Belto	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
N.	NULL
Salagnon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Rey	NULL
,	NULL
M.	NULL
R.	NULL
Guichaoua	NULL
,	NULL
L.	NULL
J.	NULL
Berge	NULL
,	NULL
B.	NULL
R.	NULL
Jordan	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Luciani	NULL
.	NULL

1989	NULL
.	NULL

Precise	NULL
in	NULL
situ	NULL
localization	NULL
of	NULL
NCAM	NULL
,	NULL
ETS1	NULL
,	NULL
and	NULL
D11829	NULL
on	NULL
human	NULL
meiotic	NULL
chromosomes	NULL
.	NULL

Cytogenet	NULL
.	NULL

Cell	NULL
Genet	NULL
.	NULL

52:7-10	NULL
.	NULL

7	NULL
.	NULL

Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1988	NULL
.	NULL

Immunoglobulin	NULL
genes	NULL
.	NULL

p.	NULL
1-60	NULL
.	NULL

In	NULL
B.	NULL
D.	NULL
Haynes	NULL
and	NULL
D.	NULL
M.	NULL
Glover	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Molecular	NULL
immunology	NULL
.	NULL

IRL	NULL
Press	NULL
,	NULL
Washington	NULL
,	NULL
D.C.	NULL
8	NULL
.	NULL

Boulukos	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
P.	NULL
Pognonec	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
F.	NULL
Galibert	NULL
,	NULL
J.	NULL
C.	NULL
Gesquiere	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
in	NULL
chickens	NULL
of	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
cellular	NULL
Ets-2	NULL
gene	NULL
(	NULL
c-Ets-2	NULL
)	NULL
encoding	NULL
nuclear	NULL
proteins	NULL
related	NULL
to	NULL
the	NULL
products	NULL
of	NULL
the	NULL
c-ets	NULL
proto-oncogene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:697-705	NULL
.	NULL

9	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
L.	NULL
H.	NULL
Defize	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
J.	NULL
R.	NULL
Woodgett	NULL
,	NULL
M.	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

ERP	NULL
.	NULL

A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
ets	NULL
FAMILY	NULL
3307	NULL
Karin	NULL
,	NULL
and	NULL
T.	NULL
Hunter	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
decreases	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
at	NULL
sites	NULL
that	NULL
negatively	NULL
regulate	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Cell	NULL
64:573-584.	NULL
.	NULL

Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1992	NULL
.	NULL

Specificities	NULL
of	NULL
protein	NULL
protein	NULL
and	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
GABPa	NULL
and	NULL
two	NULL
newly	NULL
defined	NULL
ets	NULL
related	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2502-2512.	NULL
.	NULL

Burtis	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
C.	NULL
W.	NULL
Jones	NULL
,	NULL
F.	NULL
D.	NULL
Karim	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Hogness	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Drosophila	NULL
74EF	NULL
early	NULL
puff	NULL
contains	NULL
E74	NULL
,	NULL
a	NULL
complex	NULL
ecdysone-inducible	NULL
gene	NULL
that	NULL
encodes	NULL
two	NULL
ets	NULL
related	NULL
proteins	NULL
.	NULL

Cell	NULL
61:85-99.	NULL
.	NULL

Chen	NULL
,	NULL
J.	NULL
H.	NULL
1990	NULL
.	NULL

Cloning	NULL
,	NULL
sequencing	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
mouse	NULL
c-ets-1	NULL
cDNA	NULL
in	NULL
baculovirus	NULL
expression	NULL
system	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

5:277-285.	NULL
.	NULL

Chen	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Bunting	NULL
,	NULL
F.	NULL
D.	NULL
Karim	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Thummel	NULL
.	NULL

1992	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
five	NULL
Drosophila	NULL
genes	NULL
that	NULL
encode	NULL
an	NULL
ets	NULL
related	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

151:176-191.	NULL
.	NULL

Dalton	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
SAP-1	NULL
,	NULL
a	NULL
protein	NULL
recruited	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
68:597-612.	NULL
.	NULL

Dariavach	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
K.	NULL
Campbell	NULL
,	NULL
S.	NULL
Pettersson	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Neuberger	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
mouse	NULL
IgH	NULL
3'-enhancer	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:1499-1504.	NULL
.	NULL

Delattre	NULL
,	NULL
O.	NULL
,	NULL
J.	NULL
Zucman	NULL
,	NULL
B.	NULL
Plougastel	NULL
,	NULL
C.	NULL
Desmaze	NULL
,	NULL
T.	NULL
Melot	NULL
,	NULL
M.	NULL
Peter	NULL
,	NULL
H.	NULL
Kovar	NULL
,	NULL
I.	NULL
Joubert	NULL
,	NULL
P.	NULL
de	NULL
Jong	NULL
,	NULL
G.	NULL
Rouleau	NULL
,	NULL
A.	NULL
Aurias	NULL
,	NULL
and	NULL
G.	NULL
Thomas	NULL
.	NULL

1992	NULL
.	NULL

Gene	NULL
fusion	NULL
with	NULL
an	NULL
ETS	NULL
DNA-binding	NULL
domain	NULL
caused	NULL
by	NULL
chromosome	NULL
translocation	NULL
in	NULL
human	NULL
tumours	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
359	NULL
:	NULL
162-165.	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

1M1:1475-1489.	NULL
.	NULL

Feldhaus	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
D.	NULL
Mbangkollo	NULL
,	NULL
K.	NULL
L.	NULL
Arvin	NULL
,	NULL
C.	NULL
A.	NULL
Klug	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1992	NULL
.	NULL

BLyF	NULL
,	NULL
a	NULL
novel	NULL
cell-type-	NULL
and	NULL
stage-specific	NULL
regulator	NULL
of	NULL
the	NULL
B-lymphocyte	NULL
gene	NULL
mb-/	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1126-1133.	NULL
.	NULL

Fisher	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Cambier	NULL
.	NULL

1991	NULL
.	NULL

Ligation	NULL
of	NULL
membrane	NULL
Ig	NULL
leads	NULL
to	NULL
calcium-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
proto-oncogene	NULL
product	NULL
,	NULL
Ets-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1743-1749	NULL
.	NULL

Gegonne	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Punyammalee	NULL
,	NULL
B.	NULL
Rabault	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
S.	NULL
Seneca	NULL
,	NULL
M.	NULL
Crabeel	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
Etsl	NULL
oncoprotein	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

4:512-519	NULL
.	NULL

Gitlin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1991	NULL
.	NULL

Sequence-specific	NULL
interaction	NULL
of	NULL
the	NULL
Ets	NULL
!	NULL

protein	NULL
with	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I.	NULL
J.	NULL
Virol	NULL
.	NULL

65:5513-5523	NULL
.	NULL

Grant	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
V.	NULL
Arulampalam	NULL
,	NULL
R.	NULL
L.	NULL
Ahrlund	NULL
,	NULL
and	NULL
S.	NULL
Pettersson	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
Ets-like	NULL
lymphoid	NULL
specific	NULL
elements	NULL
within	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
3	NULL
'	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:4401-4408	NULL
.	NULL

Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
R.	NULL
S.	NULL
Bryner	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
ets-1	NULL
defines	NULL
a	NULL
transcriptional	NULL
activator	NULL
sequence	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:667-679	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
inhibitory	NULL
carboxyl-terminal	NULL
domain	NULL
in	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
mediates	NULL
differential	NULL
binding	NULL
of	NULL
ETS	NULL
family	NULL
factors	NULL
to	NULL
promoter	NULL
sequences	NULL
of	NULL
the	NULL
mb-1	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8889-8893	NULL
.	NULL

Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
C.	NULL
G.	NULL
Mueller	NULL
,	NULL
E.	NULL
S.	NULL
Reddy	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1991	NULL
.	NULL

Ets	NULL
related	NULL
protein	NULL
Elk-1	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
c-fos	NULL
regulatory	NULL
factor	NULL
p62TCF	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
354:531-534	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
L.	NULL
R.	NULL
Gottschalk	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
human	NULL
Ets-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
gene	NULL
enhancer	NULL
.	NULL

Science	NULL
250:8	NULL
14-818	NULL
.	NULL

Holmes	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
W.	NULL
F.	NULL
Davidson	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Morse	NULL
.	NULL

1986	NULL
.	NULL

Murine	NULL
hematopoietic	NULL
cells	NULL
with	NULL
pre-B	NULL
or	NULL
pre-B/myeloid	NULL
characteristics	NULL
are	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
transformation	NULL
with	NULL
retroviruses	NULL
containing	NULL
fes	NULL
,	NULL
ras	NULL
,	NULL
abl	NULL
,	NULL
and	NULL
src	NULL
oncogenes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164:443-457	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1992	NULL
.	NULL

Elk-1	NULL
protein	NULL
domains	NULL
required	NULL
for	NULL
direct	NULL
and	NULL
SRF-assisted	NULL
DNA-binding	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:3317-3324	NULL
.	NULL

Kemp	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Pearson	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
recognition	NULL
3308	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

LOPEZ	NULL
ET	NULL
AL	NULL
.	NULL

sequence	NULL
motifs	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

15:342-346	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
T.	NULL
Papayannopoulou	NULL
,	NULL
J.	NULL
Moore	NULL
,	NULL
and	NULL
R.	NULL
Hromas	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
ets	NULL
oncogene	NULL
family	NULL
member	NULL
,	NULL
fli-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:5769-5773	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
B.	NULL
C.	NULL
Van	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113-124	NULL
.	NULL

Korsmeyer	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

Chromosomal	NULL
translocations	NULL
in	NULL
lymphoid	NULL
malignancies	NULL
reveal	NULL
novel	NULL
proto-oncogenes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:785-807	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
1987	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
5'-noncoding	NULL
sequences	NULL
from	NULL
699	NULL
vertebrate	NULL
messenger	NULL
RNAs	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:8125-8148	NULL
.	NULL

Kudo	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Sakaguchi	NULL
,	NULL
and	NULL
F.	NULL
Melchers	NULL
.	NULL

1987	NULL
.	NULL

Organization	NULL
of	NULL
the	NULL
murine	NULL
Ig	NULL
related	NULL
lambda	NULL
5	NULL
gene	NULL
transcribed	NULL
selectively	NULL
in	NULL
pre-B	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:103-107	NULL
.	NULL

Kuenzel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Mulligan	NULL
,	NULL
J.	NULL
Sommercorn	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Krebs	NULL
.	NULL

1987	NULL
.	NULL

Substrate	NULL
specificity	NULL
determinants	NULL
for	NULL
casein	NULL
kinase	NULL
II	NULL
as	NULL
deduced	NULL
from	NULL
studies	NULL
with	NULL
synthetic	NULL
peptides	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:9136-9140	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
227:680-685	NULL
.	NULL

Lai	NULL
,	NULL
Z.	NULL
C.	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Rubin	NULL
.	NULL

1992	NULL
.	NULL

Negative	NULL
control	NULL
of	NULL
photore-ceptor	NULL
development	NULL
in	NULL
Drosophila	NULL
by	NULL
the	NULL
product	NULL
of	NULL
the	NULL
yan	NULL
gene	NULL
,	NULL
an	NULL
ETS	NULL
domain	NULL
protein	NULL
.	NULL

Cell	NULL
70:609-620	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
C.	NULL
Thompson	NULL
,	NULL
B.	NULL
P.	NULL
Byers	NULL
,	NULL
E.	NULL
M.	NULL
Walton	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
Ets~	NULL
and	NULL
notch	NULL
related	NULL
subunits	NULL
in	NULL
GA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
253:789-792	NULL
.	NULL

Leduc	NULL
,	NULL
I.	NULL
,	NULL
J.	NULL
L.	NULL
Preud'homme	NULL
,	NULL
and	NULL
M.	NULL
Cogne	NULL
.	NULL

1992	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mb-1	NULL
transcript	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

90:141-146	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
during	NULL
T-cell	NULL
development	NULL
:	NULL
the	NULL
alpha	NULL
TCR	NULL
gene	NULL
as	NULL
a	NULL
molecular	NULL
model	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:22-30	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
,	NULL
Elf-1	NULL
,	NULL
binds	NULL
to	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
regulatory	NULL
elements	NULL
that	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
frans	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5890-5897	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Protein-binding	NULL
sites	NULL
in	NULL
Ig	NULL
gene	NULL
enhancers	NULL
determine	NULL
transcriptional	NULL
activity	NULL
and	NULL
inducibility	NULL
.	NULL

Science	NULL
236:1573-1577	NULL
.	NULL

Leprince	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
C.	NULL
Gesquiere	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
chicken	NULL
cellular	NULL
progenitor	NULL
of	NULL
the	NULL
v-ets	NULL
oncogene	NULL
,	NULL
p68c-ets-1	NULL
,	NULL
is	NULL
a	NULL
nuclear	NULL
DNA-binding	NULL
protein	NULL
not	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
of	NULL
the	NULL
spleen	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

5:255-265	NULL
.	NULL

Leung	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
McCracken	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
N.	NULL
G.	NULL
Miyamoto	NULL
.	NULL

1993	NULL
.	NULL

Requirement	NULL
of	NULL
an	NULL
ETS-binding	NULL
element	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
Ick	NULL
type	NULL
I	NULL
promoter	NULL
.	NULL

Oncogene	NULL
8:989-997	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
inter-leukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327-2334	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Aspects	NULL
Cell	NULL
.	NULL

Regul	NULL
.	NULL

6:399-421	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993.	NULL
,	NULL
a	NULL
pre-	NULL
B-cell-specific	NULL
enhancer	NULL
element	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5957-5969	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
R.	NULL
Friesel	NULL
,	NULL
M.	NULL
Jaye	NULL
,	NULL
R.	NULL
M.	NULL
Lyall	NULL
,	NULL
B.	NULL
Wester-mark	NULL
,	NULL
W.	NULL
Drohan	NULL
,	NULL
A.	NULL
Schmidt	NULL
,	NULL
T.	NULL
Maciag	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
angiogenic	NULL
growth	NULL
factor	NULL
is	NULL
expressed	NULL
in	NULL
human	NULL
glioma	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:1627-1632	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
second	NULL
lymphoid-specific	NULL
enhancer	NULL
element	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3155-3162	NULL
.	NULL

Licht	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
M.	NULL
J.	NULL
Grossel	NULL
,	NULL
J.	NULL
Figge	NULL
,	NULL
and	NULL
U.	NULL
M.	NULL
Hansen	NULL
.	NULL

1990	NULL
.	NULL

Drosophila	NULL
Kruppel	NULL
protein	NULL
is	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:76-79	NULL
.	NULL

Lieberson	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
L.	NULL
Giannini	NULL
,	NULL
B.	NULL
K.	NULL
Birshtein	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Eckhardt	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
enhancer	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
locus	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:933-937	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

Mor	NULL
.	NULL

CEL	NULL
.	NULL

BioL	NULL
.	NULL

Lim	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Kraut	NULL
,	NULL
J.	NULL
Framptom	NULL
,	NULL
and	NULL
T.	NULL
Graf	NULL
.	NULL

1992	NULL
.	NULL

DNA	NULL
binding	NULL
by	NULL
c-Ets-1	NULL
,	NULL
but	NULL
not	NULL
v-Ets	NULL
,	NULL
is	NULL
repressed	NULL
by	NULL
an	NULL
intramolecular	NULL
mechanism	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:643-652	NULL
.	NULL

Lo	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
R.	NULL
Landau	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Smale	NULL
.	NULL

1991	NULL
.	NULL

LyF-1	NULL
,	NULL
a	NULL
transcriptional	NULL
regulator	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
promoters	NULL
for	NULL
lymphocyte-specific	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5229-5243	NULL
.	NULL

Luscher	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Christenson	NULL
,	NULL
D.	NULL
W.	NULL
Litchfield	NULL
,	NULL
E.	NULL
G.	NULL
Krebs	NULL
,	NULL
and	NULL
R.	NULL
N.	NULL
Eisenman	NULL
.	NULL

1990	NULL
.	NULL

Myb	NULL
DNA	NULL
binding	NULL
inhibited	NULL
by	NULL
phosphorylation	NULL
at	NULL
a	NULL
site	NULL
deleted	NULL
during	NULL
oncogenic	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:517-522	NULL
.	NULL

Macleod	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:251-256	NULL
.	NULL

Marais	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
SRF	NULL
accessory	NULL
protein	NULL
Elk-1	NULL
contains	NULL
a	NULL
growth	NULL
factor-regulated	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
73:381-393	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
J.	NULL
Smith	NULL
,	NULL
J.	NULL
Hilfinger	NULL
,	NULL
M.	NULL
C.	NULL
Hannibal	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
is	NULL
dependent	NULL
on	NULL
purine	NULL
box	NULL
and	NULL
x	NULL
B	NULL
regulatory	NULL
elements	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5479-5484	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
T.	NULL
Kadesch	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1990	NULL
.	NULL

Complex	NULL
regulation	NULL
of	NULL
the	NULL
immunoglobulin	NULL
p	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
:	NULL
mB	NULL
,	NULL
a	NULL
new	NULL
determinant	NULL
of	NULL
enhancer	NULL
function	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3145-3154	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
G.	NULL
Tian	NULL
,	NULL
B.	NULL
Erman	NULL
,	NULL
J.	NULL
Gregoire	NULL
,	NULL
R.	NULL
Maki	NULL
,	NULL
B.	NULL
Graves	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1993	NULL
.	NULL

Regulation	NULL
of	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
mu	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
by	NULL
ETS-domain	NULL
proteins	NULL
.	NULL

Science	NULL
261:82-86	NULL
.	NULL

Nerlov	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Rorth	NULL
,	NULL
F.	NULL
Blasi	NULL
,	NULL
and	NULL
M.	NULL
Johnsen	NULL
.	NULL

1991	NULL
.	NULL

Essential	NULL
AP-1	NULL
and	NULL
PEA3	NULL
binding	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
urokinase	NULL
enhancer	NULL
display	NULL
cell	NULL
type-specific	NULL
activity	NULL
.	NULL

Oncogene	NULL
6:1583-1592	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Petersen	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
ets-1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:975-990	NULL
.	NULL

Octtgen	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Y.	NULL
Akbarali	NULL
,	NULL
L.	NULL
Binder	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Libermann	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Okamoto	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Okazawa	NULL
,	NULL
A.	NULL
Okuda	NULL
,	NULL
M.	NULL
Sakai	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
and	NULL
H.	NULL
Hamada	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
octamer	NULL
binding	NULL
transcription	NULL
factor	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
mouse	NULL
embryonic	NULL
cells	NULL
.	NULL

Cell	NULL
60:461-472	NULL
.	NULL

Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
S.	NULL
Nagulapalli	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Atchison	NULL
.	NULL

1992	NULL
.	NULL

PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
k	NULL
3	NULL
'	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:368-378	NULL
.	NULL

Prasad	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Reddy	NULL
.	NULL

1992	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
human	NULL
Fli-1	NULL
gene	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

52:5833-5837	NULL
.	NULL

Pribyl	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
D.	NULL
K.	NULL
Watson	NULL
,	NULL
R.	NULL
A.	NULL
Schulz	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1991	NULL
.	NULL

D-elg	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Drosophila	NULL
ets	NULL
gene	NULL
family	NULL
:	NULL
sequence	NULL
,	NULL
expression	NULL
and	NULL
evolutionary	NULL
comparison	NULL
.	NULL

Oncogene	NULL
6:1175-1183	NULL
.	NULL

Raney	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
A.	NULL
J.	NULL
Easton	NULL
,	NULL
D.	NULL
R.	NULL
Milich	NULL
,	NULL
and	NULL
A.	NULL
McLachlan	NULL
.	NULL

1991	NULL
.	NULL

Promoter-specific	NULL
transactivation	NULL
of	NULL
hepatitis	NULL
B	NULL
virus	NULL
transcription	NULL
by	NULL
a	NULL
glutamine	NULL
and	NULL
proline-rich	NULL
domain	NULL
of	NULL
hepatocyte	NULL
nuclear	NULL
factor	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:5774-5781	NULL
.	NULL

Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
K.	NULL
Huebner	NULL
,	NULL
M.	NULL
Isobe	NULL
,	NULL
A.	NULL
ar-Rushdi	NULL
,	NULL
C.	NULL
M.	NULL
Croce	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Reddy	NULL
.	NULL

1989.	NULL
elk	NULL
,	NULL
tissue-specific	NULL
ets	NULL
related	NULL
genes	NULL
on	NULL
chromosomes	NULL
X	NULL
and	NULL
14	NULL
near	NULL
translocation	NULL
breakpoints	NULL
.	NULL

Science	NULL
244:66-70	NULL
.	NULL

Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
W.	NULL
S.	NULL
Modi	NULL
,	NULL
H.	NULL
D.	NULL
Drabkin	NULL
,	NULL
D.	NULL
Patterson	NULL
,	NULL
S.	NULL
J.	NULL
O'Brien	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Reddy	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
erg	NULL
gene	NULL
maps	NULL
to	NULL
chromosome	NULL
21	NULL
,	NULL
band	NULL
q22	NULL
:	NULL
relationship	NULL
to	NULL
the	NULL
8	NULL
;	NULL
21	NULL
translocation	NULL
of	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Oncogene	NULL
3:497-500	NULL
.	NULL

Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Reddy	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
divergent	NULL
ets	NULL
related	NULL
protein	NULL
,	NULL
elk-1	NULL
,	NULL
recognizes	NULL
similar	NULL
c-ets-1	NULL
proto-oncogene	NULL
target	NULL
sequences	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Oncogene	NULL
7:65-70	NULL
.	NULL

Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Reddy	NULL
.	NULL

1992.	NULL
elk-1	NULL
domains	NULL
responsible	NULL
for	NULL
autonomous	NULL
DNA	NULL
binding	NULL
,	NULL
SRE	NULL
:	NULL
SRF	NULL
interaction	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

Oncogene	NULL
7:2335-2340	NULL
.	NULL

Ray	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
Spi-B	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
putative	NULL
oncoprotein	NULL
Spi-1/PU.1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4297-4304	NULL
.	NULL

Raymond	NULL
,	NULL
V.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Atwater	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1989	NULL
.	NULL

Removal	NULL
of	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88.	NULL
an	NULL
mRNA	NULL
destabilizing	NULL
element	NULL
correlates	NULL
with	NULL
the	NULL
increased	NULL
oncogenicity	NULL
of	NULL
proto-oncogene	NULL
fos	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

5:1-12	NULL
.	NULL

Reddy	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
and	NULL
V.	NULL
N.	NULL
Rao	NULL
.	NULL

1988	NULL
.	NULL

Structure	NULL
,	NULL
expression	NULL
and	NULL
alternative	NULL
splicing	NULL
of	NULL
the	NULL
human	NULL
c-ets-1	NULL
proto-oncogene	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

3:239-246	NULL
.	NULL

Reddy	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
and	NULL
V.	NULL
N.	NULL
Rao	NULL
.	NULL

1991.	NULL
erg	NULL
,	NULL
an	NULL
ets-related	NULL
gene	NULL
,	NULL
codes	NULL
for	NULL
sequence-specific	NULL
transcriptional	NULL
activators	NULL
.	NULL

Oncogene	NULL
6	NULL
:	NULL
2285-2289	NULL
.	NULL

Reddy	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
erg	NULL
gene	NULL
:	NULL
a	NULL
human	NULL
gene	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:6131-6135	NULL
.	NULL

Richards	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
D.	NULL
H.	NULL
Katz	NULL
,	NULL
and	NULL
F.	NULL
T.	NULL
Liu	NULL
.	NULL

1991	NULL
.	NULL

Complete	NULL
genomic	NULL
sequence	NULL
of	NULL
the	NULL
murine	NULL
low	NULL
affinity	NULL
Fc	NULL
receptor	NULL
for	NULL
IgE	NULL
.	NULL

Demonstration	NULL
of	NULL
alternative	NULL
transcripts	NULL
and	NULL
conserved	NULL
sequence	NULL
elements	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:1067-1074	NULL
.	NULL

Riley	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
J.	NULL
K.	NULL
Morrow	NULL
,	NULL
M.	NULL
J.	NULL
Danton	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Coleman	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
terminal	NULL
deoxyribonucleotidyltransferase	NULL
:	NULL
molecular	NULL
cloning	NULL
and	NULL
structural	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
5Â°	NULL
flanking	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:2489-2493	NULL
.	NULL

Rimokh	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
P.	NULL
Rouault	NULL
,	NULL
K.	NULL
Wahbi	NULL
,	NULL
M.	NULL
Gadoux	NULL
,	NULL
M.	NULL
Lafage	NULL
,	NULL
E.	NULL
Archimbaud	NULL
,	NULL
C.	NULL
Charrin	NULL
,	NULL
O.	NULL
Gentilhomme	NULL
,	NULL
D.	NULL
Germain	NULL
,	NULL
J.	NULL
Samarut	NULL
,	NULL
et	NULL
al	NULL
,	NULL
1991	NULL
.	NULL

A	NULL
chromosome	NULL
12	NULL
coding	NULL
region	NULL
is	NULL
juxtaposed	NULL
to	NULL
the	NULL
MYC	NULL
protooncogene	NULL
locus	NULL
in	NULL
a	NULL
t	NULL
(	NULL
8	NULL
;	NULL
12	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q22	NULL
)	NULL
translocation	NULL
in	NULL
a	NULL
case	NULL
of	NULL
B-cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
.	NULL

Genes	NULL
Chromosomes	NULL
Cancer	NULL
3:24-36	NULL
.	NULL

Rivera	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
M.	NULL
H.	NULL
Stuiver	NULL
,	NULL
R.	NULL
Steenbergen	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1993	NULL
.	NULL

Ets	NULL
proteins	NULL
:	NULL
new	NULL
factors	NULL
that	NULL
regulate	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7163-7169	NULL
.	NULL

Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
F.	NULL
L.	NULL
Hail	NULL
,	NULL
D.	NULL
Warburton	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Pelech	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
Thr-669	NULL
phosphorylation	NULL
site	NULL
peptide	NULL
kinases	NULL
as	NULL
distinct	NULL
MAP	NULL
kinases	NULL
and	NULL
p34cdc2	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1135:335-342	NULL
.	NULL

Savant	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Cleveland	NULL
.	NULL

1992	NULL
.	NULL

Evidence	NULL
for	NULL
instability	NULL
of	NULL
mRNAs	NULL
containing	NULL
AUUUA	NULL
motifs	NULL
mediated	NULL
through	NULL
trans-lation-dependent	NULL
assembly	NULL
of	NULL
a	NULL
>	NULL
208	NULL
degradation	NULL
complex	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1927-1939	NULL
.	NULL

Schlissel	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
immunoglobulin	NULL
kappa	NULL
gene	NULL
rearrangement	NULL
correlates	NULL
with	NULL
induction	NULL
of	NULL
germline	NULL
kappa	NULL
gene	NULL
transcription	NULL
.	NULL

Cell	NULL
58:1001-1007.	NULL
.	NULL

Seipel	NULL
,	NULL
K.	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1992	NULL
.	NULL

Different	NULL
activation	NULL
domains	NULL
stimulate	NULL
transcription	NULL
from	NULL
remote	NULL
(	NULL
'enhanc-er	NULL
'	NULL
)	NULL
and	NULL
proximal	NULL
(	NULL
'promoter	NULL
'	NULL
)	NULL
positions	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:4961-4968	NULL
.	NULL

Seth	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
G.	NULL
J.	NULL
Mavrothalassitis	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

3:327-334	NULL
.	NULL

Shimizu	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Ichikawa	NULL
,	NULL
A.	NULL
Tojo	NULL
,	NULL
Y.	NULL
Kaneko	NULL
,	NULL
N.	NULL
Maseki	NULL
,	NULL
Y.	NULL
Hayashi	NULL
,	NULL
M.	NULL
Ohira	NULL
,	NULL
S.	NULL
Asano	NULL
,	NULL
and	NULL
M.	NULL
Ohki	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
ets-related	NULL
gene	NULL
,	NULL
ERG	NULL
,	NULL
is	NULL
rearranged	NULL
in	NULL
human	NULL
myeloid	NULL
leukemia	NULL
with	NULL
t	NULL
(	NULL
16	NULL
;	NULL
21	NULL
)	NULL
chromosomal	NULL
translocation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10280-10284	NULL
.	NULL

Solomon	NULL
,	NULL
E.	NULL
,	NULL
J	NULL
.	NULL

Borrow	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Goddard	NULL
.	NULL

1991	NULL
.	NULL

Chromosome	NULL
aberrations	NULL
and	NULL
cancer	NULL
.	NULL

Science	NULL
254	NULL
;	NULL
1153-1160	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-Acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets	NULL
89	NULL
.	NULL

91	NULL
.	NULL

92	NULL
.	NULL

93	NULL
.	NULL

94	NULL
.	NULL

95	NULL
.	NULL

96	NULL
.	NULL

97	NULL
.	NULL

98	NULL
.	NULL

99	NULL
.	NULL

100	NULL
.	NULL

101	NULL
.	NULL

102	NULL
.	NULL

103	NULL
.	NULL

ERP	NULL
,	NULL
A	NULL
NEW	NULL
MEMBER	NULL
OF	NULL
THE	NULL
eis	NULL
FAMILY	NULL
3309	NULL
related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Convergence	NULL
of	NULL
Ets-and	NULL
notch	NULL
related	NULL
structural	NULL
motifs	NULL
in	NULL
a	NULL
heteromeric	NULL
DNA	NULL
binding	NULL
complex	NULL
.	NULL

Science	NULL
253:762-768.	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Marais	NULL
,	NULL
and	NULL
J.	NULL
Wynne	NULL
.	NULL

1992	NULL
.	NULL

Spatial	NULL
flexibility	NULL
in	NULL
ternary	NULL
complexes	NULL
between	NULL
SRF	NULL
and	NULL
its	NULL
accessory	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:4631-4640	NULL
.	NULL

Urness	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Thummel	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
interactions	NULL
within	NULL
the	NULL
ecdysone	NULL
regulatory	NULL
hierarchy	NULL
:	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
Drosophila	NULL
ecdysone-inducible	NULL
E74A	NULL
protein	NULL
.	NULL

Cell	NULL
63:47-61	NULL
.	NULL

Varticovski	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
B.	NULL
Chahwala	NULL
,	NULL
M.	NULL
Whitman	NULL
,	NULL
L.	NULL
Cantley	NULL
,	NULL
D.	NULL
Schindler	NULL
,	NULL
E.	NULL
P.	NULL
Chow	NULL
,	NULL
L.	NULL
K.	NULL
Sinclair	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Pepinsky	NULL
.	NULL

1988	NULL
.	NULL

Location	NULL
of	NULL
sites	NULL
in	NULL
human	NULL
lipocortin	NULL
I	NULL
that	NULL
are	NULL
phosphorylated	NULL
by	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
and	NULL
protein	NULL
kinases	NULL
A	NULL
and	NULL
C.	NULL
Biochemistry	NULL
27:3682-3690	NULL
.	NULL

Visvader	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Begley	NULL
.	NULL

1991	NULL
.	NULL

Helix-loop-helix	NULL
genes	NULL
translocated	NULL
in	NULL
lymphoid	NULL
leukemia	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16:330-333	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1391-1399	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
P.	NULL
Flores	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
c-ets	NULL
proto-oncogenes	NULL
encode	NULL
transcription	NULL
factors	NULL
that	NULL
cooperate	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:191-193	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Gutman	NULL
,	NULL
R.	NULL
Nicholson	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
c-Ets	NULL
oncoprotein	NULL
activates	NULL
the	NULL
stromelysin	NULL
promoter	NULL
through	NULL
the	NULL
same	NULL
elements	NULL
as	NULL
several	NULL
nonnuclear	NULL
oncoproteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1127-1134	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
P.	NULL
Kerckaert	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
modulator	NULL
domain	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:965-974	NULL
.	NULL

Watanabe	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Sawada	NULL
,	NULL
K.	NULL
Yano	NULL
,	NULL
K.	NULL
Yamaguchi	NULL
,	NULL
M.	NULL
Goto	NULL
,	NULL
and	NULL
H.	NULL
Handa	NULL
.	NULL

1993.	NULL
cDNA	NULL
cloning	NULL
of	NULL
transcription	NULL
factor	NULL
E4TF1	NULL
subunits	NULL
with	NULL
Ets	NULL
and	NULL
notch	NULL
motifs	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1385-1391	NULL
.	NULL

Watson	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
M.	NULL
J.	NULL
McWilliams	NULL
,	NULL
P.	NULL
Lapis	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lautenberger	NULL
,	NULL
C.	NULL
W.	NULL
Schweinfest	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1988	NULL
.	NULL

Mammalian	NULL
ets-1	NULL
and	NULL
ets-2	NULL
genes	NULL
encode	NULL
highly	NULL
conserved	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7862-7866	NULL
.	NULL

Watson	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
N.	NULL
Sacchi	NULL
,	NULL
S.	NULL
M.	NULL
McWilliams	NULL
,	NULL
S.	NULL
J.	NULL
O'Brien	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
avian	NULL
and	NULL
mammalian	NULL
ets	NULL
genes	NULL
:	NULL
molecular	NULL
characterization	NULL
,	NULL
chromosome	NULL
mapping	NULL
,	NULL
and	NULL
implication	NULL
in	NULL
human	NULL
leukemia	NULL
.	NULL

Anticancer	NULL
Res	NULL
.	NULL

6:631-636	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1991	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
human	NULL
transcription	NULL
factor	NULL
AP-2	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:670-682	NULL
.	NULL

Woods	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
,	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
nucleotide	NULL
preferences	NULL
in	NULL
DNA	NULL
sequences	NULL
recognised	NULL
specifically	NULL
by	NULL
c-Ets-1	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
;	NULL
699-704	NULL
.	NULL

Xin	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
A.	NULL
Cowie	NULL
,	NULL
P.	NULL
Lachance	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hassell	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PEA3	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
oncogene	NULL
family	NULL
that	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
mouse	NULL
embryonic	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:481-496	NULL
.	NULL

